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QUILL ON SCALPEL This section 
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
C.J.S. —  A REAPPRAISAL
The Canadian Journal of Surgery 
began publication in October 1957 with 
the important financial aid and editorial 
services o f the Canadian Medical As­
sociation. Robert M. Janes, the first 
Chairman o f the Editorial Board, along 
with many other Canadian surgeons, 
had long dreamed of a Canadian journal 
o f surgery. Despite suggestions at the 
time that there were enough journals 
and not sufficient publishable material, 
Janes and the Editorial Board, which 
consisted of the Chairmen of the De­
partments of Surgery in the Canadian 
universities, went ahead. They formed 
an excellent journal and, in subsequent 
years under the leadership of Frederick 
Kergin, nurtured it for very good reas­
ons. A country of over 20 million people 
and 16 medical schools should have a 
surgical journal. Furthermore, a suc­
cessful journal is very tangible evidence 
o f surgical vigour. It is our responsibil­
ity to communicate as Canadians on is­
sues of surgical interest.
Over the years the Journal has re­
flected that aspect of surgery we do best 
— clinical practice. A larger proportion 
o f operations is performed by qualified 
surgeons in Canada than in many coun­
tries including the United States. The 
overall result of surgical care in Canada 
rates high and is reflected in the pub­
lications which have emphasized deliv­
ery o f care and direct results.
The best surgical research work in 
Canada has not always appeared in the 
Journal, perhaps because of the smaller 
circulation when compared to American 
publications. The total circulation o f the 
Canadian Journal of Surgery has re­
mained stable at around 1500 for the
past 10 years. The Journal issued four 
publications a year from 1957 to 1970 
and six publications a year since 1971. 
Approximately 25% of manuscripts are 
rejected. In comparison the journal Sur­
gery has a circulation o f approximately 
10,000 and a rejection rate o f 90% .
The revenue o f the Canadian Journal 
of Surgery is a point o f interest and 
concern to us, as well as to the Canadian 
Medical Association. Advertising reve­
nue, which decreased between 1968 and 
1970 to about one-half but now appears 
to be holding steady, accounts for be­
tween 65% and 70%' o f the Journal’s 
total income. This decrease in advertis­
ing revenue has affected many journals 
throughout the world. One factor is the 
publication of journals which are cir­
culated to all surgeons free o f charge. 
The advertisers reason they are reach­
ing a wider audience in these publica­
tions of wider distribution. Over the 
past two years the Canadian Journal of 
Surgery has lost approximately $10,000 
per year.
Before suggesting changes that might 
be indicated at this time in Journal pol­
icies let us look at those features which 
should be preserved. The format with­
out interspersed advertising should be 
retained and, in the opinion of the Edi­
torial Board, the sections, History of 
Surgery, Review Articles and Quill on 
Scalpel should be maintained and 
strengthened.
Several changes appear worthy of 
discussion at this time. Most surgical 
journals, which have succeeded, have a 
close liaison with at least one scien­
tific organization. All or a portion 
o f the scientific presentations at the 
meetings o f the scientific body are pub-
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lished in the affiliated journal and, in 
some instances, the annual dues include 
a subscription to the journal. Both the 
journal and the organization benefit in 
that the oral presentation is likely to be 
more carefully prepared and docu­
mented and the journal receives mate­
rial which has passed the competition of 
selection for the scientific meeting. The 
several Canadian surgical specialty 
societies have been asked to consider 
publication in the Canadian Journal of 
Surgery of some or all of the scientific 
material presented at their annual meet­
ings. Consideration is likewise being 
given to the publication of papers of 
surgical interest delivered at the annual 
meeting of the Royal College of Phy­
sicians and Surgeons of Canada.
In Canada, sponsorship of the Jour­
nal would best come from the Royal Col­
lege of Physicians and Surgeons of Can­
ada. It is a national organization, the 
interests of which are delivery of the 
best surgical care, academic excellence, 
the training of surgeons, and the evalu­
ation of the surgical needs of the coun­
try. The Canadian Journal of Surgery 
could play an important role in accom­
plishing these goals.
It appears, then, more appropriate 
that the Journal be published by the 
Royal College than by the Canadian 
Medical Association. An alternative sug­
gested recently by Dr. J. D. Wallace, 
General Secretary of the Canadian Med­
ical Association was that an indepen­
dent publishing firm might do the job 
for all health associations in the coun­
try.
Another innovation that we would 
like to encourage at this time is Canada­
wide prospective clinical trials arranged 
to shed light on major surgical prob­
lems. These are difficult undertakings, 
but desperately needed and of interest 
to the Medical Research Council— an 
arena in which Canadian surgeons have 
not competed with great success.
The Journal should be a vehicle for 
prompt publication of surgical research. 
Hopefully much of this would be pre­
sented at the annual or regional meet­
ings of the Royal College.
The Canadian Journal of Surgery has 
had a distinguished career to date and 
there is great promise for the future but 
for financial, academic and even na­
tional reasons the Journal needs greater 
support from the surgeons of Canada, 
and from their principal academic socie­
ty— The Royal College of Physicians 
and Surgeons. The newly appointed co­
editors, Lloyd D. MacLean and C. Bar­
ber Mueller, will work to these ends.
L. D. MacLean
EDITOR PRO AUTHOR
“ I expect the editor to accept all my 
papers, accept them as they are submit­
ted, and publish them promptly. I also 
expect him to scrutinize all other papers 
with the utmost care, especially those 
of my competitors.” Thus began Earl 
H. Wood, Department of Physiology 
and Biophysics, Mayo Clinic, contribu­
ting to the panel “ What the Author Ex­
pects From the Editor” . This panel, the 
first on the program of the recent 16th 
Annual Conference of the Council of 
Biology Editors (CBE), offered a uni­
que opportunity to see and hear the 
various kinds of editor interacting with 
both users and producers of scientific 
information. Dr. Wood spoke from a 
long experience in science and scientific 
writing and against a background in 
which physicians and scientists have 
continuous contact with experienced 
“ in-house” editors. For his part, he said, 
he had the responsibility to make his 
papers readable, understandable, and 
short.
It must be emphasized that none in 
the scientific community is uniquely or 
solely an editor, a reviewer, an author, 
or a reader. In our decisions about what 
to publish we face not a dichotomy, but 
a complex, almost baffling “quadricoto- 
my” —that between the scientist-writer, 
the reviewer-critic, the various grades 
of editor, and the target of all this ac­
tivity—the ultimate user.
Every author who contributed to this 
panel acknowledged the poor quality of
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much scientific writing. Joe R. Brown, 
neurologist, pointed out that each jour­
nal has its own standards and the 
author should find out what these are 
before he makes his submission. These 
standards should be consistently ap­
plied without fear or favour. “ Editorial 
policy,” he said, “ should be flexible and 
make room for the occasional unusual 
paper that does not conform to the tra­
ditional pattern.” However, he closed by 
saying that the editor should not meddle 
with the personal qualities of a paper, 
that he should avoid the temptation to 
uniformity and encourage individual 
variation. “ Changes in wording,” he 
said, “may change meaning. If my 
wording expresses a thought clearly, 
leave it alone!” However, here is the 
rub, “ clearly” by what criteria? How 
can an author be sure that what is clear 
to him is clear to all his readers? It is 
from this point that a new specialist 
class— the editor— evolved. Someone 
has to manage the complex processes by 
which the author’s first draft becomes 
clear, lucid, unambiguous, scientific 
prose and is distributed to readers all 
over the world.
The proliferation of scientific public­
ations since 1850 has, of course, in­
creased greatly the number of parti­
cipants in the editorial process. In the 
United States, more than in Canada, a 
distinction is drawn between editor-re- 
viewers, editors-in-chief and copy edi­
tors. In Canada the one man is likely to 
play all three of these roles. However, if 
he does he must, as he changes hats, 
change roles and keep clearly in mind 
the responsibilities appropriate to each 
role.
The principal work of the Depart­
ment of Biomedical Communications 
is to prepare for publication the 
work produced at the Mayo Clinic 
and to represent the author in his deal­
ings with the various journals and pub­
lishers. The author’s editor is thus an 
author’s advocate in his dealings with 
other editors. Dr. Bernard K. Forscher, 
a biochemist, described himself as “au­
thor-editor” rather than an “editor-edi­
tor” . “ The process of creation,” he said, 
“ is highly subjective. It’s so close to the 
soul that it’s almost too much to ask an 
author to be objective about his writ­
ing.” When challenged on this point, 
and asked if he would change “ style” 
in order to clarify meaning, Dr. 
Forscher said, “ If an author has style, 
I leave it alone.” By this he seemed to 
imply that very few scientific writers 
have written enough to achieve a dis­
tinctive style.
The author’s editor has the duty to 
get his author’s paper published when­
ever possible. The journal’s editor, or 
the “ editor’s editor” has the duty, or so 
he feels, to protect the reader-user from 
papers that need not, or should not, be 
published. When he has a paper that 
in his view, and in the view of the re­
viewers, should be published the editor- 
editor then has the duty to see that the 
paper is clear, accurate and readable be­
fore it goes to the printer.
In most cases the competent author 
and the skilled editor co-operate well to 
their mutual satisfaction. For his part, 
the experienced and conscientious au­
thor has presented his work in a form 
that needs relatively little editing. On 
his side, the experienced editor can 
make such clarifications as are needed 
without endangering the author’s mean­
ing. As one contributor to the CBE 
panel said, “ If you can’t change the sty­
le without changing the meaning, you 
are not an editor.” Furthermore, the 
editorial process has a series of checks 
and balances: many editors return an 
edited or fresh copy of the author’s text 
for his review before it goes to the 
printer. Most conscientious editors go to 
considerable lengths to protect the 
author’s content.
Many authors, particularly those who 
have never had an opportunity to go 
over their papers face-to-face with an 
editor, regard editing as not only imper­
tinent, but unnecessary— an invasion of 
personal rights that they resent inten­
sely. Indeed it is salutary for editors to 
be reminded at times how deep a wound 
a blue pencil can make inadvertently.
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Joe Brown described the syndrome of 
post-rejection depression seen in some 
authors. When he receives the editor’s 
reply with the reviewer’s critical com­
ments and a demand for revision he is 
first angry; he then ventilates to his 
peers or anyone else who will listen, and 
slowly simmers down. Eventually he is 
able to consider the merits of the re­
viewer’s points and gets himself ready 
for revision.
Much was said during this confer­
ence about the extreme difficulty of get­
ting good reviews. Indeed, it is a major 
responsibility of the editor to detect the 
bad review. Reviews may be bad be­
cause the reviewer is incompetent, su­
perficial, or generally negative. On the 
other hand he may be laudatory and 
inappropriately positive. If he is a com­
petitor, the reviewer may begin posi­
tively, gradually become negative and 
end by being “ vindictive” . The “etiol­
ogy” of the bad review goes something 
like this: the paper may have been sent 
to the wrong reviewer, that is, one who 
is not knowledgeable in the subject of 
the paper. It may have been sent to a 
slothful reviewer. The bad review may 
reflect angry reaction to a paper with 
good content but with infuriatingly bad 
presentation. The reviewer may have a 
conflict of interest, either because he is 
friendly with the author, has a bias 
against the author’s hypothesis or, un­
known to the editor, may be engaged 
in a silent vendetta with the author. 
Here, of course, the conscientious re­
viewer should declare his bias and ask 
to be excused. One panelist suggested 
that the editor might ask the author 
whom he wants to review his paper, or 
conversely ask him to say whom he does 
not want to review it. Furthermore, the 
editor should give the reviewer clear 
and limiting instructions. This is neces­
sary because many knowledgeable people 
have almost no understanding of the re­
viewer’s precise function. The editor 
should also encourage the reviewer to 
use consultants himself; if there are 
aspects of the paper with which he is 
unfamiliar or about which he cannot
make up his mind, he should feel free to 
seek other opinions.
Finally, the editor should encourage 
his authors to appeal against the deci­
sion of unfavourable reviewers. The 
even-handed administration of scienti­
fic judgment makes great demands upon 
the editor because often he is not the 
master of content (as his reviewers are 
purported to be), and, whereas the 
author has one or only a few papers to 
worry about, the editor has many under 
his view at any one time.
Franz Inglefinger, the distinguished 
gastroenterologist and Editor of the 
Neiv England Journal of Medicine, be­
lieves that the editor must do selective 
rewriting in order to keep things mov­
ing. He illustrated his point by discus­
sing the abstract— that “ lure set to at­
tract the reader” . The effective abstract 
must be substantive, quantitative and 
factual and, finally, it must cover the 
whole topic in 150 words. Many other­
wise competent people cannot follow the 
journal’s instructions with respect to 
the preparation of an abstract. Rather 
than hold up everything while corres­
pondence passes back and forth, Dr. In­
glefinger recasts the abstract in its pro­
per form and seeks the author’s ap­
proval later, usually at the galley stage.
The deliberations at this one-day con­
ference, which could have been shared 
profitably by every physician who 
writes for publication, might be sum­
marized in the following terms; The 
primary aim of all scientific writing is 
to convey something worth while to the 
user. The paper is the author’s but if he 
does not do his full duty to his readers 
the editor has the right, indeed the duty, 
to contribute. But editing is full of 
hazards, as is illustrated by the story of 
the computer that could not only edit 
but could translate. It was given the 
phrase “out of sight, out of mind” , to 
translate into Chinese and then back 
into English. When it had worked its 
magic, back came the answer, “ Invi­
sible, insane.”
J. 0. Godden
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REVIEW ARTICLE
HALOTHANE AND THE LIVER: A REVIEW OF THE EPIDEMIOLOGIC IMMUNOLOGIC AND METABOLIC ASPECTS OF THE RELATIONSHIP*
MICHAEL H. M. DYKES, M.A., M.B., B.Chir., JOHN P. GILBERT MS Ph n  PETER H. SCHUR, S.B., M.D. and ELLIS N. COHEN M.D ’ ’Boston, Mass., U.S.A.
“Epidemiologic research has not occupied much of our attention or that of most other teaching hospitals, and the establish­ment of priorities has suffered as a result.” Howard H. Hiatt,1 1971
This statement depicts clearly one of the major problems currently confront­ing the medical profession, namely, the distressing extent to which much of our clinical practice is conducted in the ab­sence of satisfactory substantiating epi­demiologic data.2'14 The current concern over the relationship between the toxic­ity and the efficacy of halothane15’18 is but one example.
The general problem has been sum­
marized bluntly by Todd,11 in his paper 
entitled “The E rrors of Medicine”, when 
he points out two main errors, namely: 
“devising remedies from theory and 
assuming they must be effective” ; and 
“developing facile etiological theories, leading in turn to remedies based on 
theory”. Another Todd,17 in a statement 
on the objective of anesthesia residency 
training, made the same criticism in a 
different way, “we don’t know what ef­
fective medicine is—hence it is diffi­
cult to educate an effective physician”.
Epidemiologic Techniques
MacMahon and Pugh18 have discussed 
in depth the techniques the epidemiolo-
*From the Departments of Anaesthesia and Medicine, Harvard Medical School at the Beth Israel and Robert Breck Brigham Hospitals, and the Harvard Computing Center, Boston, Mass., and from the Department of Anesthe­sia, Stanford University Medical Center, Palo Alto, Calif.
Reprint address: Dr. M. H. M. Dykes, 330 Brookline Avenue, Boston, Mass. 02215, U.S.A.
Supported in part by United States National Institutes of Health Grants AM11414, GM- 12527, and GM15904.
gist uses to test formulated hypotheses 
and which, therefore, offer the only hope 
for generating epidemiologic data to sub­
stantiate those clinical practices th a t 
currently are not based upon such data. 
These authors noted that, to be useful, 
a hypothesis must be testable, and th a t 
such testing may be non-experimental 
or experimental. Non-experimental stu ­
dies can be of two basic types, cohort 
studies and case-control studies (pre­viously named case-history studies). In 
a cohort study, the investigator selects 
a study population of individuals, some 
of whom suffer exposure to the factor under investigation and some of whom 
do not. He then observes the groups (the 
denominators) over a period to deter­mine how many exposed and non-ex- 
posed individuals develop the disease or 
end-point (the num erators) under in­
vestigation. These studies can be either 
retrospective or prospective. In a case- 
control study, the investigator selects 
a study population of individuals, some 
of whom were affected with the disease 
or end-point under investigation and 
some of whom were n o t; he then deter­
mines the frequency with which each 
group was exposed to the factor under 
investigation. These studies are neces­
sarily retrospective. In experimental 
studies (clinical tria ls), the investigator 
imposes upon the study population the 
conditions he chooses—within accept­
able ethical constraints. These condi­
tions must always include random as­
signment of the patients to the d ifferent 
study and control groups, and, where 
feasible, should include such devices as double-blind assessment of outcome.
Sometimes, however, when a report is evaluated, it may be difficult to diffe­rentiate between an unstructured series
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of isolated cases, and a bona fide struc­
tured retrospective cohort study. It has 
been stated previously19 that a study 
should be classified as a cohort study 
only when, as a minimum, three criteria 
have been presented clearly: the exact 
size of the patient sample studied (the 
denominator) ; a single, definite, pre­
determined criterion for the end-point 
studied (the numerator) ; and some me­
chanism for ensuring that all the pa­
tients who demonstrated this end-point 
were recognized— reliable as opposed to 
voluntary surveillance. The great need 
for reliable as opposed to voluntary sur­
veillance has recently been stressed by 
Doll.20 However, these three criteria are 
indeed minimal, and retrospective co­
hort studies, although structured, often 
provide only hypothesis-formulating 
data, rather than hypothesis-testing 
data, because of certain inherent limit­
ations.21
As in similar situations, the possibil­
ity that halothane might be hepatotoxic 
was first suggested by a series of isol­
ated case reports, which had their great­
est impact early in 1963.22 Since then 
isolated case reports have continued to 
appear, even though they make no con­
tribution towards testing the hypothesis 
that the toxicity of halothane outweighs 
its efficacy.
Of the three methods for conducting 
epidemiologic investigations that were 
outlined above, only one— cohort study 
— has been applied to the problem of 
the effect of halothane on the liver.
H istory and  Background
Before its administration to man, 
halothane had been thoroughly invest­
igated in animals,23 as judged by the 
standards in effect at the time, and by 
the results of classic studies on the ef­
fect of chloroform on the liver of the 
experimental animal.22 Raventos23 re­
ported that the hippuric acid excretion 
test in eight rats, bromsulphalein reten­
tion in a dog, and histopathological ex­
amination of the livers of another 30 
rats, three dogs, and five monkeys, all 
failed to reveal evidence of hepatic dys­
function or damage, apart from some 
minor histopathological changes. Most 
of the animals had been subjected to re­
peated administrations of the drug, last­
ing from 45 to 60 minutes, for five conse­
cutive days. In addition, no delayed 
deaths, similar to those observed in 
animals following the administration of 
chloroform, were attributed to the drug 
in any of the experimental animals used 
to evaluate the general pharmacology of 
the drug. Johnstone24 reported the first 
series of patients to receive halothane 
in 1956, but, as noted above, it took until 
1963— seven years—to formulate clear­
ly the hypothesis that the drug was 
hepatotoxic in man.
Rare Unpredictable Adverse Drug
Reactions
This situation represents a specific 
example of a general problem, namely, 
that serious unpredictable adverse drug 
reactions develop in approximately 3% 
of the drugs released for general clinical 
use,25 although, of every 3000 compounds 
tested, only 20 are sufficiently active 
and non-toxic to be administered to man 
and, of these, only one is ultimately re­
leased. Although, fortunately, these re­
actions do not occur in more than one of 
several thousand patients who receive 
the drug,25 this very rarity renders their 
recognition and evaluation difficult and, 
presumably, in some cases, impossible.
Modell25 has classified these rare un­
predictable adverse drug reactions into 
four groups: intolerance (hyper-reac­
tivity) ; idiosyncrasy (metareactivity) ; 
allergy (hypersensitivity); and drug in­
teraction. He called for an “ early warn­
ing system” to ensure that the unpre­
dictable drug response is converted as 
rapidly as possible into a calculable risk. 
In this context the second formal recom­
mendation of the Subcommittee which 
conducted the United States National 
Halothane Study26' 27 stated in 1966 “We 
recommend the establishment of a co­
operating group of institutions to serve 
as a panel-laboratory for the acquisition 
of trustworthy information on new 
drugs (not merely anesthetics) as they
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come into use.” Further, the standing 
Advisory Committee on Respiratory 
and Anesthetic Drugs of the United 
States Food and Drug Administration28 
has included, in its most recent draft of 
the guidelines for the clinical testing of 
inhalation general anesthetics, a new 
phase of testing to be undertaken after 
the new anesthetic has successfully com­
pleted Phases I, II, and III testing (clin­
ical pharmacology and clinical trials) 
and has been approved for general 
use. The committee describes the 
purpose of this new phase (which is 
referred to as “ Phase IV” ) as follows: 
“ Ongoing studies of the agent may be 
necessary after approval for adequate 
monitoring of known or potential ad­
verse effects.”
Hepatic Adverse Drug Reactions
Data obtained in the United States 
suggest that adverse drug reactions af­
fecting the liver represent a small frac­
tion—less than 1%—of all adverse drug 
reactions, but that they tend to be seri­
ous when they occur.21 Babior and Trey29 
have divided drug hepatitis into four 
groups: the syndrome of hepatocellular 
disease (direct hepatotoxins and sen­
sitizing agents) ; interference with bili­
rubin metabolism; the syndrome of 
cholestasis; and alcoholic liver disease 
and have discussed the criteria for mak­
ing these classifications. Of particular 
difficulty is the problem of defining a 
sensitizing agent. These authors believe 
that a drug may be classified as such an 
agent on the basis of three criteria: re­
challenge; recognition of a specific 
clinical syndrome; and epidemiologic 
factors. The extent to which halothane 
has been evaluated by means of these 
three criteria will be discussed below. In 
brief, the drug appears to be a sensitiz­
ing agent, and the two most popular hy­
potheses concerning the etiologic me­
chanism of “ halothane hepatitis” are 
that it is either idiosyncratic (metabolic 
basis) or allergic (immunologic basis).
Current E pidemiologic A spects
At the end of the last century the hy­
pothesis was advanced that the toxicity 
of chloroform (both cardiac and hepa­
tic) outweighed its efficacy. This hypo­
thesis was accepted without ever being 
satisfactorily tested and there is some 
evidence that, by administering this 
drug as part of a “modern” anesthetic, 
these disadvantages can be overcome.30 
Fortunately, the hypothesis that the ef­
ficacy of halothane outweighs its toxic­
ity has been at least partially estab­
lished, although important questions re­
main.
Retrospective Cohort Studies
Eight retrospective cohort studies, re­
ported between 1963 and 1965, that 
evaluated the hepatotoxicity but not the 
efficacy of halothane have recently been 
discussed in detail.18 In summary, three 
of these studies used the definite and 
objective end-point of hepatic necrosis 
discovered at autopsy and encompassed 
91,494 general anesthetics— 37,050 of 
these included halothane. The other five 
used several less severe non-fatal and 
more frequently occurring end-points 
and encompassed 138,962 general anes­
thetics— 65,666 included halothane. All 
of these studies, which were conducted 
in several different geographical loca­
tions, failed to provide evidence that the 
hepatotoxic potential of halothane was 
greater than that of the alternative 
anesthetic agents and techniques.
The United States National Halo­
thane Study26 , 27 also failed to provide 
evidence that the single administration 
of halothane was followed by a statistic­
ally higher incidence of massive hepatic 
necrosis than the single administration 
of any of the alternatives. The overall 
autopsy incidence of massive hepatic 
necrosis was approximately 1:10,000. 
Of particular interest was the fact that 
after an ad hoc group, consisting of an 
anesthetist, a surgeon, an internist, and 
a pathologist, had reviewed the chart 
abstracts of the 82 patients who demon­
strated massive hepatic necrosis to de­
termine whether or not the necrosis 
could be “explained” by a primary or 
contributory cause, in only nine in-
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TABLE I — D eath R ates Standardized for Physical Status, Age, and Se x , Percentage D ying
W ithin Six  Weeks
Mortality 
level of 
surgical 
procedure Halothane N-B*
Cyclo­
propane Ether Other Total
Low 0.23 0.16 0.26 0.18 0.34 0.22
Middle 1.92 1.97 2.77 1.85 2.58 2.21
High 8.54 9.23 12.58 8.30 10.84 9.33
*N-B =  nitrous oxide-barbiturate. .
Source: Subcommittee on the National Halothane Study of the Committee on Anesthesia, National Academy 
o f Sciences-National Research Council.26 By permission of National Research Council and J.A.M.A.
stances was the necrosis classified by at 
least three members of the group as 
“ unexplained” . In seven of these the pa­
tient had received halothane for the 
final operation. The eighth and ninth 
patients had received diethyl ether and 
cyclopropane for the final operation re­
spectively. The ad hoc group members 
were unaware of the anesthetic history 
when they made their judgments. Be­
cause six of the seven patients who de­
veloped “ unexplained” massive hepatic 
necrosis following the administration of 
halothane were known to the parti­
cipating institutions before the study 
began, it was believed that the effect of 
volunteer bias* was quantitatively suf­
ficient to explain this apparent small 
excess of cases in the halothane cohort.
This large, multi-institutional study 
went beyond the eight smaller earlier 
ones in attempting to evaluate the ef­
ficacy of the drug by comparing the 
standardized in-hospital death rates fol­
lowing the five anesthetic practices 
studied, and thereby providing a pre­
sumptive assessment of the relative 
overall fatal toxicity, or level of safety, 
of the practices. In the strict sense of 
the term, this is not a true measure of 
the efficacy of the anesthetic practices 
involved. The efficacy of an anesthetic 
practice, if strictly defined, would have 
to be a measure of the extent to which 
the anesthetic state provided adequate 
operating conditions. Interestingly, an­
esthetists appear to assume that they
*Volunteer bias may exist when institutions 
volunteer to join  a study in part because they 
have observed patients who demonstrated the 
condition to be studied.
can provide equally effective operating 
conditions for a given patient, with any 
one of several anesthetic practices, al­
though proof of this assumption is cur­
rently lacking.
The in-hospital death rates, stand­
ardized for physical status, age, sex, 
and operation, for the five anesthetic 
practices studied in the United States 
National Halothane Study are presented 
in Table I. If the death rates for diethyl 
ether are excluded—they were believed 
to be less reliable than the others—it is 
clear from the table that halothane was 
associated with the lowest death rates 
with one exception, namely, nitrous 
oxide-barbiturate used for low-death- 
rate procedures. Specifically, the rates 
for cyclopropane and the “ other” agents 
were the highest, by large margins, in 
both the mid-death-rate and high-death- 
rate procedures. It must be stressed, 
however, that although the differences 
between these rates cannot be assumed 
to be causally related to the different 
anesthetic practices, because of the pre­
sumed existence of unknown biases in 
this retrospective, non-randomized stu­
dy, the following conclusion was 
reached: “ Halothane, rather than being 
a dangerous anesthetic, had a record of 
safety. .
Two further points of epidemiologic 
importance brought out by the United 
States National Halothane Study are, 
first, that the death-rate differences 
among the 34 participating institutions 
were much larger than those among the 
anesthetics, even after adjustment for 
the known interfering variables; and 
second, that “ the overall death rate
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TABLE II.—O bserved and Expected Number of Cases of M assive Necrosis Following M ultiple 
Operations* by Halothane Administration
Halothane administration
Massive hepatic necrosis
Last and 
previous 
operations
Previous
operation
only
Last
operation
only None Total
Observed
Expected
Estimated administrations
10
4.2
14,100
0
2.7
9000
3
3.6
12,000
11
13.5
45,500
24
24
80,600
* Multiple operations” is defined as two or more operations under general anesthesia in the same or suc­
cessive months.
Source: Subcommittee on the National Halothane Study of the Committee on Anesthesia, National Acade­
my of Sciences-National Research Council.26 By permission of National Research Council and J.A.M.A.
problem is of an order of magnitude 
larger in its implications for patient 
care than that of massive hepatic necro­
sis” .26
In summary, these data from the 
United States National Halothane Study 
can be accepted as having tested, and 
partially established, one important hy­
pothesis, namely, that the relative over­
all level of safety (efficacy) of a single 
administration of halothane does out­
weigh the relative incidence of fatal 
massive hepatic necrosis (toxicity) fol­
lowing a single administration of the 
drug.
Multiple Halothane Administrations
From among the 856,515 patients who 
constitute the United States National 
Halothane Study, 80,600 received mul­
tiple anesthetics— two or more gen­
eral anesthetics in the same or success­
ive months. The overall incidence of 
massive hepatic necrosis rose from 58 
in 775,900 (0.7 in 10,000) for single 
anesthetics to 24 in 80,600 (3.0 in 10,- 
000) for multiple anesthetics, and rose 
even higher to 10 in 14,000 (7.1 in 10,-
TABLE III.—Crude Overall Postoperative 
Death Rates per 10,000
Operation
No
previous
general
anesthesia
Previous
non-
halothane
Previous
halothane
Low death rate 18 82 84
Mid death rate 193 461 431
High death rate 868 1354 1183
Source: Dykes.31 By permission of International 
Anesthesiology Clinics, Little, Brown and Co., 
Boston.
000) for multiple administrations of 
halothane (Table II). From Table II it 
can also be seen that the incidence of 
massive hepatic necrosis for multiple 
administrations of anesthetics other 
than halothane was 11 in 45,500 (2.4 in 
10,000). Table III indicates that not 
only the risk of massive hepatic necro­
sis, but also the overall risk of death 
rose when a patient underwent multiple 
anesthetics and operations, irrespective 
of whether or not the patient had re­
ceived halothane previously.
Table IV contains the only epidemi­
ologic data currently available in the 
medical literature— again from the 
United States National Halothane Study 
—that bears, even indirectly, on the 
problem of choosing the anesthetic for a 
patient who has received halothane in
TABLE IV.— Postoperative M assive Hepatic 
Necrosis and Crude Overall Postoperative 
Death Rates per 10,000
Massive hepatic necrosis
Non-
halothane Halothane
Halothane plus plus
plus non- non-
halothane halothane halothane
7.1 2.4 0
Death rates
Non-
Halothane halothane Halothane
plus plus plus
Operation halothane halothane all types
Low death rate 71 91 84
Mid death rate 345 378 431
High death rate 1025 1261 1183
Source: Dykes.31 By permission of International 
Anesthesiology Clinics, Little, Brown and Co., 
Boston.
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the past. To make a reasonable clinical 
judgment one must compare the risks of 
the combinations of exposures involved.
With regard to massive hepatic nec­
rosis, in this instance both “ explained” 
and “ unexplained” , the risk was higher 
when the patients who were exposed to 
two halothane anesthetics are compared 
with those who were exposed to two 
non-halothane anesthetics. The fact that 
no patients in the cohort that was ex­
posed to a halothane plus a non-halo­
thane anesthetic developed massive he­
patic necrosis is almost certainly a 
chance finding due to the relatively 
small size (9000 patients) of the cohort. 
With regard to the crude overall post­
operative death rates, it appears that 
two administrations of halothane may 
be associated with a lower mortality 
than the administration of one halo­
thane and one non-halothane anesthetic. 
These data can only be considered to be 
hypothesis-formulating evidence be­
cause of the various biases inherent in 
this retrospective study (biased selec­
tion of the anesthetics, autopsy bias, and 
volunteer bias), and because of the very 
small numbers of patients in the num­
erators (10 and 11). Further, in only 
four of the 10 patients who developed 
massive hepatic necrosis after multiple 
administrations of halothane did at 
least three of the four members of the 
ad hoc group believe that the condition 
was “ unexplained” . The incidence of 
“ unexplained” massive hepatic necrosis 
following multiple administrations of 
halothane in this study, therefore, was 
four in 14,100 (2.8 in 10,000). Once 
again, however, the effect of volunteer 
bias must be considered because three of 
these four patients were known to the 
investigators before the study com­
menced. The possibility exists, there­
fore, that if halothane is administered 
a second time to a patient who has re­
ceived it before, a severalfold increase 
in the incidence of a rare fatal complica­
tion—massive hepatic necrosis— may be 
more than compensated for by a sub­
stantial decrease in a considerably more 
common outcome— death.
Additional data relating to the effects 
of multiple administrations of halothane 
on the liver have recently been re­
viewed,31 and the point has been made 
that data which lack either denomina­
tors or controls, or both, are not “a 
sound base on which to establish mean­
ingful conclusions” . Many of the addi­
tional reports relating to the specific 
subject under discussion lack such epi­
demiologic essentials, or are limited 
numerically, and all of them fail to 
evaluate the efficacy of the drug.
Two groups of important anecdotal 
observations remain, however. The first 
group consists of the series of individual 
patients who have received multiple ad­
ministrations of halothane and who 
failed to demonstrate evidence of hepa­
tic dysfunction— one such individual re­
ceived 89 administrations of halothane 
over a four-year period.32 These patients 
can be considered proof that multiple 
administrations of halothane do not 
necessarily damage the liver. The sec­
ond group consists of the individual pa­
tients who have demonstrated either an 
anesthetic or a true positive halothane 
challenge.* Recently these challenged 
patients, not one of whom was discov­
ered by the United States National 
Halothane Study, have been extensively 
reviewed,15,31 and have been taken to 
“ strongly suggest and essentially prove 
the existence of halothane hepatitis” re­
spectively. In this context it is note­
worthy that there are 11 patients in the 
literature who demonstrated negative
* A  challenge occurs when a drug is read­
ministered to a patient who is suspected of 
having developed an adverse reaction to the 
drug after a previous exposure to it. I f  the 
reaction recurs, the challenge is said to be 
positive; if it does not recur, the challenge is 
said to be negative. A  positive challenge in­
dicates that the drug was indeed the cause of 
the suspected reaction. An anesthetic challenge 
occurs when the agent suspected of causing 
the reaction “ is used to produce anesthesia in 
a patient who has previously demonstrated 
hepatic dysfunction following its administra­
tion” .31 A  true challenge occurs when “ a short 
challenging dose of the drug is administered to 
the individual suspected of being sensitized to 
it, in the absence of any operative or other 
reason for the induction of the anesthetic 
state” .31
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halothane challenges, and as such serve 
to provide one specific piece of evidence 
that “all the episodes of jaundice that 
develop after the administration of halo­
thane are not necessarily related to the 
presence of the drug per se” .31
As further possible support for the 
existence of “ halothane hepatitis” , 
Babior and Trey29 believe that halothane 
has been shown to be a sensitizing agent 
on the basis of two additional criteria 
which they have proposed, as noted 
earlier, for so classifying a drug. The 
first criterion is the existence of a bona 
fide “ specific clinical syndrome” , and 
the second is the existence of “ epidemi­
ologic factors”— data obtained from 
suitably controlled clinical studies. Ba­
bior and Trey believe that the criterion 
of a “ specific clinical syndrome” has 
been fulfilled in that the greatest in­
cidence of hepatitis appears to follow 
multiple administrations of the drug, 
and in that this hepatitis appears to be 
associated with eosinophilia. Although 
the two anesthetists who underwent 
true positive halothane challenges each 
developed eosinophilia, the exact signif­
icance of this finding, particularly when 
it is observed during the postoperative 
period, remains to be established and 
will be commented upon later. Babior 
and Trey believe the criterion of “ epide­
miologic factors” has been met by the 
data from the United States National 
Halothane Study,26, 27 concerning the ef­
fect of multiple administrations of the 
drug, which have just been presented.
In our opinion,* therefore, despite the 
fact that the two challenged anesthe­
tists represent the only truly compelling 
evidence for the existence of “ halothane 
hepatitis” , it would seem to be unwise to 
continue to claim that all cases of un-
“One of us (J.P.G.) dissents to the extent that 
he believes that the only valid evidence, if any, 
for the existence of an entity “halothane hepa­
titis” may be the two challenged anesthetists. 
He is concerned by the amount of general in­
terest that has been exhibited in a disease that 
has so far been demonstrated in only two in­
dividuals, despite the fact that halothane has 
been the most widely used inhalation anesthe­
tic in much of the world for approximately a 
decade.
explained hepatitis following the ad­
ministration of halothane are due to 
unrecognized viral hepatitis infection. 
Some of these cases can now reasonably 
be assumed to be cases of “ halothane 
hepatitis” . The questions that remain 
are these: “ What proportion of such 
patients have indeed developed this en­
tity ?” and “ How do we recognize them ?” 
No data currently exist to illuminate 
the first question and, in regard to the 
second question, no satisfactory specific 
diagnostic techniques for “ halothane 
hepatitis” are presently available, de­
spite the several attempts to define a 
“ specific clinical syndrome” .
With regard to a possible specific 
pathologic picture for “halothane he­
patitis” , the six-man Pathology Panel, 
which evaluated the 222 cases of hepatic 
necrosis in the United States National 
Halothane Study without knowledge of 
the anesthetic histories, was “ not able 
to determine an etiologic basis for the 
lesions with any degree of uniformity or 
consistency” .27 The panel made the fol­
lowing specific statement: “ No con­
sistent histologic pattern could be attri­
buted to halothane. It appeared, how­
ever, that cases associated with halo­
thane exhibited a lesion simulating that 
encountered in fatal viral and some 
drug-induced forms o f hepatitis more 
often than cases associated with other 
anesthetics” .27
For these reasons several calls have 
been made for a prospective clinical 
trial (experiment) to attempt to settle 
the issue.16, 33, 34 Although an attempt has 
been made to plan such a clinical trial, 
the plan did not prove to be feasible 
primarily because the current inability 
to recognize individual cases of “ halo­
thane hepatitis” meant that the end­
points of such a study would have to be 
fatal and non-fatal “ unexplained hepa­
tocellular damage” . Because epidemi­
ologists find it difficult to study a di­
sease which is ill-defined in either 
clinical, pathological or other opera­
tional terms,18 it is possible that a study 
using such an end-point, which has been 
described as a “tenuous diagnosis by ex-
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elusion” , might not have satisfactorily 
solved the problem.
Diagnosis of “Halothane Hepatitis”
Physicians have travelled two paths 
in attempting to establish the diagnosis 
of “halothane hepatitis” in the individ­
ual patient. First, there is the epidemi- 
ologically “ clean” case. This is the pa­
tient who develops hepatocellular 
damage after the administration of 
halothane, in the apparent absence of 
any other possible causal factors—for 
example: other hepatotoxic drugs; or 
exposure to blood products or a recogni­
zable source of infectious hepatitis; or 
shock; or overwhelming sepsis. The 
claim is therefore made that because it 
would seem to be too much of a coin­
cidence for the illness to be coincidental 
viral hepatitis, it is believed that the pa­
tient is probably suffering from “halo­
thane hepatitis” . A patient such as this 
was reported in the American Journal 
of Medicine in 1968,35 and it was noted, 
correctly in our opinion, that there was 
only circumstantial evidence for claim­
ing that the halothane was the causal 
agent. In fact, we would stress once 
again that currently no data are avail­
able to suggest what proportion of cases 
of unexplained hepatocellular damage 
following the administration of halo­
thane represent “ halothane hepatitis” . 
Indeed, it is of considerable importance 
that the Boston Inter-Hospital Liver 
Group36'38 has collected data on viral he­
patitis patients in a group of Boston 
hospitals, which indicate that ap­
proximately two-thirds of these patients 
could not recall an overtly recognizable 
source of infection—that is, they were 
suffering from “ unexplained” viral he­
patitis. Obviously, therefore, the fact 
that a patient has not received a trans­
fusion, has not admitted being a paren­
teral drug abuser, and cannot recall 
being exposed to any jaundiced persons, 
does not exclude the diagnosis of viral 
hepatitis. In view of the fact that per­
haps 200 to 300 patients may receive 
halothane during the incubation period 
of viral hepatitis during any one year in
the United States,15— a figure which 
rises to approximately 4000 if the in­
cidence of non-reporting and the ratios 
of anicteric to icteric cases are taken 
into account— the epidemiologically
“clean” case approach to the diagnosis 
of “halothane hepatitis” would seem to 
be much weaker than it might appear if 
viewed uncritically. In addition, it has 
been noted previously that the bias 
against halothane is currently so strong 
that this epidemiologically “ clean” case 
approach has been used to diagnose 
“halothane hepatitis” in patients who 
did not receive halothane.16
The second path involves those pa­
tients who have been subjected to either 
an anesthetic or a true challenge, and 
who, therefore, constitute the only pa­
tients in the literature who can reason­
ably be assumed to have indeed suffered 
from “halothane hepatitis” . The clinical 
and biochemical features of the illnesses 
demonstrated by these patients have 
been described in detail previously15- 31 
(Table V). The patients did not appear 
to demonstrate any special characteris­
tics other than those of a non-specific 
hepatitis. Again, the exact significance 
of the eosinophilia demonstrated by 
some of the patients remains controver­
sial. It is important, however, to recog­
nize that this small group of patients, 
even if they all did indeed exhibit “halo­
thane hepatitis” , cannot be assumed to 
represent a random sample of the di­
sease so that the incidence of the dif­
ferent clinical features demonstrated in 
this small sample cannot be assumed to 
represent their true incidence.
Prevention of “Halothane Hepatitis”
Of course, the current dilemma with 
regard to the choice of anesthetic for a 
patient who has received halothane in 
the past would cease to exist if a speci­
fic sensitive prognostic test were avail­
able. The place of “ unexplained post­
operative fever” as such a prognostic 
test has been evaluated recently.39 Data 
were collected as part of this evaluation, 
which demonstrated that, during the 
first postoperative week, 55% of tem-
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TABLE V. Clinical F eatures of 10 P atients Demonstrating Positive H alothane Challenges
Feature
Onset of illness
8 patients...........................
2 anesthetists....................
Onset of hepatic dysfunction
8 patients..............................
2 anesthetists.......................
Fever.........................................
Chills...........................................
Hepatic enlargement................
Hepatic tenderness....................
Myalgia.......................................
Arthralgia...................................
Skin rash .....................................
Nasal congestion........................
Cough..........................................
Allergic history..........................
Eosinophilia................................
Bilirubinemia.............................
Elevated alkaline phosphatase 
Elevated transaminase.............
Initial exposure Challenging exposure
8 hours to 10 days
3J^ > months and 1 year
2 days to 32 days
3}4 months and 1 year
6 (maximum 106.4° F.)
2
3
3
2
0
1
1
1
3
3 (maximum 24%)
9 (maximum 33.5 mg./lOO ml.)
8 (maximum 57*)
9 (maximum 1590+)
8 hours to 2 days
4 hours and 5 hours
1 day to 14 days
1 day
8 (maximum 105.2° F.)
3
2
3
2
0
0
1
1
3
5 (maximum 25%)
7 (maximum 56 mg./lOO ml.)
7 (maximum 14*)
10 (maximum 1500+)
*Bodansky units: normal =  4.
+Normal = 40 units.
Source: Dykes and Bunker.15 By permission of the American Society for Pharmacology and Experimental
TABLE VI.—Postoperative T emperature
Elevations Above 98.6° F. in 200 Consecutive 
P atients
First
100
Second
100 Total
No temperature ele­
vation (67 patients) 
No temperature 
record* 22 16 38
Temperature records 
< 3 postoperative 
days 14 15 29
Temperature records 
for a t least 3 post­
operative days 0 0 0
Temperature elevation 
(133 patients) 
Preoperative unex­
plained temperature 
elevation 10 10 20
Preoperative explain­
ed temperature ele­
vation 2 7 9
Unexplained tempe­
rature elevation re­
cords < 3 postoper­
ative days 8 8 16
Unexplained tempe­
rature elevation, re­
cords for at least 3 
postoperative days 28 29 57
Explained temper­
ature elevation 16 15 31
*Patients discharged on the day of operation, 
Source: Dykes.39 By permission of J.A.M .A,
p era tu re  elevations above 98.6° F . w ere 
unexplained (73 of 133 pa tien ts— Table 
V I), and fu rther, th a t  of 163 p a tien ts  
who had tem peratures recorded fo r  a t 
least th ree  postoperative days, only one 
failed to dem onstrate an elevation. A d­
ditional d a ta  (F ig . 1) indicated th a t  
the m ean values of the unexplained tem ­
pera tu re  elevations observed in conse­
cutive patien ts who underw ent fo u r d if­
feren t operative procedures, fell s tead ­
ily from  between 99.5° F. and 100.4° F. 
on the f i r s t  postoperative day to be­
tw een 98.6° F. and 99.1° F. on the 
seventh. On the basis of these data , and 
a review  of pertinent evidence from  the 
lite ra tu re , the conclusion w as reached 
th a t “unexplained postoperative fever 
alone following a p rio r adm in istra tion  
of halo thane cannot necessarily be con­
sidered a contraindication to the sub­
sequent use of the d rug  in th a t  p a tie n t” .
On the basis of cu rren t knowledge, 
the com m ent made in the U nited S ta tes 
N ational H alothane Study26 th a t  “ un ­
explained fever and jaundice in a 
specific patien t following halo thane 
adm in istra tion  m ight reasonably be 
considered a contraindication to its 
subsequent use in th a t  p a tien t” , appears
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POSTOPERATIVE DAY
Fig 1.—The mean, and maximum and minimum unexplained temperature elevations above 
98 6° F orally, observed daily in four groups of 20 consecutive patients who underwent four 
operative procedures. (Source: Dykes.39 Reproduced by permission from J.A.M.A.)
reasonable. However, even this position 
cannot be accepted without two assump­
tions for which supporting epidemi­
ologic data are not currently available, 
namely, that something more than a 
minute proportion of such patients are 
indeed suffering from “halothane hepa­
titis” , and that this form of hepatitis is 
commonly a serious or a life-threatening 
disease.
Some physicians currently contend 
that halothane should not be adminis­
tered to a patient who has recently re­
ceived it, until a specific period of time 
has elapsed— usually the chosen period 
varies between several weeks and a 
year. The assumption is that if such a 
patient has been sensitized to the drug 
by the first administration, the likeli­
hood of a serious reaction to a second 
administration will diminish with the 
passage of time. We know of no reliable
data supporting this contention. On the 
contrary, in one of the few patients in 
the literature who demonstrated a posi­
tive anesthetic challenge,31 a period of 
four years and 10 months elapsed be­
tween the two administrations of halo­
thane. This situation suggests, but ob­
viously does not prove conclusively, that 
once a patient has become sensitized to 
halothane, such sensitization may re­
main for several years, if not perma­
nently.
Incidence of “Halothane Hepatitis”
The incidence of “halothane hepati­
tis” has been estimated to be no greater 
than 1:10,000 administrations,15 pre­
sumably because this was the approxim­
ate total (“ explained” and “unex­
plained” ) incidence of massive hepatic 
necrosis following the administration of
July 1972 H ALOTHANE AND LIVER 227
halothane in the United States National 
Halothane Study (25 cases in 255,000 
administrations). However, in 18 of the 
25 cases the cause of the massive hepatic 
necrosis was attributed to factors other 
than the halothane, that is, to either: 
pre-existing hepatic disease; shock, 
especially with prolonged use of vaso­
pressors ; severe or prolonged congestive 
cardiac failure; or overwhelming sepsis. 
The overall incidence of “ unexplained” 
massive hepatic necrosis alone follow­
ing the administration of halothane in 
the United States National Halothane 
Study was, therefore, seven in 255,000 
(0.27 in 10,000). This figure can, how­
ever, only be taken as a very rough 
estimate of the incidence of fatal “halo­
thane hepatitis” because of the many 
biases involved in its derivation. Fac­
tors tending to bias it downward include 
the autopsy bias inherent in the United 
States National Halothane Study (40%  
of the deaths did not have an autopsy), 
and the possibility that patients in 
the study left the hospital alive and 
well and then died of massive hepatic 
necrosis outside the hospital. It is also 
possible, of course, that patients left 
the hospital alive and well and died of 
other causes, for example, pulmonary 
embolism, outside the hospital.40 Factors 
tending to bias it upward include the 
volunteer bias inherent in the United 
States National Halothane Study, and 
the fact that factors other than the 
halothane, notably the hepatitis virus, 
might have produced the cases of “ un­
explained” massive hepatic necrosis ob­
served in the study.
The possibility also exists that the in­
cidence of “halothane hepatitis” might 
have changed since the United States Na­
tional Halothane Study (1959 to 1962). 
It is generally presumed, despite the 
total lack of any confirmatory data, 
that any change would be in the direc­
tion of a higher incidence, because if 
the disease is indeed due to a sensitiza­
tion reaction, its incidence should rise 
as more and more patients become re­
exposed to the drug.15 In view of these 
facts, and the fact that no information
currently exists with regard to the ratio 
of non-fatal to fatal “halothane hepati­
tis” , it can be stated unequivocally that 
the incidence of “ halothane hepatitis” 
is unknown, and that the estimates that 
have been made are likely to be grossly 
inaccurate. It is of interest that of the 
total membership of approximately 10,- 
000 of the American Society of Anesthe­
siologists, only one individual has so far 
been discovered who appears to have de­
monstrated a bona fide hepatic sensi­
tization reaction to halothane.41
Five Anecdotal Case Reports
Hill42 has stated that carefully de­
scribed case reports form a useful part 
of the body of scientific knowledge, as 
long as they are not used as the basis of 
an appeal from the particular to the 
general. He noted that their value lies 
in the fact that they are an indication 
of what can happen, regardless of the 
fact that they obviously cannot illumin­
ate the incidence nor the causation of 
the event described. W e will, therefore, 
now present five case reports which in­
dicate what can happen with regard to 
the hepatotoxicity of halothane, al­
though nothing is known of the inci­
dence nor the exact cause of the re­
ported events. They can obviously only 
be considered as highly tentative hypo­
thesis-formulating data.
In 1968 a 48-year-old woman drank 
250 ml. of halothane, and became un­
conscious to the extent that 41/2 hours 
later a disorientative response could be 
obtained only with very painful stimu­
li.43 She required a tracheostomy and 
artificial ventilation, and external car­
diac massage for an episode of cardiac 
arrest. She improved gradually, and 
was discharged after two weeks without 
any clinical or biochemical evidence of 
hepatic dysfunction. She was well 14 
weeks after discharge. A  second similar 
case was reported as an addendum to 
this case report. Together these cases 
support the theory that the hepatotoxic 
action of halothane does not resemble 
that of chloroform or carbon tetrachlo­
ride.44
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In 1971 a 16-year-old girl received 2.5 
ml. of halothane intravenously.45 The 
drug had been placed inadvertently in a 
bottle labelled “ Brevital” . She developed 
severe pulmonary edema and right heart 
failure, possibly because of a toxic pul­
monary vasculitis, requiring endotra­
cheal intubation and intermittent posi­
tive-pressure breathing, but ultimately 
she recovered completely without de­
veloping any clinical or biochemical 
evidence of hepatic dysfunction.
A third case report,46 concerned with 
an unusual route or quantity of halo­
thane administration, described a 5- 
year-old boy with severe tetanus who 
was treated with nitrous oxide and halo­
thane for six weeks. No clinical signs of 
hepatic damage developed during life, 
and no histologic evidence of such dam­
age was found at autopsy, despite ad­
ministration of 1500 ml. halothane dur­
ing the first three weeks of the illness.
The final two cases concern the rela­
tionship between the viscerotoxicity of 
halothane and that of methoxyflurane. 
Lindenbaum and Leifer47 reported a 49- 
year-old man with a history of moderate 
chronic alcoholism, who developed min­
imal evidence of hepatic dysfunction fol­
lowing plication of a perforated duo­
denal ulcer under nitrous oxide and 
halothane anesthesia. A month later 
this patient received nitrous oxide and 
methoxyflurane for a partial gastrec­
tomy and vagectomy. On this occasion 
he developed hepatic coma and died on 
the eleventh postoperative day. On the 
basis of this single case report, consi­
dered in the light of the several addi­
tional published cases of hepatic dam­
age following the administration of me­
thoxyflurane,19 including a recently de­
scribed case of a possible positive me­
thoxyflurane anesthetic challenge,48 it 
appears that hepatic cross-sensitization 
may exist between these two drugs. 
Therefore, we recommend, partly to pro­
tect the drugs themselves, that either 
one of these drugs should not be ad­
ministered to a patient who has de­
veloped evidence of hepatic damage fol­
lowing a prior administration of the
other, until further evidence accumu­
lates which satisfactorily tests this hy­
pothesis of cross-sensitization.
A second case report,49 however, ar­
gues against a possible cross-sensitiza­
tion between methoxyflurane nephro­
toxicity and halothane hepatotoxicity. A 
55-year-old woman developed a course 
“ considered typical of methoxyflurane- 
induced nephrotoxicity” following a ra­
dical hysterectomy performed under 
methoxyflurane and d-tubocurarine. 
The postoperative courses of three prior 
and one subsequent nitrous oxide and 
halothane anesthetics were uneventful. 
Because it is now apparent that these 
two disease processes are quite dissim­
ilar in incidence, possible dose-to-re- 
sponse relationships, and apparent 
etiologic mechanisms, this clinical find­
ing is not unexpected.
Epidemiologic Perspective
An attempt has been made recently 
to place in perspective postoperative he­
patic dysfunction as a cause of post­
operative morbidity and mortality.16 It 
was noted that “ it does not appear that 
a study has ever been performed in 
which the incidences of postoperative 
hepatic, pulmonary, and cardiac com­
plications were compared under care­
fully controlled conditions” . In the ab­
sence of such a study, Dykes and Wal- 
zer50 combined the incidences of post­
operative extrahepatic biliary tract ob­
struction and acute parenchymatous he­
patic disease at the Massachusetts Gen­
eral Hospital (1959 to 1962) and com­
pared the resultant figure with the pub­
lished incidences of postoperative pneu­
monia and atelectasis, and myocardial 
infarction. The results of those compa­
risons of retrospective data, collected 
by different authors in different insti­
tutions, but in an essentially similar 
manner, are presented in Table VII. 
From this table it can be seen that the 
hypothesis can be formulated that “he­
patic complications contribute far less 
to postoperative morbidity and mor­
tality than do pulmonary and cardiac 
complications” .
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TABLE V II—Comparative Incidences of Postoperative H epatic, P ulmonary, and Cardiac Com­
plications
No. of patients
Series Complication Total Complication Incidence
Died from
complication Mortality
Massachusetts
General
Extrahepatic biliary tract 
obstruction 46,923 11 1:4266 1 1:46,923
Acute parenchymatous 
hepatic disease 46,923 18 1:2607 2 1:23,461
Total hepatic com­
plications 46,923 29 1:1618 3 1:15,641
Whipple Atelectasis and pneumonia 3719 72 1:52 9 1:413
Cleveland Atelectasis and pneumonia 1940 56 1:35 1 1:1940
Eliason Atelectasis and pneumonia 7326 35 1:209
King Atelectasis and pneumonia 7065 426 1:17 13 1:543
Dripps Atelectasis and pneumonia 1240 68 1:18
Bunker Atelectasis and pneumonia 673 104* 1:6 — —
Mean pulmonary com­
plications 21,963 761 1:29 23 1:553
Wroblenski Myocardial infarction 20,000f 15 1:1333 5 1:4000
Wasserman Myocardial infarction 37,000f 25 1:1480 3 1:12,333Feruglio Myocardial infarction 21,000t 35 1:600 11 1:1909Knapp Myocardial infarction 8984 85 1:106 26 1:346
Mean cardiac com­
plications 86,984 160 1:544 45 1:1933
*In some patients diagnosis of atelectasis was made on basis of distinctive physical signs without radiologic 
confirmation, 
t  Approximate number.
Source: Dykes and Walzer.50 By permission of Surgery, Gynecology and Obstetrics.
W ith regard to the m ortality  due to 
postoperative hepatic dysfunction, a 
comparison of the data  from  the United 
S tates National Halothane S tudy26,27 
w ith those from  the postoperative m or­
ta lity  study of Beecher and Todd,51 has 
been made16 with the following conclu­
sion : “The overall incidence of fa ta l 
postoperative massive hepatic necrosis 
is fa r  less than the overall risk of anes­
thesia.” In addition, a fu rth e r conclu­
sion was reached: “The risk of such he­
patic necrosis from  all causes following 
multiple adm inistrations of halothane, 
if a conclusion draw n from  only 10 pa­
tien ts  is acceptable, appears to be no 
g rea ter than the overall risk of anesthe­
sia .”
Goldstein and K eats52 have recently 
reviewed the literatu re  rela ting  to over­
all anesthetic m ortality . From  th is  re ­
view it appears th a t a “prospective” on­
going cohort study of such m ortality  has 
yet to be undertaken. In  fact the U nited 
S tates National H alothane Study26, 27 re ­
commended “the in itia tion  of ra n ­
domized studies of death  ra te s  associ­
ated w ith anesthetic ag en ts”— th a t is, a 
series of clinical tr ia ls  or experim ents 
to illum inate this a rea . The overall m or­
tality  in the  U.S.A., due to anesthesia, 
has been estim ated, presum ably on the 
basis of the  data from  the Beecher and 
Todd s tudy51 and an  overall estim ate 
th a t approxim ately 15,000,000 anesthe­
tics are  adm inistered in the  U nited 
S tates p e r annum ,15 to be a t least 10,000 
deaths p e r annum.53, 54 This fig u re  is a p ­
proxim ately one-fifth  th a t  due to au to ­
mobile accidents, and  g rea te r th an  those 
due individually to tuberculosis, in fluen ­
za, peptic ulcer disease, hern ia  and in ­
testinal obstruction, nephritis  and 
nephrosis, and ren a l infections.55 No 
data  ex ist curren tly  which allow even 
such an approxim ate quan tita tion  of 
anesthesia m orbidity. The m orbid ity  
and m ortality  of anesthesia, including 
as its does the m orb id ity  and m orta lity  
due to “halothane h e p a titis”, is there-
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fore obviously in desperate need of ade­
quate epidemiologic study, to the extent 
that the choice of anesthetic agent or 
technique for a specific patient cannot 
currently be made on a sound scientific 
basis in the majority of instances. Per­
haps, in addition, the true nature of un­
explained hepatitis following the ad­
ministration of anesthesia will become 
apparent as more is learned concerning 
the true nature of viral hepatitis. It re­
mains possible that a relationship exists 
between the etiology and mode of con­
traction of the many cases of “ unex­
plained”  viral hepatitis delineated by 
the Boston Inter-Hospital Liver 
Group,36-38 and the etiology and mode of 
contraction of the cases of unexplained 
hepatitis, which can follow the adminis­
tration of anesthesia irrespective of 
whether or not halothane was included 
therein.
It has recently been stated in an edi­
torial in the British Medical Journal56 
“ that surgeons can offer enormously 
more comfort and relief to humanity 
than they could 50 years ago is un­
doubted, but like practitioners in other 
branches of medicine, they are now 
having to make painful decisions on 
whether it is really in the patient’s best 
interest to be treated at all, and if so, 
how” .
There appears little doubt, therefore, 
that the reasons for choosing one anes­
thetic agent or technique rather than 
another, or for choosing one operation 
rather than another, or no operation at 
all—two of the most important deci­
sions involved in the care of the surgical 
patient—both obviously require a much 
more widespread basis in satisfactory 
epidemiologic data than they currently 
enjoy. Clearly this situation represents 
further evidence of the validity of 
Hiatt’s1 contention that, “ Epidemiologic 
research has not occupied much of our 
attention. . .”
Current Immunologic A spects
Many of the advances in clinical med­
icine can be divided into four major 
phases. First, there are careful clinical
observations at the bedside and the 
recording of all pertinent, as well as 
seemingly irrelevant, information. Sec­
ond, there comes a moment of inspira­
tion when facts and fancies seem to 
have some relationship and a possible 
causal mechanism is considered which 
may explain the illness. This hypothesis 
is then tested in an appropriate labo­
ratory model— the third phase. Finally, 
in the fourth phase, the basic informa­
tion gathered in the laboratory is applied 
in the clinic to provide the epidemiologic 
proof required to guarantee improved 
medical care for the individual patient. 
The so-called “ halothane hepatitis” syn­
drome is still in the first phase.
From the clinical immunologist’s 
point of view, many of the features of 
well-described— if not all proven— 
cases41,57 have the characteristics of a 
hypersensitivity (allergic) phenome­
non: the cases are rare; they seem to 
occur more frequently after repeated 
exposures; and are often clinically as­
sociated with many of the features of 
serum sickness including fever, rash, 
myalgias, arthralgias, and eosinophilia. 
At least one anesthetist has developed 
some of these features, as well as liver 
necrosis, after deliberate challenge with 
a small dose of halothane.41 However, it 
is of course possible that halothane acts 
directly upon the liver, despite the fact 
that the drug does not appear to pro­
duce a direct lesion in the experimental 
animal even after repeated exposures.23 
Further, the possibility that a metabo­
lite of the drug may be produced in cer­
tain genetically predisposed individuals, 
which is directly toxic to the liver, will 
be discussed below.
We will, therefore, speculate here on 
possible immunologic mechanisms for 
“ halothane hepatitis” . Classical immu­
nologic syndromes involving tissue in­
jury usually either involve an antigen- 
antibody interaction which then ac­
tivates other mediators of inflammation 
(a typical example is the nephritis of 
systemic lupus erythematosus),58 or in­
volve sensitized lymphocytes which may 
interact with the antigen, thus trigger-
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ing interactions with other cells and 
thereby activating mediators of inflam­
mation. An example of this la tter “de­
layed” or “cellular” hypersensitivity is 
contact skin sensitivity such as is ob­
served in the lesion caused by poison 
ivy.59 Both of these theoretical immu­
nologic mechanisms require tha t halo- 
thane be antigenic.
Although the molecule of this halo- 
genated hydrocarbon is probably too 
small to be antigenic, it may come w ith­
in the range of size of many haptens— 
that is, it may have the ability to com­
bine with other substances, namely, pro­
teins, to become antigenic. Some pos­
sible mechanisms for halothane-induced 
hepatic injury are depicted in Fig. 2. 
In the first type of immunologic reac­
tion, halothane might initially combine 
with some hepatic surface substance to 
become antigenic. Antibodies might 
then be produced against this new struc­
ture, or lymphocytes might become sen­
sitized to it. Upon re-exposure to halo­
thane, the immunologic response would 
be enhanced, halothane would react with 
the hepatocytes, and antibodies or sen­
sitized lymphocytes would react with the 
halothane-hepatocyte structure. There 
is little evidence, however, to support 
this hypothesis because antibodies to a 
halothane-liver “complex” have yet to 
be found, although lymphocytes may be­
come sensitized to a halothane-liver 
“complex”.60 In addition, neither gamma 
globulin nor sensitized lymphocytes 
have been found in the livers of patients 
suspected of suffering from “halothane 
hepatitis”—that is, the potential medi­
ators have not been identified a t the 
site of the pathology.
A second immunologic mechanism 
known to cause tissue damage is the “in­
nocent-bystander reaction”. Here an an­
tigen reacts with an antibody, or sen­
sitized lymphocytes, when, by chance, it 
is in close proximity to an “innocent- 
bystander” cell, which is then injured. 
An example of this type of reaction is 
drug-induced thrombocytopenia,61 but 
there is no evidence tha t halothane can 
act in this manner. Perhaps halothane
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Fig. 2 .-F °ur possible mechanisms for “halo­
thane hepatitis”: A. Direct action of halothane 
upon the hepatocyte; B. Combination of halo­
thane with hepatocyte surface substance to 
become antigenic; C. “Innocent-bystander reac­
tion (see text); D. Halothane induces patients 
to produce antibodies or sensitized lympho- 
cytes to some constituents of the hepatocyte.
reacts with a serum protein. An an ti­
body or sensitized lymphocytes then 
react with that complex, so th a t the re­
sulting complex might injure the liver. 
No evidence exists to support th is con­
jecture either.
A third immunologic mechanism tha t 
has been proposed is tha t halothane, in 
a manner as yet unknown, induces pa­
tients to produce antibodies, or sensi­
tized lymphocytes, to some liver consti­
tuents. Upon re-exposure to the drug, 
the antibody titre would increase, and 
antibodies would somehow interact with 
the liver substance and cause tissue in­
jury. Although some patients suspected 
of having “halothane hepatitis” have 
been noted to have antimitochondrial 
antibodies, such antibodies are also 
found in patients with other form s of 
liver disease.62 In addition, there is no 
evidence th a t these, or any other an ti­
bodies, can enter the liver cells. Al­
though the origin of these antibodies re­
mains unknown, they are probably 
found in many individuals in response 
to many form s of liver injury.
A fu rther mechanism, albeit a non- 
immunologic one, tha t has been sug­
gested is th a t halothane might activate 
latent viral hepatitis. To date, however, 
no evidence—such as finding viral in­
clusions in pathological m aterial or he­
patitis-associated antigen in blood— 
exists to support th is  hypothesis.
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TABLE VIII.— Some Conditions A ssociated W ith Eosinophilia
Vol. 15
ALLERGIC:
Bronchia i asthma 
Urticaria
Angioneurotic edema 
Hay fever
PARASITIC:
T richinosis
Echinococcosis
Cysticercosis
T oxoplasmosis
Schistosomiasis
Clonorchiosis
Filariasis
Ascariasis
T  aeniasis
Strongyloidiasis
SKIN DISORDERS: 
Pemphigus
Dermatitis herpetiformis 
Exfoliative dermatitis 
Psoriasis 
Eczema
Dermatitis venenata 
Ichthyosis 
Mycosis fungoides 
Pityriasis rubra 
Scabies
HORMONAL: 
Addison’s disease
PULMONARY: 
Loffler’s syndrome 
Tropical eosinophilia 
Pleural effusions
INFECTION:
Gonorrhea
Meningococcal meningitis
Meningococcal pneumonia
Staphylococcal osteomyelitis
Puerperal fever
Brucellosis
Tuberculosis
Scarlet fever
Measles
Mumps
Whooping cough
Diphtheria
Smallpox
Syphilis
Malaria
T rypanosomiasis 
Amebiasis
PHYSICAL:
Post x-irradiation 
Radium therapy
INTESTINAL:
Ulcerative colitis 
Peptic ulcer
GENETIC:
Familial eosinophilia
HEMATOLOGIC:
Chronic myelogenous leukemia 
Erythemia 
Hodgkin’s disease 
Post-splenectomy 
Pernicious anemia 
Sickle-cell anemia 
Henoch's purpura
COLLAGEN DISEASE: 
Feriarteritis nodosa 
Rheumatic fever 
Lupus erythematosus 
Dermatomyositis 
Rheumatoid arthritis
NEOPLASTIC:
Ovarian carcinoma 
Cervical carcinoma 
Intestinal carcinoma
POISONING:
Copper sulfate
Camphor
Pilocarpine
Phosphorus
Mercury
A rsenic
Acetanilid
SKELETAL:
Osteomalacia
Rickets
Paget’s disease
In summary, we find little evidence to 
support the hypothesis that an immu­
nologic mechanism is important in the 
development of “halothane hepatitis” .
One of the major pieces of “ evidence” 
used to support a hypersensitivity 
etiology for “halothane hepatitis” has 
been the finding of eosinophilia in some 
of the patients suspected of demon­
strating this entity, and in both of the 
anesthetists who demonstrated true posi­
tive challenge tests. Table VIII has been 
culled from references too numerous to 
cite,63 but is ample evidence that many 
non-immunologic mechanisms and di­
sorders have been associated with peri­
pheral eosinophilia. Because of this, and 
the fact that little is known of the in­
cidence or causes of eosinophilia in the 
postoperative patient, the diagnostic 
significance of eosinophilia in the in­
dividual patient who develops hepatitis 
following the administration of halo­
thane, remains to be established.
C u r r e n t  M e t a b o l ic  A s p e c t s  
Although halothane (2-bromo-2- 
chloro-l,l,l-trifluoroethane) was orig­
inally introduced as a “ biologically 
stable” halogenated anesthetic, its me­
tabolism was soon demonstrated in vitro 
and in vivo.**'™ The carbon-to-fluorine 
bond is exceedingly stable, but the car- 
bon-to-chlorine and the carbon-to- 
bromine linkages are enzymatically 
cleaved, resulting in increased urinary 
bromide and non-volatile fluoride levels 
following halothane anesthesia. By 
measuring the amount of halothane 
taken up into the body during the course 
of an inhalation anesthetic, it has been 
shown that 12% to 20% of the anesthe­
tic can be accounted for in terms of 
non-volatile urinary metabolites.70 Such 
metabolites remained detectable in the 
urine 13 days after the anesthetic. Later 
studies, utilizing trace (non-anesthetic) 
doses of 14C-labelled halothane, indicate 
an even higher level of metabolism.71
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Recent studies have succeeded in isolat­
ing a number of urinary metabolites and 
identifying the major components as 
trifluoroacetic acid and the trifluoro- 
acetyl derivative of ethanolamine. 72 
Significant species differences are 
found in the metabolism of halothane in 
man compared with mice and monkeys.
Animal studies have indicated that 
large amounts of non-volatile halothane 
metabolites accumulate in the liver fol­
lowing anesthesia, but data in man are 
difficult to obtain.73- 74 A recent study 
employing 14C-labelled halothane con­
firms the presence of non-volatile liver 
metabolites in man, and further sug­
gests that many of these materials are 
of high molecular weight. 75 Subcellular 
fractionation of liver homogenates in­
dicates that the highest concentration of 
radioactive metabolites is associated 
with the microsomes, mitochondria, and 
cell membranes. Since the majority of 
these metabolites are fluorine-contain­
ing compounds, the suggestion has been 
made that the trifluoroacetate ion may 
represent the key step in the metabolism 
of halothane. This is a highly reactive 
material which can readily combine 
with proteins, polypeptides, amino 
acids, and lipids. 72
Pre-treatment of animals with en­
zyme-inducing drugs serves to stimulate 
the metabolism of halothane adminis­
tered at a later time,76, 77 and prior ad­
ministration of halothane will increase 
the metabolism of a subsequently ad­
ministered halothane anesthetic. 73 The 
possibility of enzyme induction in man 
has been indicated by a comparative 
study of halothane metabolism in anes­
thetists and pharmacists. 71 The former 
group evidenced higher levels of me­
tabolism following the injection of trace 
doses of 14C-labelled halothane. The sug­
gestion has therefore been made that an 
increase in halothane metabolism re­
sults from an induction of enzyme sys­
tems following repeated exposure of the 
anesthetist to trace concentrations of 
halothane present in the operating-room 
atmosphere.
The presence of trace concentrations
of halothane in the operating room dur­
ing the conduct of anesthesia has been 
verified in several recent studies. 78' 80 
While the toxicologic effects of these 
trace anesthetic concentrations has not 
yet been fully defined as noted above, 
there is evidence that they are of suf­
ficient magnitude to have resulted in a 
“ sensitization” response in at least two 
anesthetists. 41' 81 Of added concern is the 
possible influence of these trace con­
centrations of anesthetic upon the fetus, 
since an increased spontaneous miscar­
riage rate has been reported in female 
operating-room personnel. 82-84 In this 
context it should also be noted that after 
an anesthetic machine has been used to 
deliver halothane, its anesthetic circle 
becomes contaminated with the drug, to 
the extent that low concentrations of 
halothane can be administered to a suc­
ceeding patient whether this is intended 
or not. 85 This contamination of the anes­
thetic circle with halothane is reduced, 
but not eliminated, when the rubber 
goods and soda lime are changed be­
tween anesthetic administrations.
Considerable variations in the amount 
of halothane metabolism can be demon­
strated between individuals. 71 Differen­
ces are also present in the ability of the 
same individual to metabolize the dif­
ferent halogenated anesthetics. 86 An 
evaluation of possible genetic and en­
vironmental influences* of halothane 
metabolism has been studied in a series 
of identical and fraternal twins . 87 Intra­
pair differences in the amounts of non­
volatile urinary metabolites were less 
in the identical than in the fraternal 
twins, suggesting the greater influence 
of genetic than environmental factors.
Finally, the possibility must be con­
sidered that “halothane hepatitis” is a 
metabolic disease. As noted previously, 
an increase in hepatotoxic reactions has 
been reported to follow repeated expo­
sures to halothane anesthesia and, in a 
number of instances, these appear to 
represent a sensitization response. Al­
though the responsible haptene has not 
yet been discovered and is unlikely to be 
represented by a small molecule such as
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halothane, larger antigenic molecules 
may result from the metabolism of halo­
thane in which the reactive metabolites 
combine with large protein fractions. 
Evidence for such conjugates is now 
available.75 An alternative explanation 
for the hepatotoxicity of halothane is 
that the metabolites themselves are he- 
patotoxic and may accumulate to dam­
aging concentrations within the liver 
following repeated anesthetic adminis­
trations, enzyme induction playing an 
additional role. The toxicity of such ma­
terials in man is presumptive and re­
mains to be established.
C o m m e n t
Ideally medicine should be practised 
on the basis of established fact, or to 
use an alternative term, on the basis of 
tested hypotheses. To be more specific 
this implies that each therapeutic 
maneuver, be it operative or non-oper­
ative, should be justified by the exist­
ence of hypothesis-testing data. These 
data should indicate not only that the 
efficacy of the maneuver outweighs its 
toxicity, but that it offers the patient a 
greater chance of achieving a successful 
outcome than any of the alternatives 
that might be available.
Unfortunately, as noted in the open­
ing paragraph of this review, the med­
ical profession has not always been suc­
cessful in providing hypothesis-testing 
data to underlie its clinical practice.
Pickering5 has noted that “medicine 
still retains more than a trace of the 
habit of mind of the mediaeval school­
man in its make-up which science has 
shed” . That medicine has not shed such 
attitudes needs no more dramatic proof, 
to the anesthetist at least, than the fact 
that 15 years after the introduction of 
halothane, during which time the agent 
has become one of the most popular 
drugs available to him, no data exist 
which test the hypothesis that the toxic­
ity of multiple administrations of the 
halothane outweighs its efficacy.
Another statement by Pickering,5 “ If 
for a moment we stand aside and look 
at Medicine as it exists today we find
that the method of theoretical disputa­
tion still holds a dominant place,” is 
exemplified in the current controversy 
surrounding multiple administrations of 
halothane. There is much “theoretical 
disputation” , but no definitive epidemi­
ologic experimentation is currently 
being conducted.
A substantial proportion of the thera­
py that is prescribed today finds its ba­
sis in formulated rather than tested hy­
potheses. Quantification of this “ sub­
stantial proportion” , if it were possible, 
would provide a direct measure of the 
extent to which “academic medicine” 
has not been successful in providing 
“ clinical medicine” with a raison d’etre. 
The successful investigation of the me­
chanisms of disease by the basic scien­
tist, and the unravelling of pharmaco- 
physiologic responses to therapeutic in­
terventions in intact man, may lead to 
“ rational medicine” . However, without 
a concomitant demonstration by the epi­
demiologists of a benefit to those suf­
fering from the disease in question, “ ra­
tional medicine” may well be of little 
practical value to the patient. Likewise, 
the practice of “numerator medicine” , 
that is, the basing of clinical practice on 
hypotheses formulated on one or more 
anecdotal isolated case reports, may of­
ten be of no value to the patient. Only 
when denominator, and thereby inci­
dence— or preferably comparative in­
cidence-—data are available, can the 
practice of medicine be what it should 
be, that is, “ denominator medicine” .
Wasmuth88 has noted recently that, in 
the United States at least,* if it can be 
established that “ the selection of halo­
thane meets the community’s stand­
ards” , and that “ due care and skill were 
exercised in the use of the agent” , for a 
physician to be liable in malpractice if 
he uses the drug, “ the plaintiff, by ex­
pert testimony, must establish that the 
administration of halothane in fact
*We hope readers outside the United States 
will understand that we feel constrained to 
confine our comments on medicolegal matters 
to the situation as it pertains to the United 
States.
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caused the hepatic dam age”. The m eans 
fo r establishing this relationship in the 
individual patient do not curren tly  exist. 
However, the basic scientists m ight 
some day provide us w ith the m eans of 
m aking the diagnosis of “halothane he­
p a titis”, before the epidemiologists have 
dem onstrated th a t the efficacy of the 
drug  outweighs its toxicity, and th a t  the 
agen t offers the patien t a g rea te r  
chance of achieving a  satisfactory  out­
come than  any of the available a lte rn ­
atives, if indeed such is the case. I f  th is 
situation develops the medicolegal posi­
tion could be altered drastically, and 
possibly to the detrim ent of our p a ti­
ents, if  anesthetists, through fe a r  of 
legal action, began to withhold halo­
thane from  patients who would have a 
g rea te r chance of achieving a sa tisfac ­
to ry  outcome if they received the drug.
In addition, W asm uth 88 has w arned of 
w hat he called “tria l by press” in the  
following m anner: “T hat prom inent 
anesthesiologists made statem ents th a t  
were so newsworthy as to be fea tu red  in 
prom inent news publications m ight well 
weigh heavily in favor of the p la in tiff  
against the defendant physician.”
Because “halothane hepatitis” cannot 
yet be diagnosed in the  individual pa­
tient, we recommend strongly th a t such 
a diagnosis not be w ritten  in the  pa­
tie n t’s hospital record. A diagnosis such 
as “unexplained hepatitis following h a ­
lo thane” would be a b e tte r reflection of 
cu rren t knowledge. Such a patient, how­
ever, should be w arned not to receive 
halothane again. We a re  strongly of the 
opinion th a t th is is ne ither a specious 
nor a trifling  point. W eed89 has sta ted  
th a t “A diagnosis is a step  forw ard  only 
when it can be sustained by the evidence 
a t  hand,” and P ickering 5 has commented 
upon the difficulties of being both a 
scientist and a physician, by s ta ting , 
“ Intellectual nihilism is the very s tu ff  
of which scientists are made, bu t it is 
scarcely convenient fo r a p rac tis ing  
physician.” The research w orker goes 
on “collecting and classifying and fo r ­
m ulating and testing hypotheses” , while 
the  physician “gathers all the relevant
data he can, form s the  best judgm en t he 
can, and ac ts ” . 5 T herefore, in th is  con­
text, as scientists we will not be able to 
make the diagnosis of “halothane hepa­
tit is” un til a specific diagnostic te s t  be­
comes available, b u t m eanw hile, as phy­
sicians, we will be expected to act and to 
tre a t (anesthetize) as best we can those 
patien ts who have developed “unex­
plained hepatitis” following the  ad ­
m in istration  of halothane.
In th is tim e of acu te  and u nders tand ­
able concern with the  d istribu tion  or 
availability  of health  care, i t  would 
seem p ruden t to b ear in mind th a t  an 
even g rea te r  concern should be the  
“health” of the scien tific  basis upon 
which all health care  m ust rest. W eed89 
has stated , “There have been m ajo r h u ­
m an ita rian  and sociologic fa ilings in 
medicine, bu t alm ost all of them  can be 
a ttribu ted  to  our poor behavior as scien­
tis ts ,” and W annam aker 10 has exhorted, 
“In our eagerness to deliver m edical 
care— in both the old and the new  w ays 
—it is certain ly  w orth  pausing to  con­
sider th a t we do not know  the value of 
some of th e  sim plest goods being deliv­
ered. W ithout built-in  com parisons and 
means of evaluation, we may continue 
to perform  old ritu a ls  u nder new guises 
on ever la rge r num bers of innocents.”
It is to be hoped th a t  the  cu rren t lack 
of knowledge concerning the efficacy 
and toxicity  of m ultiple adm in istra tions 
of halothane is not allowed to p ersis t 
indefinitely.
Summary
This review  of th e  relationship  be­
tween halothane and the  liver has evalu­
ated the cu rren t s ta tu s  of its epidem ­
iologic, immunologic and m etabolic 
aspects.
We have noted the types of epidem ­
iologic technique th a t  a re  available to 
illum inate such associations and have 
discussed th e  h isto ry  and background 
of th is particu la r rela tionship . The cu r­
ren t s ta tu s  of rare , unpredictable, ad ­
verse drug  reactions in  general, and of 
the liver in particu lar, has also been dis­
cussed.
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Our discussion of the epidemiologic aspects of the relationship between halo- thane and the liver included comment upon: the retrospective cohort studies; multiple halothane administrations; the diagnosis, prevention, and incidence of “halothane hepatitis” ; and five anec­dotal case reports. We believe that the only truly compelling evidence for the existence of “halothane hepatitis” re­mains the two anesthetists who demon­strated a true positive halothane chal­
lenge.We find little evidence to support the hypothesis that an immunologic me­chanism is important in the develop­ment of “halothane hepatitis”, and also believe that it remains to be established that halothane is metabolized in such a manner that a hepatotoxic metabolite accumulates to damaging concentrations 
within the liver.
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R esum e
La presente revue des rapports existant 
entre l’halothane et le foie constitue une eva­
luation recente de leurs aspects immunologi- 
ques, epidemiologiques et metaboliques.
Dans cette revue, nous avons etudie les types 
de methodes immunologiques permettant d’elu- 
cider ce genre de rapports et avons passe en 
revue l’historique de cette relation particuliere. 
Nous avons egalement precise l’etat actuel des 
reactions medicamenteuses defavorables, rares 
et souvent imprevisibles generates sur le foie 
en particulier.
Dans notre expose sur les aspects epidemio­
logiques de la relation entre l’halothane et le 
foie, figuraient notamment des commentaires 
sur: une analyse retrospective d’une cohorte, 
l’administration multiple d’halothane, le dia­
gnostic, la prevention et la frequence de “ l’he- 
patite a Thalothane” et sur cinq cas simple- 
ment anecdotiques. Nous croyons que la seule 
preuve reelle de l’existence d’une “hepatite a 
l’halothane” a ete apportee par deux anesthe- 
sistes qui ont demontre l’existence d’une veri­
table reaction defavorable provoquee par l’ha- 
lothane.
Nous n’avons guere trouve de preuves pour 
confirmer l’hypothese qu’un mecanisme immu- 
nologique jouerait un role important dans la 
genese de “ l’hepatite a l’halothane” et nous 
continuous de croire qu’il reste a etablir que 
l’halothane est metabolise de telle sorte qu’un 
metabolite hepatotoxique s’accumule a des con­
centrations qui peuvent leser le foie.
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EXPERIMENTAL “ANTERIOR” SPINAL FUSION IN GUINEA PIGS- 
A HISTOLOGIC STUDY OF THE CHANGES IN THE 
ANTERIOR AND POSTERIOR ELEMENTS*
S. H. SINGH, M.B., B.S., F.R.C.SJEng & Cl and 
W. H. KIRKALDY-WILLIS, M.A., M.D., F.R.C.S [Edin. & C ] ,
Saskatoon, Sask.
F.A.C.S.,
T his study describes the histologic 
changes found following anterior inter­
body vertebral bone grafting in guinea 
pigs. Our interest was stimulated by the 
accidental clinical observations by one 
of us1 that the posterior vertebral ele­
ments undergo spontaneous bony fusion 
following anterior surgery in the treat­
ment of spinal tuberculosis. While an­
terior intervertebral fusion has gained 
an accepted place in the management of 
various spinal disorders,2'6 so far as we 
know, no account has been published of 
the histologic changes that occur follow­
ing this technique.
Materials and  Methods
Forty-two mature guinea pigs, 
ranging in weight from 650 g. to 950 g., 
were used. This was found to be an ade­
quate size for carrying out anterior 
fusion. While it was impossible to pro­
vide external immobilization after the 
operation, we hoped that by using a 
large number of animals a sufficient 
number of bony fusions would occur to 
provide adequate material for histologic 
study.
The operations were performed under 
general anesthesia using sodium pento­
barbital (Nembutal) by ii^traperitoneal 
injection and with standard aseptic 
technique. The lumbosacral junction 
was exposed transperitoneally through 
a midline abdominal incision. Most of 
the disc with the annulus fibrosus, 
nucleus pulposus and cartilage plates 
was removed, but a small amount of an­
nulus fibrosus was left posteriorly to 
protect the cauda equina. With a dental 
drill, a tunnel in the bone was cut obli­
quely across the left ventrolateral aspect 
of the body of the last lumbar vertebra, 
across the disc space and into the body 
of the first sacral segment. An auto-
*From the Department of Surgery, University 
of Saskatchewan, Saskatoon, Sask.
TABLE 1.—T ime at Which Animals Were 
Sacrificed
Time {weeks) No. of animals
3 .....................
6 .................
12.................
18.................
24 .................
30............
36 .................
42 .................
48 .................
54.................
58.............
60................. 9
genous bone graft, taken from the right 
iliac crest, was shaped to form a dowel 
and was introduced as tightly as pos­
sible into the tunnel across the vertebral 
bodies. Cancellous bone chips, also taken 
from the iliac crest, were packed in the 
disc space around the main graft. Ad­
ditional cancellous bone was placed in 
front of the disc space and the adjacent 
vertebral bodies.
The guinea pigs were sacrificed at 
intervals ranging from three to 60 
weeks after operation (Table I). The 
three lumbar vertebral bodies above the 
level of the fusion, the lumbosacral junc­
tion and the sacrum were excised en 
bloc, fixed in 10% formalin, decalcified 
in Kirstensen’s fluid and sectioned in 
paraffin in the sagittal plane. Sections 
from all the blocks were stained with 
hematoxylin and eosin. Selected sections 
were stained with Gomori’s aldehyde 
fuchsin, periodic-acid-Schiff (PAS),  
Masson’s stain, alcian blue and Hale’s 
stain.
Observations
During the first 12 weeks, similar 
changes were noted in each animal. 
Thereafter, the nature of the histologic 
changes depended upon the degree of 
immobilization achieved with the ex­
perimental procedure. To simplify the 
interpretation of our results, therefore,
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Fig. 1.—At six weeks. Graft fragments with 
many empty lacunae. Numerous new vascular 
channels are seen within the substance of the 
graft. A  mass of new cartilage is seen dor- 
sally at the top (H & E X 40).
we present them under three headings:
(1) early changes (up to 12 weeks);
(2) late changes (12 to 60 weeks) when 
immobilization was not achieved; and
(3) late changes (12 to 60 weeks) when 
immobilization was achieved.
Intermediate changes in 15 animals 
are not reported. In these it was not 
possible to determine whether the end 
result would be the changes of complete 
immobilization or not.
(1) Early Changes (three to 12 
weeks, four animals)
Betiueen the vertebral bodies.—By 
the end of 12 weeks, the grafts had been 
absorbed by osteoclastic activity and 
were replaced by fibrous tissue (Fig. 1). 
Thin trabeculae of new bone extended 
into this from the cancellous bone of the 
adjacent vertebral bodies (Fig. 2).
Ventral and lateral to the graft a pro- 
truberant mass of callus formed. Two 
areas of new cartilage appeared in this.
Fig. 2.—At 12 weeks. The graft has com­
pletely disappeared. In its place is a mass of 
fibrovascular tissue (large arrow). Trabeculae 
of new bone can be seen arising from the ver­
tebral bodies on both sides. New cartilage can 
be seen ventral to the area where the graft has 
been (small arrow). The dorsal part of the an­
nulus fibrosus is adherent to a nerve (N) 
(H & E X  10).
These fused to form one mass. Some en- 
chondral ossification of this mass took 
place.
Dorsal to the graft the remnants of 
the annulus fibrosus bulged into the 
bony spinal canal. Some new fibrocar- 
tilage resembling callus formed in this 
region. The nerves of the cauda equina 
were adherent to this tissue.
In all the specimens there was a well- 
defined band of cartilage that extended 
from the dorsal to the ventral aspect of 
the original disc space. Numerous new 
trabeculae of bone arose from the verte­
bral bodies and a few of these traversed 
the cartilage band.
Dorsally, in one specimen, a mass of 
fibrous tissue was seen protruding into 
the spinal canal and apparently press­
ing on the nerves of the cauda equina.
Between the posterior elements.— In 
the specimens observed up to 12 weeks, 
a pannus of synovial tissue arising from 
the periphery of the posterior joint en­
tered it and became adherent to one or 
both surfaces. Synovial processes pene­
trated the articular cartilage which was 
replaced by fibrovascular tissue with 
some new bone formation. The deeper 
layers of the articular cartilage ap­
peared to be normal but there was loss 
of ground substance in some areas. In 
the subchondral region there was in­
vasion of the cartilage from the under-
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Fig. 3.—Twenty-four weeks. The band of 
cartilage can be seen (large arrow) extending 
right across the excised disc space. On either 
side of this are many new bony trabeculae con­
tinuous with the bone of the vertebral bodies 
(small arrows) (H & E X 10).
r ig. 4.—At 60 weeks. In the central and 
ventral part of the section is an area of car­
tilage with numerous clefts in its substance 
(large arrow). A narrow cleft can be seen ex­
tending between the two masses of bone (small 
arrow) which are in contact but not fused to­
gether (H & E X 10).
lying bone by vascular channels with 
new bone formation. This replaced the 
deepest layers of the cartilage.
(2 ) Late Changes When Interver­
tebral Fixation had not Occurred 
(19 animals)
Between the vertebral bodies.— In 19 
specimens a mass of fibrocartilage filled 
the space where the disc had been and 
extended from the dorsal to the ventral 
aspect of this space (Fig. 3). Numerous 
large irregular clefts were seen in this 
fibrocartilage. On either side of this 
were numerous thick trabeculae of new 
bone, arising from the cancellous bone 
of the vertebral bodies. None of these 
trabeculae had crossed the cartilage
Fig. 5.—At 60 weeks. The fibrocartilage fills 
the space between the two vertebral bodies. A 
series of large clefts passes from top to bot­
tom. The arrow points to one o f these 
(H & E X 25).
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Fig. 6.—At 16 weeks. Pannus covers the ar­
ticular surface of a posterior joint (arrow). At 
this point the pannus has extended into and 
eroded the cartilage in the centre of the field 
(H & E X  160).
plate to unite with one another (Figs. 4
Fig. 7.—At 60 weeks. The articular surface 
is distorted. A  synovial frond (small arrow) is 
adherent to the lower surface on the right. In 
one place (large arrow) the surface is com­
posed of bone with no cartilage over it (H & 
E X  401.
and 5). A mass of fibrocartilage was 
seen which protruded posteriorly into 
the spinal canal and pressed on the 
cauda equina.
Between the posterior elements.— The 
articular surfaces of the posterior joints 
were deformed and irregular, but a 
well-defined joint surface and joint 
space was maintained. In one specimen 
a pannus crossed the joint from one 
surface to the other in its medial part 
(Fig. 6). In another a synovial frond 
was attached to superficial bone. In a 
few cases a pannus covered articular
Fig. 8.—At 54 weeks. The articular surfaces 
are clearly seen. Synovial pannus adheres to 
the lower surface in the left of the field (large 
arrow). Several areas of superficial and sub­
chondral new bone formation are seen (small 
arrow) (PAS X  100).
cartilage at the periphery of the joint.
The total area of the cartilage surface 
of the joint appeared to be diminished. 
In some places the cartilage was thicker 
than normal, while in others it was thin­
ner, because of new bone formation both 
from superficial pannus and from sub­
chondral bone. In some areas the articu­
lar cartilage was acellular; in others 
there was clumping of chondrocytes; 
and in others there was fibrillation of 
the articular surface (Figs. 7 to 9).
The bony articular processes were 
thicker than normal, because of the for-
Fig. 9.—At 48 weeks. There is gross distor­
tion of the articular surfaces. In many areas 
there is clumping of chondrocytes. Fibrilla­
tion of the cartilage is seen in one area (ar­
row) (H & E X 100).
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Fig. 10.—At 24 weeks. Part of the surface 
of an articular process showing’ the formation 
of cartilage deep to the periosteum (arrow) 
(H & E X  100).
mation of new subperiosteal bone. In 
some specimens osteophytes were seen 
at the periphery of the articular pro­
cesses (Fig. 10).
(3) Late Changes When Interver­
tebral Fixation had Occurred (four 
animals)
Between the vertebral bodies.— Ver­
tebral body fusion by bone was seen in 
four specimens only, in one at 18 weeks, 
in one at 42 weeks and in two at 60 
weeks. In each instance the two ver­
tebral bodies were completely united by 
numerous thick trabeculae of bone. In 
this new bone some small islands of 
cartilage were seen in a few sections. 
There was angulation of the vertebral 
bodies to produce a kyphosis. Dorsally 
new bone appeared to protrude into the 
spinal canal and cause pressure on the 
cauda equina (Fig. 11).
Between the posterior elements.— The 
changes were similar to, but more ad­
Fig. 11.—At 42 weeks. Complete fusion by 
bone from one vertebral body to the other 
across the disc space, with numerous trabe­
culae of new bone from the ventral to the 
dorsal aspect. Dorsally new bone impinges on 
the cauda equina (arrow) (H & E X  10).
vanced than, those seen during the first 
12 weeks. At the periphery of the poste­
rior joint there was a thick pannus with 
vascular channels in it. This pannus was 
adherent to both cartilage surfaces 
causing obliteration of the joint space 
(Fig. 12). There was new bone covering 
the superficial layers of cartilage. The 
chondrocytes in the intermediate zone 
were pyknotic, and the staining reac­
tion of the ground substance was al­
tered. In some areas there was a com­
plete loss of chondrocytes. Invasion of 
the deep layers of the cartilage by sub­
chondral bone with formation of new 
Haversian systems was more extensive. 
In some places areas of new bone, 
formed both superficially and from the 
subchondral bone, were almost in con­
tact with each other, with complete loss 
of cartilage.
In the centre of some joints one car­
tilage surface was in complete contact 
with the other giving the impression of
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and joined together by a layer of pannus 
(large arrow) (H & E X 100).
a “ chondrodesis” (Fig. 13). The super­
ficial dorsal surfaces of the bony ar­
ticular processes appeared to be irre­
gular, and the processes themselves 
thicker than normal. On microscopic 
examination these surfaces showed 
marked subperiosteal new cartilage for­
mation. This was later replaced by new 
bone formed by endochondral ossifica­
tion.
In the four specimens in which com­
plete bony interbody fusion was ob­
served, two had complete fusion by bone 
across the original articular surfaces of 
the posterior joints (Fig. 14). In this 
bone were a few small islands of car­
tilage. In one specimen there was com-
Fig. 14.—At 42 weeks. The original plane 
of the posterior-joint articular surface was on 
a line passing between the two small arrows. 
There is a complete osseous fusion of this pos­
terior joint. Islands of cartilage are still 
present (large arrow) (PAS X  25).
Fig. 13.—At 24 weeks. The articular car­
tilage on both sides of the joint is in contact 
producing what appears to be a chondrodesis 
(arrow) (H & E X  160).
plete fusion of one joint by bone, but in 
the other joint there was fusion by bone 
at the periphery and by cartilage in the 
centre (Fig. 15). In one case the lami­
nae were fused by cartilage and it was 
not possible to identify the posterior 
joint surfaces.
Changes were also noted in the lami­
nae and ligamenta flava. In one speci­
men both laminae were fused by car­
tilage, a “chondrodesis” (Fig. 16). The 
underlying ligamentum flavum was 
thick and cellular. In three specimens 
the laminae were fused by bone lateral­
ly. Remnants of the ligamentum flavum 
could be seen deep to this new bone. 
Medially there was no fusion of the
Fig. 15.—At 60 weeks. There is osseous fu­
sion at the periphery of the posterior joint on 
the right (small arrow) and fusion by car­
tilage, a chondrodesis, in the centre (large 
arrow) (H & E X  100).
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F ig . 16.—A t 18 weeks. The tw o lam inae  
(L, L) a re  bonded to g e th e r by ca rtilag e  to  
fo rm  a chondrodesis (a rro w ) (H  & E X 25).
laminae. The transverse  processes were 
fused in two specimens.
New subperiosteal bone was seen as 
a complete ring  around the foram en in 
three specimens with apparen t nerve- 
root compression (Fig. 17). In all four 
specimens there  was m arked subperio­
steal bone form ation on the surface of 
the bony a rticu la r processes.
D i s c u s s i o n
Changes Between the Vertebral
Bodies
D uring the f ir s t  12 weeks, the main 
g ra f t  and the cancellous chips were re­
moved rapidly. A mass of fibrocartilage 
was form ed between the vertebral 
bodies, and trabeculae of new bone were 
laid down from  the cells of vertebral 
body bone. I t  was impossible to say 
w hether the final result would be fusion 
by bone or by fibrocartilage.
I t appears th a t there is a critical 
phase during  which either endochondral 
ossification takes place with complete 
osseous union of the two vertebral 
bodies or th is process fails and clefts 
appear in the m ass of fibrocartilage. 
The low ra te  of bony fusion in these ex­
perim ents may well be the result of (1) 
failure of rigid in ternal immobilization 
because the main g ra f t  was removed ra ­
pidly; (2) the lack of external immobil­
ization; or (3) both of these factors. In 
repeating  these experim ents it would be
F ig . 17.—A t 42 w eeks. O sseous fu s io n  of 
v e rte b ra l bodies is seen  a t  th e  b o tto m  o f th e  
fie ld  ( la rg e  a rrow ). O sseous fu s io n  o f  th e  
p o s te r io r  jo in ts  can be seen a t  th e  to p  (sm a ll 
a r ro w ). The nerve ro o t (N ) is com p le te ly  s u r ­
rounded  by bone and ap p ea rs  to  be com pressed  
(H  & E X 10).
b e tte r  to use a more rig id  m ain g r a f t  of 
cortical bone, possibly from  the  fibu la .
Kirkaldy-W illis and Thom as7 believe 
th a t  it  is necessary to in se rt a rig id ly  
fixed cortical g ra ft, pack cancellous 
bone chips around the fusion site  and 
immobilize the spine fo r a t least th ree  
m onths in order to achieve a h igh ra te  
of fusion. Radiologic studies showed 
th a t  it was from  one to two years  a f te r  
the operation before complete bony fu ­
sion w ith a trabecular p a tte rn  w as seen. 
In  patien ts on whom an te rio r fusion  is 
perform ed, one to two years m ay elapse 
before there  is complete invasion of the  
cartilag inous mass by bone from  the  
ad jacen t vertebral bodies to produce 
osseous fusion.
D uring  the evolution of the process in 
these anim al experiments, th e re  w as 
(1) collapse of the original disc space 
w ith  angulation of the  verteb ra l bodies 
to produce a lumbosacral kyphosis and
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(2) dorsal protrusion of the fibrocar- 
tilage or bone between the bodies to 
produce pressure on the cauda equina; 
this was more pronounced when no bony 
fusion took place. In clinical practice 
following anterior lumbar fusion, car­
tilage or bone may impinge on the 
cauda equina, produce localized spinal 
stenosis and cause persistent pain both 
when there is successful fusion by bone 
and when a pseudarthrosis develops. 
Greater care should be used to investi­
gate this possibility, using tomography 
or myelography, or both.
Changes in the Posterior Elements
Reference to the work of other 
authors emphasizes the probability that 
changes in joints, here in the posterior 
joints of the vertebrae, are caused by 
prolonged immobilization and pressure 
on articular cartilage. Trias8 and Salter 
and Field9 noted necrosis of cartilage 
following compression of knee joints in 
experimental animals. Salter and Field9 
noted that immobilization of joints 
without compression led to erosion of 
cartilage, either from compression or 
from lack of nutrition when the surface 
of the cartilage was covered by synovial 
pannus which sealed it from the syno­
vial fluid. Evans et al.,10 following com­
pression of joints, noted the presence of 
fibrillation within the cartilage, changes 
in the cells and ground substance, proli­
feration of connective tissue within the 
joint space, and the presence of adhe­
sions across the joint. On remobilizing 
the joint they noted that the changes 
produced by compression persisted but 
did not appear to advance over a pro­
longed period. Trias8 and Hall11 noted 
fibrillation of articular cartilage follow­
ing immobilization. Hall11 also noted a 
vascular penetration of the cartilage 
and destruction of it at the periphery of 
the joint. Harrison, Schajowicz and 
Trueta,12 studying the early changes in 
osteoarthritis of the hip, observed in­
vasion of the joint cartilage by subchon­
dral vessels and osteophyte formation in 
areas where there was no pressure on 
the cartilage. Parker and Keefer13 noted
that, in rheumatoid arthritis, the arti­
cular cartilage beneath synovium often 
disappeared. Weichselbaum,14 Lang15 and 
Pommer16 all described the presence of 
spaces with loss of ground substance in 
diseased articular cartilage. Menard17 
observed the presence of spontaneous 
fusion by bone of all the elements of 
the spine in advanced tuberculosis. 
Baker, Thomas and Kirkaldy-Willis1 de­
scribed the changes that take place in 
the posterior joints and laminae after 
anterior fusion in children with tuber­
culosis of the spine. They noted com­
plete fusion by bone of both the poste­
rior joints and the laminae, but were 
only able to describe the early changes 
and the late changes (fusion of the pos­
terior elements by bone) and did not see 
the intermediate changes. They were of 
the opinion that a normal range of 
movement was necessary to maintain 
cartilage in a healthy state and that lack 
of movement or lack of frequent inter­
mittent compression interfered with the 
nutrition of cartilage. Apparently two 
factors were important in initiating the 
changes described in articular cartilage 
(1) prolonged immobilization and (2) 
abnormal strains on the posterior joints 
when the vertebral bodies collapsed an­
teriorly. The changes seen by us in the 
posterior elements of the vertebrae were 
most striking. The factor of chief im­
portance appears to be prolonged im­
mobilization. In the early phase, im­
mobilization is obtained by the main 
graft in the vertebral bodies anteriorly. 
When anterior fusion by bone occurs it 
produces complete immobilization and 
the result is a posterior fusion by bone. 
This immobilization may act (1) by the 
formation of synovial pannus which 
covers the surface of the articular car­
tilage and impairs its nutrition from the 
synovial fluid; (2) by diminishing the 
normal circulation of synovial fluid in 
the joints with impairment of nutrition 
of the cartilage; (3) by diminishing or 
abolishing the normal intermittent com­
pression of the cartilage surfaces of the 
joints; or (4) by all three of these me­
chanisms. Superficial erosion of car-
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tilage and replacement by bone follows 
the invasion of the cartilage by synovial 
pannus. Deep erosion and invasion of 
cartilage from subchondral bone may be 
due to impaired nutrition of the car­
tilage which permits bone to form 
across the chondro-osseous junction.
Proliferation of chondrocytes occurs 
at a number of different sites. The pro­
liferation of the cells of the deep layer 
of the periosteum covering the articular 
processes leads to the formation of car­
tilage which later is replaced by bone. 
The proliferation of cells in fibrous tis­
sue between the laminae leads to meta­
plasia with the production of cartilage 
which later ossifies. The proliferation 
of cells beneath the perichondrium at 
the periphery of the joint leads first to 
the production of chondrophytes and 
then of osteophytes. The proliferation 
of chondrocytes in some areas of the 
cartilage covering the articular sur­
face of the posterior joint leads to an 
increase in the width of cartilage in 
these areas.
The changes seen in the posterior 
joints when the vertebral bodies are 
joined by fibrocartilage are those of de­
generation of the articular cartilage. It 
appears that these changes are initiated 
during the early phase of immobiliza­
tion of the first 12 weeks. When, at the 
end of this time, the main graft has 
been absorbed and some movement 
again takes place between one vertebra 
and the other, the posterior joints do not 
fuse but the degenerative changes per­
sist. Initially this may be due to impair­
ment of nutrition and later to distor­
tion of the articular facets.
Clinical Applications
These findings suggest a number of 
causes for persistent pain in patients 
who have previously had an anterior 
spinal fusion leading either to fusion by 
bone or to a fibrocartilaginous pseudar- 
throsis. Posterior spinal fusion may 
possibly produce similar side effects.
Successful fusion by bone.— (1) In 
these experiments the two parts of the 
foramen unite to form a complete bony
ring which causes pressure on the nerve 
root. We have seen the same thing in a 
patient after posterior fusion. (2) Proli­
feration of fibrocartilage or of bone 
posteriorly between the vertebral bodies 
at the fusion site may cause spinal ste­
nosis with pressure on the nerves of the 
cauda equina. In one patient after re­
peated attempts at posterior fusion for 
persistent sciatica, myelography showed 
extensive spinal stenosis.
Fibrocartilaginous pseudarthrosis.—  
(1) Spinal stenosis may develop both 
from backward extension of fibrocar­
tilage or from proliferation of cartilage 
deep to the periosteum lining the bony 
canal, which later forms bone,' produ­
cing pressure on the nerves of the cauda 
equina. (2) Advanced degenerative ar­
thritis in the posterior joints may be a 
cause of severe and persisting pain.
When anterior (or posterolateral) fu­
sion is undertaken for severe cases of 
low-back pain, the overall results are too 
often unsatisfactory. Great care should 
be exercised in selecting patients with 
low-back pain for spinal fusion. Per­
sistent pain following operation may 
well have a definite physical basis. The 
presence of a pseudarthrosis may not 
be the cause of the pain of which the 
patient complains.
Paine18 has observed that lumbar 
spondylosis with segmental stenosis of 
the bony canal is one of the causes of 
pressure on nerve roots and the cauda 
equina. A patient who had an operation 
to remove an extruded disc 15 years 
earlier, followed by two operations to 
fuse the lumbosacral spine, continued to 
suffer from low-back pain and sciatica. 
Myelography revealed marked spinal 
stenosis. A wide laminectomy consider­
ably reduced the pain in both legs and 
almost completely relieved the low-back 
pain. In retrospect it seems that, when 
the first operation failed, a wide lami­
nectomy should have been undertaken 
rather than a spinal fusion.
Su m m ar y
Following anterior lumbosacral fu­
sion in the guinea pig, osseous fusion
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was seen in four animals and fibrocar­tilaginous fusion in 19. In both in­stances there was marked spinal steno­sis at the operation level.Anterior fusion by bone led to com­plete posterior joint fusion, and anterior fibrocartilaginous fusion led to degen­eration of the posterior joints. In other words when the vertebral bodies were fused by bone, the posterior joints were also fused, mainly by bone but to some extent by cartilage. When there was a pseudarthrosis between the vertebral bodies, the posterior joints showed marked degenerative changes but there was no posterior joint fusion.In clinical practice it is at least pos­sible that stenosis of the bony canal and of the foramina, and degenerative changes in the posterior joints are causes of persistent pain, both with os­seous fusion and fibrocartilaginous pseudarthrosis.
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R e s u m e
Apres arthrodese lombosacree anterieure chez le cobaye, on a note une fusion osseuse chez quatre animaux et une fusion fibrocar- tilagineuse chez 19 autres. Dans les deux cate­gories, on observait une stenose spinale consi­derable au niveau operatoire. L’arthrodese an­terieure osseuse s’est traduite par une fusion posterieure complete de l’articulation et l’ar- throdese anterieure fibrocartilagineuse condui- s it a la degenerescence des articulations pos­terieures. En d’autres termes, quand les corps vertebraux etaient fusionnes par du tissu osseux, les articulations posterieures se fusion- naient egalement, principalement par du tissu osseux, mais dans une certaine mesure par du cartilage. En presence d’une pseudo-arthrose entre les corps vertebraux, les articulations posterieures presentaient des modifications degeneratives im portantes, mais sans fusion articulaire posterieure. Dans la pratique cli- nique, il est au moins possible que la stenose du canal osseux e t des trous sacres e t les si- gnes de degenerescence dans les articulations posterieures puissent etre la cause de douleur rebelle, tan t dans l’arthrodese osseuse que dans la pseudarthrose fibrocartilagineuse.
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ANTERIOR TIBIAE COMPARTMENT SYNDROME- 
A CLINICAL AND EXPERIMENTAL REVIEW
CECIL H. RO R ABECK , M.D., IA N  M A C N A B , M.B., Ch.B., F .R .C .S rEng & C l and
JA M E S P. W A D D E L L , M.D., L S J a
Toronto, Ont.
T h e  condition of ischemic muscle nec­
rosis was described by Volkmann in 
1881.1 He observed necrosis after the ap­
plication of constricting bandages and 
attributed it to the “ prolonged blocking 
of arterial blood” associated with the 
“ simultaneous occurrence of massive 
venous thrombosis” and subsequent 
muscle paralysis. Anterior tibial com­
partment syndrome (ATCS), a very 
specific form of ischemic muscle nec­
rosis, was first described as a separate 
entity in 1945.2 The occurrence of acute 
muscle necrosis without evidence of con­
striction due to bandages or tourniquets, 
and without evidence of major proximal 
vascular occlusion, raised many ques­
tions regarding the etiology of certain 
forms of muscle ischemia.
Several theories regarding the etiol­
ogy of muscle necrosis in ATCS have 
been postulated.3’5 Those cases that oc­
cur secondarily to vascular occlusion are 
readily explained. However, those cases 
that occur without apparent trauma and 
in the presence of demonstrably patent 
vessels still remain unexplained. The 
present authors have formed a hypo­
thesis supported by experimental evi­
dence, which may shed some light on 
this particular form of ischemic muscle 
necrosis.
Anterior tibial compartment syn­
drome is a clinicopathologic entity 
characterized by generalized pain and 
swelling within the anterior tibial com­
partment, weakness of dorsiflexion, and 
variable degrees of sensory loss over 
the distribution of the deep peroneal 
nerve. Pathologically, the condition con­
sists of ischemia of the dorsiflexors of 
the foot, which may progress to varying 
degrees of muscle necrosis and subse­
quent foot-drop.
’‘ Research Fellow, Division of Orthopedic Sur­
gery, The Wellesley Hospital, Toronto, Ont.
fChief, Division of Orthopedic Surgery, The 
Wellesley Hospital; Assistant Professor, De­
partment of Surgery, University o f Toronto.
TAB LE I. Classification of the Anterior 
T ibial Compartment Syndrome
TyPe Description
I Idiopathic
11 Secondary to local trauma
III Secondary to arterial obstruction
IV Following embolectomy with resto­
ration of normal arterial flow
Between the years 1962 and 1971, 11 
patients with ATCS were treated at 
hospitals associated with the University 
of Toronto. On reviewing the case his­
tories, four distinct clinicopathologic 
entities were recognized, described here 
as Types I to IV. Type I corresponds 
to the idiopathic entity, Type II to post- 
traumatic, Type III to post-embolic, and 
Type IV to the development of the syn­
drome following relief of acute arterial 
insufficiency (Table I).
T y p e  I— I d io p a t h ic
In 1945, Horn2 described the first case 
of idiopathic ATCS. The typical patient 
was a young otherwise-healthy army in­
ductee who suddenly developed pain and 
swelling associated with some weakness 
of dorsiflexion over the anterior part of 
the leg following unaccustomed strenu­
ous exercise or marching. The term 
“ march gangrene” has been used to de­
scribe this condition. The patient de­
veloped symptoms of an anterior com­
partment syndrome some time after the 
cessation of activity. Within a few 
hours the pain becomes excruciating, 
the leg begins to swell and, at this point, 
the patient usually seeks medical ad­
vice. The anterior tibial compartment is 
tense, swollen, and diffusely tender and 
there may be some weakness of dorsi­
flexion, particularly of the tibialis ante­
rior and the extensor hallucis longus. 
Frequently the skin is red and shiny 
and, on palpation, feels warmer than the 
unaffected leg. Sensation is frequently 
diminished over the distribution of the 
deep peroneal nerve, particularly in the
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first web space. The femoral, popliteal, 
posterior, and anterior tibial pulses are 
well maintained.
Only one of our 11 cases could be clas­
sified as idiopathic. A 47-year-old man 
had been riding- a horse two days before 
admission. Twelve hours later he 
awakened with severe, constant, gen­
eralized pain over his right anterior 
tibial compartment. He also complained 
o f numbness and tingling of his right 
foot. The patient endured his pain over 
the next 24 hours and did not seek med­
ical advice. By this time, the anterior 
compartment in his right leg was tense, 
swollen, erythematous and warm. The 
circumference of the calf was 1y% inches 
greater than the unaffected side. A 
femoral arteriogram was normal, and 
pulses below the femoral artery were 
present and full. He had marked weak­
ness of the dorsiflexors, particularly of 
the extensor hallucis longus and tibialis 
anterior, and a questionable loss of sen­
sation in the first web space. A diag­
nosis of ATCS was made and he was 
taken to the operating room within six 
hours of admission. An anterior fascio- 
tomy was performed throughout the 
length of the compartment. The muscles 
were pale and grey, but colour rapidly 
returned after fasciotomy. Muscle that 
was obviously necrotic was excised and 
the skin was closed loosely. After opera­
tion, he could move his foot easily and 
sensation in his right foot returned to 
normal.
This case represents an unusual pre­
sentation of idiopathic ATCS, in which, 
despite the long delay from the onset of 
symptoms to fasciotomy, the patient 
recovered full power of ankle dorsi- 
flexion.
Type II— Post-traumatic
Anterior compartment syndrome that 
occurs after local trauma frequently 
follows fractures of the tibia, but 
may also develop after relatively minor 
local soft-tissue injuries. Five of the 
11 patients in this series had lesions 
of this type. One patient in particular il­
lustrates the importance of early rec­
ognition of this syndrome. While visit­
ing another city, this young physical 
education teacher was struck over the 
anterior border of his tibia during a 
soccer game. He finished the game but 
one hour later developed generalized 
pain over the anterior tibial compart­
ment and could not dorsiflex his foot. 
When admitted to hospital, his only ab­
normality was a complete foot-drop. He 
was treated conservatively for 10 days 
and, when discharged, had complete 
paralysis of all the anterior compart­
ment muscles. On his return to Toronto, 
examination failed to reveal any swell­
ing or tenderness in the anterior com­
partment. All the pulses below the 
femoral were full. The dorsiflexors of 
the foot were completely paralyzed. An 
anterior fasciotomy was done and all 
necrotic muscles were excised from the 
anterior compartment, including tibialis 
anterior, extensor hallucis longus and 
most of the extensor digitorum longus. 
In this patient, the sequela, complete 
foot-drop, points out the importance of 
early diagnosis and aggressive operative 
treatment. If fasciotomy and debride­
ment had been done during his original 
admission to hospital, he probably 
would have regained at least partial 
function of the dorsiflexors.
Anterior compartment syndrome may 
follow major trauma to an extremity. A 
17-year-old boy suffered a transverse 
fracture of the middle one-third of the 
tibia and fibula in a motorcycle accident 
and was unable to get medical help for 
12 hours. The fracture was subsequently 
immobilized in a long leg plaster but 
despite this he continued to have severe 
unremitting discomfort in the lower 
leg. Because the patient had “good cir­
culation in his foot” , the plaster was not 
removed. Two days later the patient had 
marked weakness of his extensor hallu­
cis longus and the cast was removed. At 
that time, the anterior compartment 
was diffusely swollen and tender and 
the overlying skin was markedly erythe­
matous and warm. The patient could not 
move his toes and could not dorsiflex his 
ankle. He still had plantar flexion. He
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had total anesthesia over the distribu­
tion of the deep peroneal nerve and 
pulses were full below the femoral. He 
was transferred to the Wellesley Hospi­
tal, Toronto, and, on the day of admis­
sion, a long- anterior fasciotomy was 
done. At the time of decompression, the 
entire anterior compartment was nec­
rotic and the muscles simply “ poured 
out” on to the operating table. All nec­
rotic muscle was excised.
This unfortunate case illustrates the 
form of ATCS occurring after a simple 
undisplaced fracture of the tibia with­
out major neurovascular damage. This 
boy complained of excruciating pain af­
ter the plaster was applied and ap­
parently his physician did not consider 
this serious complication. Although he 
apparently had adequate circulation to 
his foot, he still developed a severe an­
terior compartment syndrome. Every 
patient who develops severe pain in the 
leg after treatment of a fractured tibia 
or an isolated fracture of the fibular 
shaft should be observed closely for as­
sociated anterior compartment syn­
drome.
Type III— Post-embolic
Acute embolic or thrombotic occlusion 
of the anterior tibial artery or its parent 
trunk may produce ATCS. This develop­
ment is frequently overlooked because 
the anterior tibial compartment is not 
swollen clinically. Two of our 11 cases 
were of this type. One such patient, a 
55-year-old woman, was admitted to 
hospital for an elective tibial valgus 
osteotomy. Two days after operation, 
she complained of severe generalized 
pain over the anterior aspect of her leg, 
and examination revealed weakness of 
the extensor hallucis longus. The dor­
salis pedis artery was not palpable. De­
spite this, her foot had good colour and 
sensation. On the eighth postoperative 
day, all the dorsiflexors of her foot were 
completely paralyzed. On the eleventh 
day, because of persisting pain and 
gross weakness of the dorsiflexors, we 
decompressed the anterior tibial com­
partment even though there had been no
clinical evidence of tension or swelling 
of the compartment.
At operation the extensor hallucis 
longus and tibialis anterior, which were 
totally necrotic, were excised. A signif­
icant portion of the extensor digitorum 
longus was also necrotic and was ex­
cised. The anterior tibial artery was 
thrombosed throughout its length. In 
this instance early surgical intervention 
probably could not have prevented this 
complication.
T ype IV— A fter Relief of A cute
A rterial Insufficiency
We noted an unusual presentation of 
this syndrome in three patients, whose 
histories have several factors in com­
mon. In all three, an episode of acute ar­
terial insufficiency produced a pale cold 
pulseless limb below the level of the ob­
struction or injury. All were operated 
upon as an emergency and arterial flow 
was re-established as proved by arterio­
graphy and clinical examination. After 
“ normal” arterial flow was restored, 
all three developed an acute ATCS in 
the presence of normal pulsations. The 
interval between the restoration of flow 
and the development of the syndrome 
varied from 18 to 24 hours.
One of these patients, a 55-year-old 
man, illustrates these points. He de­
veloped a thrombosis in his left femoral 
artery immediately below the origin of 
profunda femoris and had all the signs 
of peripheral ischemia. Thromboendar- 
terectomy restored normal pulses distal 
to the operative site. Twenty-four hours 
later he developed severe pain over the 
anterior compartment of his left leg 
and, clinically, had a tense, swollen, dif­
fusely painful, left anterior compart­
ment, with marked weakness of dorsi- 
flexion of his left ankle. All pulses in 
the limb were present and full. The pa­
tient was taken to the operating room at 
once and a vertical fasciotomy per­
formed throughout the length of the 
compartment. At exploration, the an­
terior tibial artery was pulsating nor­
mally. Postoperatively he recovered full
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power in his left foot dorsiflexors as did 
the other two patients in this group.
Conflicting theories regarding the 
etiology of the ATCS have been ex­
pressed previously. In 1945, Horn2 de­
scribed fibrosis in the media and ad­
ventitia of the anterior tibial artery six 
days after the development of an ATCS 
and postulated that the overwhelming 
demands made upon the anterior tibial 
artery during exercise in some way pre­
disposed the media and adventitia to 
fibrosis. Other authors3 thought that 
most of these cases were due to embo­
lism or thrombosis of the anterior tibial 
artery or its parent trunk, while others4 
concluded that decreased arterial inflow 
was not the fundamental problem. We 
have demonstrated experimentally the 
pathophysiology of Type I (idiopathic) 
ATCS (see Experimental Investiga­
tion). From this we have suggested hy­
potheses to explain the pathophysiology 
of the other three types.
Many authors agree that acute ATCS 
may occur following obstruction of the 
anterior tibial artery or its parent 
trunk. However, this does not explain 
the development of this syndrome in 
the presence of normal peripheral pul­
sations. To explain this, one must post­
ulate a rise in interstitial pressure with­
in the anterior compartment, sufficient 
to obstruct the intramuscular venules, 
capillaries, and small arterioles. Two 
factors may precipitate a rise in intra- 
compartmental pressure— one mechan­
ical and one hemodynamic. When a mus­
cle contracts during exercise, its bulk 
increases 20%.2 Anatomically, the an­
terior compartment has rigid unyielding 
walls and when a muscle contracts dur­
ing exercise, the pressure within the 
compartment rises.6 We postulate that 
both the interstitial osmotic pressure 
and the intravascular hydrostatic pres­
sure increase during exercise. The net 
effect of the simultaneous occurrence of 
these events is a fluid shift from the in­
travascular to the interstitial spaces 
along an osmotic and hydrostatic gra­
dient. As fluid accumulates in the inter- 
stitium, the interstitial pressure rises
until it exceeds the critical closing pres­
sure7 of the feeding arteriole, and the 
arteriole collapses. The term “ critical 
closing pressure’ ’7 refers to the intra­
luminal pressure below which the ar­
teriole will collapse and blood flow 
cease. Collapse normally occurs when 
the differential between the pressure 
inside and the pressure outside the arte­
riole wall falls below 20 mm. Hg. If we 
assume that the mean intraluminal ar­
teriolar pressure is 50 mm. Hg, the 
critical closing pressure will not be 
reached. However, if the interstitial 
pressure rises from the normal of zero 
or slightly negative pressure to 30 mm. 
Hg, the critical closing pressure of the 
feeding arteriole will be reached and 
the arteriole will collapse. After this has 
occurred, a state of equilibrium will be 
reached between the intravascular and 
interstitial compartments, because the 
effects of an elevated intracapillary hy­
drostatic pressure are negated. Once the 
critical closing pressure is exceeded, 
arteriolar blood flow shuts down and 
cellular anoxia and tissue death occur.
E xperimental Investigation
To test this hypothesis concerning 
critical closing pressure, we designed an 
experiment to determine whether par­
tial obstruction to venous drainage in a 
dog’s leg would lead to a self-perpetu­
ating rise in pressure in the anterior 
tibial compartment sufficient to cause 
muscle ischemia and necrosis.
As a preliminary step, we determined 
resting muscle blood flow by injecting 
100 me. of S9Tc into the tibialis anterior 
muscle of a dog. Arbitrarily a standard 
site and depth were chosen— one inch 
distal to the tibial tuberosity and 1 cm. 
in depth. The dosage was standardized 
according to the decay factor of the 
isotope. By plotting the counts per min­
ute versus time, the clearance constant 
(K) was determined. After this, a hol­
low screw was inserted through the 
shaft of the tibia from the medial to the 
lateral border, so that the tip of the 
screw just pierced the lateral cortex. In 
this way, we did not have to open the
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clearance is reduced by 50% ) against time 
with a constant volume of fluid introduced in 
the anterior tibial compartment at time zero. 
The graph demonstrates a self-perpetuating 
rise in pressure within the anterior tibial com­
partment as reflected by a prolongation of 
T % . This rise continues until the critical 
closing pressure of the feeding arterioles is 
reached (240 to 300 minutes).
lateral compartment to insert any meas­
uring or recording device. A three-way 
stopcock was attached to the end of the 
screw protruding from the medial cor­
tex. A constant infusion pump with a 
built-in pressure gauge was used to in­
troduce hyperosmolar fluid (mannitol) 
into the compartment. A second tube 
connected the screw to a Statham pres­
sure transducer which, in turn, was 
connected to a Beckman four-channel 
recorder. The entire system was stand­
ardized to atmospheric pressure. Using 
this method, it was possible to record 
retrograde pressure measurements 
within the anterior tibial compartment.
Several preliminary observations are 
worthy of note. After 100 c.c. of fluid 
was introduced into the compartment, 
pressure within the compartment in­
creased and over the next few minutes 
fell slightly, presumably due to the 
equilibration of fluid within the intra-
fascial spaces. The increase in pressure 
so produced within the anterior tibial 
compartment slowed down the rate of 
clearance of the injected "Tc. The in­
creased intracompartmental pressure 
impeded the venous return, and the rate 
of clearance of the isotope was inver­
sely proportional to the pressure main­
tained. The greater the pressure the 
slower the rate of clearance, and when 
the pressure was lowered, i.e. less fluid 
was introduced at time zero, the rate of 
clearance was increased.
However, if the interstitial pressure 
was maintained for more than one or 
two hours at a constant level by inject­
ing a standard volume (100 c.c.) of fluid 
at time zero, not only does the rate of 
clearance of the isotope abruptly fall 
but the clearance rate falls progres­
sively even though no more fluid is 
being introduced into the compartment 
(Figs. 1 and 2). This observation sug­
gests that the experimentally produced 
partial obstruction to venous outflow it­
self produced a further increase in in­
terstitial pressure within the compart­
ment and hence a further shutdown in 
the venous return. This observation was 
confirmed with periodic interstitial 
pressure measurements performed at 
60-minute intervals (Fig. 3). After four 
hours there was no further fall in the 
rate of clearance. This suggests that the
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Fig. 3.—Average values obtained at each 
time interval when a fixed volume of fluid is 
injected into the anterior tibial compartment 
at time zero. When plotted with time the in­
terstitial pressure gradually increased up to 
240 minutes. At this point, the critical closing 
pressure of the feeding arterioles had been ex­
ceeded, an equilibrium was established, and the 
interstitial pressure rose no farther.
intracompartmental pressure had now 
exceeded the critical closing arteriolar 
pressure, and the intravascular capil­
lary hydrostatic pressure had reached 
equilibrium with the interstitial osmotic 
pressure.
This sequence of events could explain 
the pathophysiology of Type I (idiopa­
thic) ATCS. A limiting point is reached 
in Type I so that intracompartmental 
pressure can never rise sufficiently high 
to obstruct totally the systolic pressure 
in the anterior tibial artery. Once the 
critical closing pressure of the small 
arterioles entering the muscles is ex­
ceeded, no blood passes through the ca­
pillary anastomoses. Thus, there is no 
longer any tendency toward fluid shift 
from the intravascular to the intersti­
tial spaces because the capillary hydro­
static pressure is markedly lowered. A 
state of equilibrium is therefore reached 
between the interstitial pressure and 
the intravascular capillary pressure. 
This phenomenon would explain the pre­
sence of the normal arteriograms in the 
face of an acute idiopathic ATCS.
In Type II (post-traumatic), direct 
blunt trauma to the anterior aspect of 
the leg may result in the formation of a 
hematoma. A hematoma within a closed 
space will cause a rise in pressure with­
in that space. When the pressure be­
comes sufficiently high, venous obstruc­
tion occurs, thereby raising the capil­
lary hydrostatic pressure, resulting in 
a tendency for fluid to shift from intra­
vascular to interstitial spaces along a 
pressure gradient until the critical clos­
ing pressure of the feeding arterioles is 
exceeded. The initiating stimulus in the 
development of Type I ATCS is an in­
crease in muscle bulk, while the initial 
stimulus in Type II is a space-occupying 
hematoma.
The pathogenesis of Type III (post- 
embolic) ATCS is totally different from 
Types I and II. Here an obstruction to 
the anterior tibial artery or one of its 
parent trunks produces ischemia of the 
anterior compartmental muscles, with 
rapid progression to frank necrosis. A 
sudden blockage of arterial inflow to the 
compartment will produce three events 
simultaneously: (1) a fall in the intra­
vascular capillary hydrostatic pressure; 
(2) a fall in interstitial pH; and (3) a 
rise in interstitial osmotic pressure.
The net effect of the simultaneous oc­
currence of these three events would be 
a fluid shift from intravascular spaces 
to the interstitial spaces across an osmo­
tic gradient. Large fluid shifts do not 
occur, however, because of the markedly 
lowered capillary hydrostatic pressure 
and the absent arteriole inflow and, 
clinically, there will be no swelling of 
the anterior compartment.
Type IV ATCS (after relief of ar­
terial insufficiency) occurs some time 
after a successful embolectomy and re­
storation of normal pulses. These pa­
tients are subjected to an acute episode 
of arterial insufficiency, which, in the 
normal course of events, could progress 
to a Type III anterior compartment syn­
drome if surgical intervention was de­
layed. However, if the arterial supply 
is re-established, capillary hydrostatic 
pressure will increase. The capillaries 
will be excessively permeable secondary 
to the prolonged anoxia and the destruc­
tion of capillary endothelium. Thus, a 
massive outpouring of plasma into in­
terstitial spaces will raise the intersti­
tial pressure. The interstitial pressure
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rises until the critical closing pressure 
of the feeding arterioles is exceeded as 
in Types I and II. At this point, a vi­
cious circle is established.
D is c u s s io n
We have not attempted to provide full 
experimental evidence to explain satis­
factorily all aspects of acute ATCS. 
However, we believe that the experi­
mental observations cited here establish 
the validity of the critical-closing-pres­
sure theory and explain the sequence of 
events in idiopathic ATCS. We agree 
with Leach, Hammond and Stryker4 
that decreased arterial inflow is not the 
fundamental problem; the basic pathol­
ogic condition underlying this syndrome 
is arteriolar occlusion distal to main ar­
terial trunks.
Clinically, there is no effective med­
ical management for this condition at 
the present time. If you suspect the 
diagnosis of ATCS search for distant 
antecedent cause— microembolism from 
aortic aneurysm, femoral artery em­
bolism from myocardial infarction with 
mural thrombus, as well as local ones— 
fractures of the tibia or fibula, or soft- 
tissue injury. The only effective way of 
treating this condition is rapid and 
thorough decompression of the anterior 
tibial compartment by fasciotomy. Fas- 
ciotomy may be done open or closed de­
pending upon the preference of the sur­
geon and the amount of compression 
being imposed upon the compartment 
by an intact skin as well as intact fascia.
The concurrence of direct injury to 
the leg and arterial occlusion secondary 
to arterial injury is not uncommon, and 
the combination of the two may be 
especially dangerous to the vulnerable 
muscles of the anterior tibial compart­
ment. In cases such as this, immediate 
fasciotomy following arterial repair is 
necessary to prevent muscle necrosis.
S u m m a r y
Between 1962 and 1971, 11 patients 
with ATCS were treated at the Welles­
ley Hospital, Toronto. A classification 
based on hemodynamic principles de­
scribes this disorder according to four 
basic etiologic types. Representative 
clinical cases are presented and dis­
cussed.
An experimental investigation, using 
radioactive isotope scanning techniques 
was done to determine the etiology of 
idiopathic ATCS (Type I). From this 
work it was concluded that the inter­
stitial pressure within the anterior 
tibial compartment would continue to 
rise until it exceeded the critical closing 
pressure of the feeding arterioles. At 
this point a state of equilibrium is 
reached, such that the interstitial pres­
sure can never rise sufficiently high to 
totally obstruct arterial systolic pres­
sure. From the experimental findings in 
Type I anterior compartment syndrome, 
the pathophysiology of Types II, III and 
IV is presented and discussed. Our work 
suggests that an acute ATCS may re­
sult from either venous or arterial 
causes.
The clinical application of this work 
also suggests that the only effective way 
of treating this condition is by rapid 
and thorough decompression of the 
fascia overlying the anterior tibial com­
partment.
The authors wish to thank the surgeons of 
the University of Toronto teaching hospitals 
for the case material included in this paper. 
The experimental studies were supported by a 
grant from the Workmen’s Compensation 
Board of Ontario.
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R esum e
De 1962 a 1971, 11 malades souffrant du 
syndrome du compartement tibial anterieur ont 
ete traites a l’hopital Wellesley de Toronto. Les 
auteurs proposent une classification descriptive 
basee sur les principes hemodynamiques et re- 
partissent les malades en quatre types etiolo- 
giques principaux. Ils presentent quelques cas 
typiques.
Une etude experimental, faite par la me- 
thode scintigraphique, a permis d’etablir les 
bases etiologiques du syndrome idiopathique 
(type I). Partant de ce travail, on a pu con-
clure que la pression interstitielle a l’interieur 
du compartiment continuait de monter jusqu’a 
ce qu’elle depasse la pression systolique criti­
que des arterioles. Un etat d’equilibre est alors 
atteint, tel que la pression interstitielle ne peut 
jamais monter suffisamment pour obstruer 
completement la pression systolique arterielle. 
A partir de ces constatations experimentales 
sur le type I du syndrome, les auteurs presen­
tent la physiopathologie des types II, III et IV. 
Ils estiment que le syndrome etudie peut avoir 
indifferemment des causes veineuses ou arte- 
rielles.
Quant a l’application clinique de ce travail, 
elle permet de croire que le seul traitement ef- 
ficace consiste a pratiquer une decompression 
rapide et complete du fascia de revetement du 
compartiment tibial anterieur.
BILATERAL TRANSABDOMINAL RETROPERITONEAL NODE 
DISSECTION IN EMBRYONAL CARCINOMA AND 
TERATOCARCINOMA OF THE TESTIS*
M. WEISLER, M.D., O. G. THURSTON, M.D., F.R.C.S.fC] and 
A. B. McCARTEN, M.D., F.R.C.S.[C], Edrnonton, Alta.
M ost authorities agree that following 
radical orchidectomy, the patient with 
seminoma is best managed with radia­
tion therapy to the nodes draining the 
testis. There is, however, no agreement 
regarding the management of retroperi­
toneal nodes in embryonal carcinoma 
and teratocarcinoma of the testis; sur­
gical resection of nodes and radiation 
therapy, alone and in combination, 
have been used most frequently.1'3 
This report reviews our experience with 
18 patients with embryonal carcinoma 
and teratocarcinoma of the testis 
treated by bilateral transabdominal 
lymphadenectomy; postoperative radia­
tion was reserved for those with his­
tologically proven nodal metastases. 
These 18 patients were seen and treated 
at the University of Alberta Hospital 
and the W. W. Cross Cancer Institute, 
Edmonton, between September 1959 and 
December 1969.
M a t e r ia l s  an d  M ethods
These men ranged in age from 19 to 
43 years, with 10 of the 18 in the third
‘ From the Department of Surgery, University 
o f Alberta, Edmonton, Alta.
decade of life. The primary tumour was 
in the left testis in 13, and in the right 
in five. None had a past history of ip- 
silateral undescended testis. Two had a 
contralateral undescended testis. This 
testicle had been excised in one patient 
but not in the other. All 18 patients pre­
sented with a mass in the testis which 
they had noted one day to 40 months 
earlier. Other less frequent symptoms 
were testicular pain or a dragging sen­
sation, abdominal pain, gynecomastia 
and weight loss. Six had a history of 
trauma to the affected testis. A testi­
cular mass was palpable in all 18 pa­
tients, an associated hydrocele was 
present in two. Three patients had 
gynecomastia, and an abdominal mass 
was present in one. A pregnancy test 
(immunological or Aschheim-Zondek) 
and/or an FSH assay were done on 12 
patients. A positive pregnancy test was 
obtained in only one patient.
All patients had an intravenous pye- 
logram preoperatively. The films from 
12 of these examinations were available 
to us, the remainder having been re­
turned to outside institutions after they
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had been interpreted as normal. Films 
available for us to examined showed in 
one patient evidence of retroperitoneal 
node metastases, a finding confirmed 
at operation. Foot-injection lymphan­
giography was done before opera­
tion on only one patient and indicated 
involvement of the contralateral retro­
peritoneal nodes, a finding also con­
firmed at operation.
Sixteen patients underwent radical 
orchidectomy and two simple orchidec- 
tomy. Seventeen had transabdominal 
bilateral retroperitoneal lymphadenec- 
tomy. One patient whose metastatic di­
sease was too extensive to resect, had 
laparotomy and biopsy. Bilateral trans­
abdominal lymphadenectomy using the 
technique of Stehlin et al* strips all 
fatty areolar and lymphatic tissue from 
the level of the upper margin of the 
renal veins superiorly, to the internal 
inguinal ring on the affected side and 
just beyond the bifurcation of the iliac 
vessels on the unaffected side. The 
fascia and fat are stripped from around 
the convex border and posterior surface 
of the lower two-thirds of the ipsilateral 
kidney. The hilum of each kidney is dis­
sected. The testicular vessels and lym­
phatics on the affected side are freed 
and excised to the point of the previous 
ligation of the spermatic cord. If a sim­
ple orchidectomy was done initially, the 
inguinal incision is reopened and the 
radical orchidectomy completed. The 
vas on the affected side is removed. 
Central dissection consists of stripping 
the fatty areolar and lymphatic tissue 
from the groove between the abdominal 
aorta and inferior vena cava, as well as 
anteriorly, posteriorly and laterally to 
these vessels.
After operation, radiation was given 
to the periaortic node-bearing areas in 
all patients with histologically proven 
node metastases except one, the first 
patient in this series. The calculated 
tumour dose given through anterior and 
posterior ports, ranged from 3500 to 
6000 r given over a three- to five-week 
period. The radiation was given up to 
the level of the diaphragm only. Pa­
tients without histologic evidence of 
metastases had no postoperative radia­
tion.
Results and D iscussion
The testicular primary was predomin­
antly embryonal carcinoma in 10 pa­
tients and teratocarcinoma in eight. All 
the tumours would fall into Groups II 
to IV of the Dixon-Moore classification5 
(Group II: embryonal carcinoma, pure 
or with seminoma; Group III: terato­
ma, pure or with seminoma; Group IV : 
teratoma with either embryonal carci­
noma, choriocarcinoma, or both, and 
with or without seminoma).
Study of the nodes removed at opera­
tion showed that 10 patients had histol­
ogic evidence of nodal metastases and 
eight had no involvement. Nine of the 
10 with histologically positive nodes had 
ipsilateral metastases only, and one pa­
tient had bilateral lumboaortic node me­
tastases. The operative assessment of 
nodes was reasonably accurate— no fal­
se-positive and only one false-negative 
estimates were made. No patient had his­
tologic evidence of spread to the iliac 
lymph nodes. In three men with right­
sided tumours and positive retroperi­
toneal nodes, we did not find a node 
draining the right testis in the external 
iliac chain, where the ureter crosses the 
iliac artery as described by Jamieson 
and Dobson.6 Similarly by combined 
foot-injection lymphangiography and 
testicular lymphangiography, Busch, 
Sayegh and Chenault7 demonstrated 
that the nodes in the inguinal or iliac 
region were never opacified unless pre­
vious inguinal or scrotal operation had 
disrupted the normal lymphatic drain­
age.
None of these 18 patients died as a re­
sult of operation. After operation, three 
patients had one of the following com­
plications: pancreatitis, wound infec­
tion and massive hemorrhage from a 
gastrostomy site.
Ten patients had histologically proven 
retroperitoneal node metastases at the 
time of laparotomy or node dissection. 
Nine of these had postoperative radia-
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TABLE I.—Follow-Up (Positive Nodes)
Patient
Status
(alive/dead)
Time 
{mos.)
G.S. A 121
C.B. A* 116
P.L. A* 87
C.B. A* 71
H.W. A* 42
S.K. D* 30
G.M. D* 24
J.B. D* 14
G.S. D* 13
J.K. D* 3
‘Postoperative radiation.
tion to the retroperitoneal node-bearing 
area. Five of the 10 are alive without 
evidence of disease, 42 to 121 months 
after operation. Five died of their di­
sease after three to 30 months, in­
cluding the patient who had laparotomy 
and biopsy only (Table I). The longest 
survivor (121 months) is the only man 
in the positive-node group who did not 
receive postoperative radiation.
Eight patients had no histologic evi­
dence of metastases in their retroperi­
toneal nodes. None of these had post­
operative radiation therapy. One patient 
in this group died of his disease after 28 
months, the rest are alive without di­
sease seven to 114 months after opera­
tion (Table II).
In patients with histologically proven 
lymph-node metastases, our results with 
lymphadenectomy and postoperative ra­
diation are comparable to those of Pat­
ton, Hewitt and Mallis8 and Whitmore3 
who used lymphadenectomy only (Table 
III). There were no serious complica­
tions of radiation therapy in our pa­
tients and the side effects were well 
tolerated, hence we propose to continue 
our present regimen until we have ac­
cumulated enough cases to make a 
meaningful comparison with unirra­
diated patients.
TABLE II.—F ollow-up (Negative Nodes)
Patient
Status
(alive/dead)
Time
(mos.)
A.M. A 114
D.S. A 98
M.S. A 96
G.T. A 83
L.C. A 55
N.N. A 46
B.D. A 7
C.Z. D 28
The transabdominal approach to the 
primary lymphatic drainage of the 
testis used in this study offers an ad­
vantage over the retroperitoneal ap­
proach through a long flank incision 
because, with it, bilateral dissection can 
be done in one stage.9 One of the 10 pa­
tients in this series with positive nodes 
had bilateral metastases; these were re­
sected at one operation. We did not per­
form lymphadenectomy on one patient 
with extensive metastatic disease above 
the renal pedicle, because such metasta­
ses are so close to the cysterna chyli and 
thus distant dissemination has probably 
already occurred via the thoracic duct. 
None of these patients died from the 
operation and, as noted by others using 
the transabdominal approach,10 post­
operative morbidity was minimal.
In testicular embryonal carcinoma 
and teratocarcinoma, the prognosis de­
pends to a great degree on the presence 
of metastases in regional nodes. Ac­
curate staging in patients who have had 
lymphadenectomy identifies those in 
whom further therapy is indicated. 
Lym phangiography is undoubtedly 
valuable in the staging of testicular tu­
mours. However, there are discrepan­
cies between foot-injection, lymphangio­
graphy and spermatic cord injection 
studies, and there is some doubt con­
cerning the accuracy of foot-injection
TABLE III .—R esults of Lmphadenectomy
Author Tumour Five-year survival (%), positive nodes
Patton, Hewitt a d Mallis Embryonal carcinoma 65
Teratocarcinoma 30
Whitmore Embryonal and 
teratocarcinoma
54
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studies in testicular tumour patients.12
In this small series we cannot deter­
mine the effect of postoperative radia­
tion on prognosis, either by comparing 
different patients in this series or com­
paring this series with those of others. 
However, even this small group of pa­
tients suggests that postoperative radia­
tion can be safely omitted in those with 
histologically negative nodes.
S u m m a r y  an d  Conclusions
During a 10-year period, 18 patients 
with embryonal carcinoma and/or tera- 
tocarcinoma of the testis underwent 
laparotomy and bilateral retroperito­
neal lymphadenectomy via the transab­
dominal approach. Nine of the 10 pa­
tients with histologically proved me- 
tastases had postoperative radiation the­
rapy to the retroperitoneal node-bearing 
areas. Radiation therapy was omitted in 
patients with histologically negative 
nodes. From analysis of the patients, 
the following conclusions are drawn.
(1) We could not substantiate an ear­
lier description of a node draining the 
right testis in the iliac group. This ob­
servation supports the earlier recom­
mendation that the ipsilateral external 
iliac dissection may be omitted.
(2) The superiority of combined 
operation and radiation therapy over 
either modality alone for patients with 
histologically proved metastases has not 
been demonstrated in this small series 
of patients. The morbidity from com­
bined treatment has been minimal. It is 
evident, however, that radiation therapy 
need not be given to a patient with his­
tologically negative retroperitoneal 
nodes.
(3) The bilateral transabdominal ap­
proach to retroperitoneal nodes is sa­
tisfactory from the standpoint of mor­
tality and morbidity, its ability to deal 
with contralateral node metastases, and 
patient survival.
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R e su m e
Au cours d’une periode de 10 ans, 18 malades 
souffrant de carcinome embryonnaire et de 
teratocarcinome des testicules (ou de l’une de 
ces pathologies) ont ete soumis a une laparo- 
tomie et a une lymphadenectomie retropOri- 
toneale bilaterale, par voie transabdominale. 
Des 10 malades chez lesquels l’histologie avait 
demontre des metastases, neuf ont ete soumis 
a des seances de radiotherapie postoperatoire 
au niveau retroperitoneal des ganglions. La 
radiotherapie n’a pas ete pratiquea chez les 
malades dont Phistologie etait negative au 
point de vue ganglionnaire. Apres analyse de 
ces cas, on peut tirer les conclusions suivantes:
(1) Nous n’avons pu confirmer une descrip­
tion anterieure d’un ganglion drainant le tes- 
ticule droit dans la fosse iliaque. Cette obser­
vation permet de confirmer un conseil deja 
donne que la dissection iliaque externe homola- 
terale n’est pas indispensable.
(2) La superiorite du traitement associant 
chirurgie et radiotherapie sur Pun des traite- 
ments employe isolement, chez des malades 
dont Phistologie avait revele des metastases, 
n’a pu etre demontree dans cette petite serie 
de cas. La morbidite du traitement combine a 
ete minimale. II est cependant clair qu’il n’est 
pas neeessaire de recourir a la radiotherapie 
chez les malades dont les ganglions retroperi- 
toneaux etaient negatifs d’apres Phistologie.
(3) La voie transabdominale bilaterale pour 
acceder aux ganglions retroperitoneaux, est 
satisfaisante aux points de vue morbidite et 
mortality, permet d’eviter le probleme des me­
tastases ganglionnaires contralaterales et d’as- 
surer la survie du malade.
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SOME CHANGES IN CARDIOVASCULAR FUNCTION 
ACCOMPANYING THORACOTOMY*
C. E. KINLEY, M.D., F.R.C.S.[C] and A. E. MARBLE, M.Eng., P.Eng.,
Halifax, N.S.
M e a s u r e m e n t s  of cardiovascular func­
tion are often made immediately after 
thoracotomy, and the results are ac­
cepted as representing intact cardiovas­
cular parameters. Typical of the tech­
niques are blood-flow studies using elec­
tromagnetic flow probes on exposed 
aortas1'3 and coronary arteries,4 investi­
gation of aortic flow characteristics,5' 6 
of arterial linearity,7"3 and measure­
ments of mechanical properties of the 
exposed thoracic aorta.10'13 Some authors 
have created mathematical and elec­
trical models of the aorta in order to 
predict pressure and flow wave forms 
in closed-chest animals, but based their 
models on data from open-chest animal 
experiments.14,15 Other authors appear 
to believe that measurements made on 
exposed aortas, using electromagnetic 
flowmeters, can readily be compared16 
to non-surgical studies of blood flow 
such as dye dilution,4 pressure gradi­
ent,1, 3 or pulse contour.2
Current interest in total and regional 
blood flows during thoracotomy, and in 
postoperative monitoring of cardiovas­
cular parameters has led us to conduct 
experiments to show more clearly the 
alterations in cardiovascular dynamics 
accompanying thoracotomy. The para­
meters studied include cardiac output, 
stroke-volume, arterial pressure, heart 
rate and total peripheral resistance.
M e t h o d s
Thirty-four mongrel dogs of various 
weights, and of either sex, were used. 
Premedication was with morphine sul­
fate, 1 mg./kg. body weight, and a uni­
form dose of atropine sulfate (0.6 mg.). 
Anesthesia was induced one-half to 
three-quarters of an hour later with in­
travenous pentothal sodium, 20 mg./kg. 
body weight; small additional doses of 
this drug were given as needed to main-
*From the Department of Surgery, Dalhousie 
University and the Victoria General Hospital, 
Halifax. N.S.
tain light surgical anesthesia. Assisted 
respiration was given with a Bird res­
pirator, connected to an endotracheal 
tube with an inflated cuff. The gas mix­
ture was 50% oxygen in room air, with 
intermittent positive pressure of 14 cm. 
H20. Respiration rate was 18/min. with 
the inspiration :expiration time dura­
tion set at one:two.
After anesthesia a cutdown was done 
on the femoral, brachial or carotid ves­
sels on one side. An 18-gauge polyethy­
lene catheter was advanced in the artery 
to near the aortic arch. The catheter 
was connected via a three-way stopcock 
to a mercury manometer to record mean 
arterial pressure. The accompanying 
vein was exposed for later use as the 
site of injection of rubidium-86. In one 
experiment a second vein was exposed 
for placement of a central venous pres­
sure recording catheter.
Cardiac output was measured by mul­
tiple arterial sampling, after the rapid 
intravenous injection of rubidium-86. 
Each dog received heparin in a dose of 
0.5 mg./kg. body weight to prevent 
clotting of arterial samples. When tho­
racotomy was done, the incision was 
completed to the intercostal muscle level 
before giving heparin or measuring car­
diac output, so as to minimize blood loss 
from the incision. Thoracotomy con­
sisted of a two- to three-inch opening 
in the fourth interspace anteriorly, usu­
ally on the right side. One dog had a bi­
lateral anterior thoracotomy with stern­
al transection. During anesthesia the 
animals lay on their left sides. Heart 
rate and electrocardiogram (lead II) 
were recorded continuously on a Grass 
Model 5 polygraph.
Rubidium-86 was mixed with saline 
to a dilution of 10 /jlc./ml. One millilitre 
of this solution was injected for each 
cardiac output determination. Immedi­
ately after intravenous injection of the 
isotope, 10 arterial samples were with­
drawn every two seconds from the ar-
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terial catheter. Samples were taken in 
test tubes supported on a disc, which 
rotated a new test tube into position be­
neath the open arterial catheter every 
two seconds. The volume of each ar­
terial sample was about 0.75 ml., hence 
the total blood removed during each car­
diac output measurement amounted to 
7 ml. or 8 ml. This volume was replaced 
by flushing saline through the catheter 
after each sampling period.
After arterial sampling, 0.5 ml. from 
each test tube was withdrawn, and 
placed in a well-type scintillation coun­
ter for determination of its radioac­
tivity. Each sample was counted for a 
three-minute period, so that the maxi­
mum point on any curve represented at 
least 1000 counts, with most curves 
reaching a peak of at least 5000 to 10,- 
000 counts. Cardiac output was calcul­
ated according to the formula:
Cardiac output (l./min.) =  ~2(30( / e
where “ I” is the total counts injected 
and “E” the sum of all counts at two- 
second intervals on the curve of primary 
circulation.
R esults
These studies were completed on 34 
closed-chest dogs. Cardiac output was 
expressed as the number of cubic cen­
timetres of blood pumped per kilogram 
of body weight per minute (c.c./kg./ 
min.). This seemed preferable to using 
litres per square metre of body surface 
per minute (i.e. cardiac index) because 
tables for the conversion of dog weights 
to surface area are not accurate for 
pups.17
Cardiac Output in Closed-Chest Dogs
Table I shows the values for cardiac 
output (CO), stroke-volume and cal­
culated total peripheral resistance 
(TPR) from 34 dogs. These animals 
were under anesthesia for up to 45 min­
utes at the time of these measurements. 
Mean values and standard deviations 
are given at the bottom of each column.
The average value for the cardiac out­
put of closed-chest dogs, 195 c.c./kg./ 
min., compares well with the findings of 
others18'22 (Table II). The stroke-vol­
ume per beat averaged 12.2 c.c.; a more 
meaningful figure is stroke-volume per 
kilogram body weight per beat, which 
was 1.3 c.c./kg. The mean arterial blood 
pressure was 126 mm. Hg, and heart 
rate was 155/min. The average total 
peripheral resistance was calculated as 
0.086.
The time course of the cardiovascular 
functions during uncomplicated anes­
thesia for one dog is shown graphically 
in Fig. 1. The mean arterial blood pres­
sure and heart rate remained relatively 
constant; changes in stroke-volume 
paralleled changes in cardiac output. 
Changes in total peripheral resistance 
were inverse to changes in cardiac out­
put.
Cardiac Output in Open-Chest Dogs
Table III lists the values for cardiac 
output, stroke-volume, heart rate, mean 
arterial pressure and total peripheral 
resistance in 24 dogs; chests had been 
opened for periods of five to 20 minutes 
at the time of these measurements. In 
most dogs the same measurements had 
been made before thoracotomy (Table 
I). The average cardiac output was 138 
c.c./kg./min., which represents a dec­
rease of 29.2% from the mean closed- 
chest cardiac output. The mean stroke- 
volume was 7.2 c.c./beat, and 0.9 c.c./ 
kg./beat. The mean arterial pressure 
was 128 mm. Hg, and mean heart rate 
161/min. The calculated total peripheral 
resistance was 0.128. Table IV com­
pares our findings on opened-chest car­
diac output with results reported br­
others.23'25 Table V summarizes the mean 
values and percentage differences for 
open- and closed-chest experiments.
Changes in cardiovascular parame­
ters in thoracotomized dogs under anes­
thesia are shown in Fig. 2. Immediately 
after opening the chest there is a signif­
icant fall in cardiac output. Also, with 
the chest open, heart rate and mean ar­
terial pressure are much less stable.
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TABLE I.—Cardiovascular Functions in Closed-Chest D ogs
Experi­
ment
no.
Weight 
(kg.)
Cardiac output Stroke-volume
Heart
rate/
min.
Mean
BP
{mm. Hg)
TPRm(.l./min.) (c.c./kg./min.) {c.c./beat) {c.c./kg./ beat)
1010 8.2 1.637 200 15.7 1.9 104 120 0.073
1013 8.6 2.035 237 11.3 1.3 180 180 0.089
1013 8.6 2.066 240 12.0 1.4 172 170 0.083
1015 4.6 1.356 295 8.1 1.8 168 110 0.081
1016 7.8 2.122 272 12.9 1.7 164 160 0.076
1017 6.6 0.627 95 3.3 0.5 188 100 0.159
1018 11.0 2.056 187 12.9 1.2 160 135 0.065
1019 8.4 0.875 102 4.3 0.5 200 105 0.122
1021 9.2 1.634 178 9.5 1.0 172 130 0.080
1022 9.1 1.424 156 13.2 1.5 108 150 0.105
1023 11.2 2.027 181 13.7 1.2 148 140 0.069
1024 8.4 1.378 165 7.7 0.9 180 100 0.072
1025 8.2 1.315 160 7.6 0.9 172 130 0.098
1028 8.9 1.740 196 9.7 1.1 180 100 0.058
1030 9.4 1.169 124 7.0 0.7 168 110 0.094
1031 4.4 0.753 171 5.4 1.2 140 130 0.172
1032 9.0 2.864 318 18.9 2.1 152 86 0.030
1033 5.2 0.981 188 7.2 1.4 136 145 0.148
1034 8.4 2.234 266 14.7 1.7 152 130 0.058
1035 9.2 1.719 187 11.3 1.2 152 135 0.079
1036 30.0 6.439 215 53.7 1.8 120 118 0.018
1037 5.2 1.146 220 6.7 1.3 180 90 0.079
1038 5.2 0.775 149 6.2 1.2 126 95 0.122
1039 9.2 1.312 143 9.5 1.0 138 150 0.114
1040 11.0 1.668 152 11.1 1.0 150 145 0.086
1043 8.0 2.285 286 13.1 1.6 174 145 0.063
1044 9.2 1.793 195 15.7 1.8 114 125 0.069
1045 16.2 1.461 90 8.9 0.6 164 160 0.110
1046 5.9 1.012 172 6.5 1.1 156 100 0.099
1049 11.6 1.415 122 11.8 1.0 120 125 0.088
1050 25.5 4.826 189 29.8 1.2 162 155 0.033
1051 5.4 1.637 304 9.4 1.7 174 120 0.073
2002 8.8 2.704 307 14.1 1.6 192 125 0.047
1052 11.0 1.212 110 10.6 1.0 114 70 0.058
Mean 9.6 1.814 195 12.2 1.3 155 126 0.086
SD 5.2 1.106 61 8.6 0.4 25 35 0.033
TABLE II.—A verage Values for the Cardiac Output of Closed-Chest D ogs
Author
Cardiac output 
{c.c../kg./min.)
No. 
of dogs Method Anesthesia
Ebert et al.IS 208 15 Dye dilution Local
Huff et al.19 205 12 Isotope (RISA) Nembutal 
30 mg./kg.
Fowler,
Franch and Bloom20
175 10 Fick Nembutal 
25 mg./kg.
Present study 195 33 Isotope (86Rb) Pentothal 
20 mg./kg.
Etsten and Li21 179 15 Dye dilution Pentobarbital 
25 mg./kg.
Noble et al.22 172 10 Implanted
electromagnetic
flowmeter
No anesthesia
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-------- STROKE VOLUME I cc/stroke)
Fig. 1.—Time course of cardiovascular func­
tions in closed-chest dogs.
If the thoracotomy incision is closed, 
without evacuating- the pneumothorax, 
cardiac output decreases further (Fig. 
3). Evacuating the pneumothorax after 
closing the thoracotomy restores cardiac 
output to higher levels. This finding we 
could consistently demonstrate, al­
though, in some dogs, the relative rise in 
cardiac output was less than the in­
crease in stroke-volume. Fig. 4, which 
shows the results of an experiment in 
which artificial pneumothorax was 
created, demonstrates that the pneumo­
thorax itself reduces cardiac output 
about as much as does thoracotomy. 
Subsequent thoracotomy in this dog 
caused only a slight additional decrease 
in cardiac output. In three dogs, cardiac 
outputs were measured before and after 
laparotomy. The cardiac outputs after 
opening the abdomen were slightly 
higher in two dogs and slightly lower 
in the third.
D iscussio n  of R e su l t s
The literature contains only a few re­
ports concerning the effect of thora­
cotomy on cardiac output, and these are 
somewhat conflicting. Ferguson, Shadle 
and Gregg26 studied the cardiovascular 
effects of intravenous infusions in 13 
dogs, and commented that, in three, the 
cardiac output with the chest open was 
only about one-half that found in the
TABLE III.—Cardiovascular Functions in Open-Chest D ogs
Experi­
ment
no.
Weight
(kg.)
Cardiac output Stroke-volume
Heart
rate/
min.
Mean
BP
(mm. Hg)
TPRm(l./min.) (c.c./kg./min.) (c.c./beat) (c.c./kg./beat)
1010 8.2 0.861 105 8.6 1.0 100 120 0.136
1011 4.5 0.766 170 4.6 1.0 168 110 0.143
1015 4.6 0.436 95 3.6 0.8 120 80 0.183
1016 7.8 1.202 154 6.3 0.8 190 145 0.120
1017 6.6 0.892 135 4.7 0.7 188 125 0.140
1018 11.0 1.600 146 6.8 0.6 188 160 0.100
1019 8.4 0.834 99 4.8 0.6 172 130 0.155
1024 8.4 0.862 103 5.5 0.7 156 110 0.128
1025 8.2 0.904 110 5.9 0.7 152 160 0.177
1030 9.4 0.983 105 5.5 0.6 180 110 0.112
1030 9.4 1.046 113 6.8 0.7 156 110 0.103
1031 4.4 0.652 148 4.4 1.0 148 120 0.184
1031 4.4 0.588 134 4.5 1.0 132 95 0.162
1033 5.2 0.761 146 5.1 1.0 146 130 0.1711033 5.2 0.741 142 4.6 0.9 160 140 0.189
1038 5.2 0.780 150 4.1 0.8 192 115 0.1471041 11.0 1.178 107 6.5 0.6 180 150 0.1271044 9.2 1.327 144 10.5 1.1 126 125 0.0941045 16.2 1.416 87 8.0 0.5 176 175 0.1241046 5.9 1.091 185 7.6 1.3 144 105 0.0961049 11.6 1.742 150 7.9 0.7 220 140 0.0811050 25.5 4.515 177 26.8 1.1 168 160 0.0351051 5.4 1.427 264 8.5 1.6 168 125 0.0872002 8.8 1.593 181 11.7 1.3 136 14 0.087
Mean 8.5 1.176 138 7.2 0.9 161 128 0.128
SD 6.4 0.773 38 4.5 0.3 26 22 0.037
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TABLE IV.— Average Values for the Cardiac Output of Open-Chest D ogs
Author
Cardiac output 
0c.c./kg./min.)
No. 
of dogs Method Anesthesia
Race,
Dedichen and 
Schenk23
122* 12 E1 ectromagr.etic 
flowmeter
Sodium 
pentobarbital 
30 mg./kg.
Present Study 138 21 Isotope (86Rb) Fentothal 
20 mg./kg.
Bartle et al.2* 120 9 Dye dilution Pentobarbital 
25 mg./kg.
O’Rourke25 133 22 E lectromagnetic 
flowmeter
Pentobarbital 
20-40 mg./kg.
*Hematocrit =  44%.
same dogs with the chest closed. Nealon 
et al,27 observed a rise in cardiac output 
in five of seven patients following tho­
racotomy; in the other two, no change 
occurred. Rushmer, Smith and Frank­
lin28 showed radiographically that the 
left ventricular diameter was reduced to 
a level about half way between its min­
imal and maximal dimensions following 
thoracotomy. Bernstein and Evans,29 
using pulse contour and dye dilution 
methods, found that cardiac output de­
creased after thoracotomy, but they did 
not give percentage changes. The most 
conclusive evidence to date concerning 
the effect of thoracotomy on cardiac 
output is that given by Fermoso, Ri­
chardson and Guyton.30 They found that 
cardiac output decreased by an average 
of 18.8% after the chests of 10 dogs 
were opened.
TABLE V.—A verage Values of Cardiovas­
cular Functions Before and After a T hora­
cotomy
Function
Chest
closed
Chest
open
Percentage
change
Cardiac output 
(c.c./kg./min.)
195 138 -29.2
Stroke volume 
(c.c./kg./beat)
1.3 0.9 -30.6
Heart rate/min. 155 161 +  4
Mean blood pressure 
(mm. Hg)
126 128 +  1.6
Total peripheral 
resistance
0.086 0.128 +  47
Studies on the effects of pneumotho­
rax on cardiac output have also been 
somewhat conflicting.31,32 O’Neill, Valet 
and Cudkowicz,33 studying the effects of 
artificial alterations in intrathoracic 
pressure in 18 patients, found that the 
cardiac index increases as the pressure 
is made more negative, and decreases as 
the pressure is made more positive.
There is a similarity in the cardiac 
output changes following thoracotomy 
and in the alterations in distension of 
the thoracic aorta before and after tho­
racotomy. Measurements on closed- and 
open-chest dogs showed that the cardiac 
output decreased by 29.2% after thora­
cotomy. In a previous paper from our 
group,34 we reported the average aortic 
distension in closed-chest dogs and hu­
mans as being approximately 10%. 
Other workers,35'37 who have studied
------- STROKE VOLUME (cc/stroke)
0-----0 MEAN ARTERIAL BP i mm. Hg I
TIME IN HOURS FROM START OF ANESTHESIA
Fig. 2.—Time course of cardiovascular func­
tions in open-chest dogs.
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--------- STROKE VOLUME (cc/stroke)
°------ 0 MEAN ARTERIAL BP (mm. Hg)
*------• HEART RATE l per min.)
TIME IN HOURS FROM START OF ANESTHESIA
Fig. 3.—Effects of closing the thoracotomy 
incision with and without evacuating the pneu­
mothorax.
open-chest aortic distension give average 
values of 3%. Flow rate in arteries is 
proportional to the fourth power of the 
radius. If one denotes the flow rate for 
closed-chest dogs Qcc, the flow rate for 
open-chest dogs Qoc, and the diastolic 
radius by “ a” , one can relate the flow 
rates to the radial distension as follows:
Qcc (a +  -la)4 _  1 „„
Q0C (a +  .03a)4 ~ ^
If one makes the foregoing assump­
tions, these distension results indicate 
that the closed-chest flow (Qcc) is 
30% greater than the open-chest flow 
(Qcc).
---------  CARDIAC OUTPUT (Qc/lg/mln.l
--------- - STROKE VOLUME I ccAtroke I
°------ °  MEAN ARTERIAL BP fm m .Hgl
•------ • HEART RATE i per min.)
---------  TOTAL PERIPHERAL RESISTANCE
Fig. 4.—Time course of cardiovascular func­
tions after a needle pneumothorax.
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P o s s ib l e  E x p l a n a t io n s  of
T h o r a c o t o m y  E f f e c t s
There was a consistent and direct re­
lationship between alterations in car­
diac output and changes in stroke-vol­
ume in both closed- and open-chest dogs 
(Figs. 5 and 6). This relationship was 
also observed by Stead and Warren38 in 
their studies on cardiac output. Rush- 
mer38' 40 demonstrated that the exposed 
dog heart shrank after thoracotomy. 
Similarly, Hamilton, Dow and Hamil­
ton,41 in describing a method of deriving 
heart volume from radiographic appear­
ances, found that hemorrhage reduced 
both cardiac output and heart size. More 
recently, Fermoso, Richardson and Guy­
ton,30 studied 10 dogs and found that 
thoracotomy produced an average de­
crease in cardiac output of 18.8%.
Pneumothorax alone had an effect on 
cardiac output similar to that of thora­
cotomy, and pneumothorax has been as­
sociated with a fall in cardiac output 
previously in animals42 and humans.43 
Hilton44 ascribed the fall in cardiac out­
put to partial collapse of great veins in 
the thorax, which interfered with ve­
nous return. Likewise, shrinkage in 
heart size probably increases resistance 
to diastolic filling. Fermoso, Richard­
son and Guyton,30 concluded that thora­
cotomy increased right atrial pressure 
by 3 mm. Hg. They plotted the transfer 
characteristics (CO:BP) for both the 
pulmonary and systemic circulations 
and showed that the 3.0 mm. Hg in­
crease shifted the entire cardiac func­
tion curve to a point on the systemic 
circulation transfer characteristic which 
represented a reduced cardiac output. 
Carey and Hughes,45 concluded that the 
hemodynamic consequences of open 
pneumothorax are related to pulmonary 
collapse causing increased pulmonary 
resistance and hypoxemia. In one dog 
in the present study, pressure was re­
corded in the inferior vena cava; a rise 
of 2 cm. of saline occurred on opening 
the chest; and closing the chest with 
pneumothorax remaining was accom­
panied by a further rise of 1 cm. When 
the pneumothorax was evacuated, the
c a r d i a c  f u n c t i o n  i n  t h o r a c o t o m y
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Fig. 5.—Relationship between cardiac output 
and stroke-volume in closed-chest dogs.
venous pressure fell to preoperative 
levels. These venous changes could be 
used to support Hilton’s explanation. 
Guyton46 points out that changes in re­
sistance to flow occurring near the right 
atrium greatly affect venous return and 
in turn may decrease cardiac output. 
Caldini, Ho and Zingg47 have reported 
this finding as well. On the other hand, 
such a venous pressure rise could be 
secondary to the decreased cardiac out­
put as in certain types of heart failure. 
The relationship of central venous pres­
sure (right atrial pressure) to cardiac 
output has in any event been the subject 
of much controversy.48
The further fall in cardiac output ob­
served when the chest was closed with­
out evacuating the pneumothorax could 
be explained by a further increase in in- 
trathoracic pressure with each expan­
sion of the lungs. This, in turn, results 
in increased resistance to cardiac dilata­
tion and filling and/or further compres­
sion of great veins in the thorax. These 
possibilities are strengthened by the rise 
in cardiac output and stroke-volume 
that occurred after the pneumothorax
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Fig. 6.—Relationship between cardiac output 
and stroke-volume in open-chest dogs.
had been evacuated.
The circulatory changes following 
thoracotomy may possibly be explained 
by an increase in pulmonary vascular 
resistance due to the decreased lung size 
(not atelectasis). In a series of animal 
experiments42 the effect of pneumotho­
rax in anesthetized dogs was invest­
igated. The control values for dogs sub­
jected to anesthesia alone are similar to 
those of the present study. In the group 
subjected to pneumothorax, the cardiac 
output had fallen to 80% of control 
values at one hour; and a further fall of 
60% of control values was seen at five 
hours. These authors also measured pul­
monary artery pressure, observing no 
change for the first three hours after 
pneumothorax; but, in the three- to six- 
hour period, there was a rise from a 
mean of 15 to 19 mm. Hg. No other- 
significant effect of pneumothorax on 
pulmonary artery systolic, diastolic, or 
pulse pressures was noted. These work­
ers did, however, find a significant rise 
in systemic arterial pressure. Such a 
rise in systemic pressure has not been 
reported consistently by others31 and
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was not seen in the present study.
In sum m ary, the m ost probable ex­
planation of the cardiovascular changes 
observed with thoracotom y seem to be 
th a t opening the pleural space exposes 
the in tra thoracic  structu res to atm os­
pheric a ir  p ressu re ; th is is accompanied 
by shrinkage in heart size and partia l 
collapse of the lungs. The decreased 
h ea rt size results in increased resistance 
to diastolic distension and filling, caus­
ing the stroke-volume to lessen and th is 
leads directly to a fall in cardiac output.
S u m m a r y  a n d  C o n c l u s io n s
The m easurem ents of cardiovascular 
param eters in open-chest dogs are  not 
equivalent to sim ilar m easurem ents in 
closed-chest dogs. This difference has 
already  been illustrated  for such aortic 
properties as radial distension, geome­
tric  tap e r ,34 and wall thickness.49 The re ­
su lts reported from  open-chest experi­
m ents concerning such arte ria l p roper­
ties as linearity, elasticity, viscosity, and 
compressibility, will have to be reinvest­
igated in closed-chest experim ents in the 
light of the results presented in th is 
paper.
Num erous papers have compared ao r­
tic blood flow m easured during non-sur- 
gical techniques w ith th a t m easured 
using the electrom agnetic flow m eter on 
the exposed aorta . Our results indicate 
th a t one cannot make a valid com pari­
son between non-surgical blood-flow 
m easurem ents and surgical m easure­
m ents and assess the accuracy of the 
non-surgical method unless the  flow 
probe is im planted and the pneum otho­
rax  evacuated. Results34 of studies of 
aortic  radial distension also indicate 
that, owing to the large radius varia tions 
th a t the ao rta  undergoes during the 
norm al cardiac cycle, rigid electro­
m agnetic probes constrict the a rte ria l 
motion more than  has previously been 
appreciated. Fox, Castaneda and W eber50 
noted the effects th a t constriction 
due to flow probes have on the pulmo­
nary  a rte ry  of dogs. We suggest th a t  the 
prevalent philosophy of using open- 
chest experim ents to determ ine in tact
cardiovascular functions and a rte ria l 
p roperties will have to be revised. The 
use of in vivo techniques should be re ­
stricted  to  closed-chest experim ents.
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R esum e
La mesure des parametres cardiovasculaires 
chez le chien a thorax ouvert differe des mesu- 
res similaires pratiquees chez le chien a thorax 
ferme. On avait deja mis cette difference en 
lumiere pour certaines proprietes de l’aorte, 
comme la distension radiale, la conicite geome- 
trique et l’epaisseur de la paroi. Quant aux re-
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sultats signales dans les experiences a thorax ouvert concernant certaines proprietes arte- rielles, corame la linearite, l’elasticite, la v is­cosite et la compressibility, ils devront etre reexamines dans des experiences a thorax fe r­ine, a la lumiere des resu ltats qui fon t l’objet du present article.Dans de nombreux articles, on avait deja compare le debit circulatoire de l ’aorte mesure par des methodes non chirurgicales avec celui qui e ta it mesure par le debitm etre electroma- gnetique sur l’aorte a nu. Nos resu lta ts  per­sonnels m ontrent qu’on ne peut fa ire  de com- paraison valable entre la mesure de la circula­tion par dtis moyens non chirurgicaux e t celle etablie par des moyens chirurgicaux e t qu’il n ’est pas possible d’etablir la precision de la methode non chirurgicale a moins que la sonde
circulatoire soit inseree e t que le pneum othorax soit evacue. Les re su lta ts  de l’etude de la dis­tension radiate de 1’ao rte  indiquent egalem ent que, en raison des variations considerables que subit le rayon de l’ao rte  pendant le cycle car- diaque normal, les sondes electrom agnetiques rigides ont pour e ffe t de con trarier le mouve- m ent de l’artere  plus qu’on ne l’av a it pense auparavant. Fox, C astaneda et W eber avaient d-eja note la  constriction que les sondes circu- latoires exer?aient su r l’a rte re  pulm onaire du chien. Nous estimons qu’il faudra  rev iser les principes actuels a l’e ffe t que les experiences a thorax ouvert perm etten t d ’e tab lir les fonc- tions cardiovasculaires e t les proprietes arte- rielles intactes. L’emploi des techniques in  vivo devraient e tre  limitees aux experiences a  tho ­rax  ferme.
DIAGNOSIS AND MANAGEMENT OF DUODENAL INJURIES*
W. L. M. KING, M.D., F.R.C.S.[C] and J. L. PROVAN, M.B., M.S., F.R.C.S.rEng-.lToronto, Ont.
T h e  duodenum is not often injured. Be­cause of its small calibre and protection by bone or abdominal viscera, it is usually spared even in severe trauma involving neighbouring structures. However, these anatomical features may make detection of a duodenal in­jury extremely difficult. The physician needs informed awareness of the vari­ous duodenal injuries in order to recog­nize their presence in the diagnosis of a puzzling acute abdomen.
The following three cases present a spectrum of duodenal injuries.
Ca se  R eports
Case 1.—J. B., a 42-year-old man, was 
adm itted to the Emergency D epartm ent of 
the Wellesley Hospital, Toronto, on May 9, 
1970, with a history of severe epigastric 
and righ t upper quadrant pain of 12 hours’ 
duration, spreading throughout the righ t 
side of the abdomen. The patient, a heavy 
beer drinker, was grossly inebriated on ad­
mission and had had a particularly  heavy 
intake during the previous 48 hours. He 
also complained of two episodes of vom iting 
of bile-stained m aterial bu t had had no 
vom iting before the  onset of pain. The 
patient gave no history of previous abdo-
*From the D epartm ent of Surgery, The Wel­lesley Hospital, Toronto, Ont.
minal complaints, and specifically no h is­
to ry  of ulcer, gallbladder symptoms or tr a u ­
ma. His blood pressure was 170/120 mm. 
Hg with a regular pulse ra te  of 104/m in. 
He had generalized chronic bronchitis. He 
had no abrasions or discolouration of the 
abdominal wall but had d iffuse tenderness 
and rig id ity  with m arked tenderness in the 
r ig h t costovertebral angle. Bowel sounds 
were absent. His hemoglobin was 16.1 g ./ 
100 ml., and the leukocyte count was 16,- 
700/c.mm. The serum am ylase and electro­
lytes were normal. Three views of the  ab­
domen showed no in traperitoneal a ir  but 
w hat was originally in terp re ted  as “gas” in 
the righ t colon was subsequently recognized 
as a ir  in the right re troperitoneum  which 
outlined the lower pole of the r ig h t kidney (Fig. 1).
Over a short period the p a tien t’s periton i­
tis  rapidly worsened. An intravenous in fu ­
sion had been started ea rlie r and 10,000,000 
units of aqueous penicillin G and 1 g. of 
ampicillin were added to the in travenous 
infusion. He was prepared fo r im m ediate 
operation w ith a diagnosis of perforated  peptic ulcer.
A t laparotomy the f i r s t  p a r t of th e  duo­
denum was normal but th ere  was a two-inch 
tea r on the antim esenteric border of the 
th ird  p a rt of the duodenum. There was con­
siderable extravasation of bile, and edema 
of the surrounding tissue. There was no 
evidence of in ju ry  or o ther abnorm ality  of
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Fig. 1.—Case 1. Flat plate of the abdomen 
demonstrating free air in the right retroperi- 
toneum.
the kidney, liver, pancreas, biliary tree or 
the gut. The duodenal defect was closed 
transversely so as to preserve an adequate 
lumen.
The patient made an uneventful recovery. 
Subsequently he recalled that, 24 hours be­
fore admission, he had bumped the right 
side of his abdomen against a stair railing 
but had no pain at the time and considered 
the mishap trivial. He continued to deny 
stoutly any dyspeptic symptoms. An upper 
gastrointestinal series done on the tenth 
postoperative day showed no abnormality of 
the stomach or duodenum except the oper­
ative deformity. Gastric acid determina­
tions showed normal total hydrochloric acid 
values of 2.2 mEq./hr. basal secretion and 
of 4.4 mEq./hr. with maximal stimulation. 
We never determined whether this trifling 
injury was the cause of the severe 
duodenal injury, or whether, in his drunken 
state, the patient had sustained more severe 
abdominal trauma, later forgotten.
Case 2 —  B.R., a 60-year-old chronic al­
coholic, was admitted drunk and unco­
operative to the Wellesley Hospital on May 
27, 1970. He had been stabbed in the right 
upper quadrant of the abdomen about one 
hour before. He had no abdominal symp­
toms but soon began to complain of pain in 
the right upper quadrant which gradually 
became generalized. There was a clean 2- to 
3-cm. puncture wound just below the right 
costal margin, and diffuse abdominal ten­
derness, which was maximal in the right
upper quadrant, with generalized guarding 
and absent bowel sounds. Vital signs were 
normal as were hemoglobin, leukocyte count, 
serum amylase and electrolytes. Three views 
of the abdomen showed no free intraperi- 
toneal air or fluid. The patient was pre­
pared for laparotomy without delay.
It was found that the knife wound had 
transfixed the liver edge just to the medial 
side of the gallbladder fossa and had passed 
through the anterior and posterior walls of 
the first part of the duodenum to end in the 
head of the pancreas. The liver was not 
bleeding significantly but duodenal contents 
were leaking freely into the peritoneal cavi­
ty. After careful inspection, we elected not 
to repair the pancreatic wound, but to close 
the anterior and posterior duodenal wounds 
in two layers with drainage of the gen­
eral peritoneal cavity and the lesser sac. 
The liver wound was not treated. A Stamm 
gastrostomy was created to decompress and 
defunction the duodenum.
The patient’s course was uneventful and 
he had no apparent leakage from the duo­
denum, liver or pancreas. The gastrostomy 
tube was removed on the tenth day after 
preliminary periodic clamping.
Case 3.— S. K , a 31-year-old woman, was 
admitted to another hospital on February 
1, 1970, with a comminuted fracture of the 
right tibia and fibula sustained while ski­
ing. These were treated by closed reduc­
tion, plaster immobilization and elevation 
in bed. On the second hospital day, she de­
veloped some upper abdominal discomfort 
with a feeling of epigastric fullness. A 
serum amylase at this time was minimally 
elevated. The next day she began to vomit 
frequently, bringing up small amounts of 
bile-stained material; her symptoms were 
thought to represent pyloroplasm with a 
paralytic ileus. A nasogastric tube was in­
serted and a large amount of fluid was 
aspirated. Gastric suction and intravenous 
alimentation were maintained for one week 
but pyloric obstruction persisted.
On February 10, she was transferred to 
the Wellesley Hospital. At that time the 
abdomen was soft; there was marked ten­
derness in the right upper quadrant and 
epigastrium but no evidence of peritoneal 
irritation. Bowel sounds were active and the 
rectum contained normal stool. Three views 
of the abdomen showed distension of the 
stomach with fluid and air, and a normal 
bowel pattern distally. Serum bilirubin and 
amylase determinations were normal.
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Fig. 2.—Case 3. The stomach is distended 
and the normal pattern of the duodenal cap is 
reversed by a huge smooth filling defect in the 
greater curve of the second part of the duo­
denum.
An upper gastrointestinal series showed 
incomplete but severe duodenal obstruction. 
There was marked delay in gastric empty­
ing caused by a large intramural mass in 
the second portion of the duodenum, which 
was interpreted as an intramural hematoma 
(Figs. 2 and 3).
Because the nasogastric tube was no 
longer draining large quantities of fluid 
and because the obstruction was radio- 
logically incomplete, the tube was removed 
and the patient was started on a gradually 
increasing regimen of oral fluids which she 
tolerated well after the second hospital day. 
On February 16, 1970, the gastrointestinal 
series was repeated and showed a marked 
diminution in the size of the mass with free 
passage of dye to the small bowel. The pa­
tient’s diet was rapidly advanced to full and 
she had no further gastrointestinal com­
plaints throughout her hospital stay and 
outpatient follow-up.
E t io l o g y
Retroperitoneal Rupture
It has long been recognized that the 
duodenum can be ruptured by blunt
Fig. 3.—Case 3. The mucosal pattern of the 
duodenal loop demonstrates the characteristic 
“ coil-spring” appearance.
trauma to the abdomen. In 1910, Schu­
macher collected 91 cases o f duodenal 
rupture, 24 of which were retroperito­
neal, and each year another five  to 10 
cases are added to the literature. None 
the less, the diagnosis o f retroperitoneal 
duodenal rupture remains one o f  the 
most d ifficult in abdominal traum a and 
the syndrome of intramural hematoma 
o f  the duodenum is even less well 
known.
The usual cause o f blunt duodenal in­
ju ry  is a blow of some force  to the up­
per abdomen, most frequently from  the 
steering wheel in a m otor vehicle acci­
dent. Duodenal injury o f some sort oc­
curs in approximately 10% o f  blunt ab­
dominal trauma.' However, a seem ingly 
trivial force can cause retroperitoneal 
duodenal rupture, particularly i f  the 
abdominal musculature is relaxed by 
sleep, drugs, alcohol or inattention. In­
deed, the blow may be so slight as to be 
completely forgotten by the patient.
The mechanisms whereby such rup­
ture can occur have been reviewed by 
Cocke and Meyer.2 The retroperitoneal 
duodenum is fairly well fix ed ; it is held 
against the unyielding vertebrae by  the 
posterior parietal peritoneum and later­
al movements are prevented by the ori-
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gin of the superior mesenteric artery 
from the aorta. Thus, when a force is 
directed against the epigastrium, the 
duodenum cannot evade it. In some in­
dividuals the duodenum appears to un­
dergo a temporary closed-loop obstruc­
tion. The proximal end is occluded ap­
proximately one-third of the time by the 
action of the pylorus in normal peristal­
sis. The distal obstruction at the duo­
denojejunal flexure is particularly 
likely to occur because, in 5% of the 
population, the ligament of Treitz con­
tains smooth muscle and is attached 
only over the narrow duodenojejunal 
junction. In such individuals, contrac­
tions of the ligament musculature, 
which are co-ordinated with normal pe­
ristalsis, may increase the already acute 
duodenojejunal flexure to the point of 
obstruction. Cocke and Meyer2 believe 
that the relative infrequency of this 
anatomical arrangement accounts for 
the lower incidence of this type of in­
jury, but this mechanism may explain 
duodenal rupture after apparently 
minor trauma. It may also explain why 
only the duodenum is injured in most 
cases of blunt abdominal trauma. In­
jury to other anatomically associated or­
gans is remarkably low— 10% to 15%.3
The most common site of perforation 
is the greater curvature of the second 
part of the duodenum, possibly because 
of its larger lumen and less-protected 
position. The exact composition of the 
fluid entering the retroperitoneal space 
from the perforated duodenum varies 
with the state of digestion but it is high­
ly irritative due to its alkalinity, al­
though it is bacteriologically innocuous.
Penetrating Wounds
Penetrating wounds of the duodenum 
(Case 2) present different features and 
pose different challenges from blunt in­
juries. With blunt duodenal trauma, as­
sociated injury is uncommon, but with 
penetrating trauma it is virtually uni­
versal. Indeed, it is because these lesions 
involve the duodenum’s anatomic neigh­
bours that the mortality of “ penetrating 
duodenal injury” remains high. How­
ever, involvement of the duodenum in 
penetrating trauma is uncommon. In 
the cases analyzed by Cave,4 duodenal 
injuries constituted 10% of small-bowel 
injuries and 3.7% of all abdominal 
operations (military).
Intramural Hematoma
Intramural hematoma of the duo­
denum was, until recently, infrequently 
reported. Despite a description of the 
lesion as long ago as 1838,5 Golding, De 
Jong and Parker' could find only 23 
cases in the literature up to 1962. Since 
then, increased awareness has resulted 
in greater frequency of recognition, and 
numerous case reports and series have 
been added to the literature.
The etiology of this lesion is some­
times obscure. While most hematomas 
result from blunt trauma to the upper 
abdomen, the lesion has also been seen 
in association with operative trauma, 
liver disease, pancreatitis, blood dyscra- 
sias (hemophilia and Henoch-Shonlein 
purpura) and anticoagulant therapy. In 
a few cases no cause is demonstrable 
and, while many are doubtless examples 
of minimal trauma, a few may be spon­
taneous. Children seem particularly 
prone to this injury by virtue of their 
high wide costal arches which do not 
provide the bony protection of the adult 
configuration.7
The mechanism of injury appears to 
be a shearing or crushing of the duo­
denum between the external object and 
the vertebral bodies.8 The hematoma, 
which commonly collects at the junction 
of the second and third parts of the duo­
denum, may be submucosal, intramus­
cular or subserosal. In those cases that 
present clinically, the hematoma and 
secondary edema usually produce ob­
struction of the duodenal lumen.
D iagnosis
Retroperitoneal Duodenal Injury
The diagnosis of this type of duo­
denal injury is often difficult. Because 
the onset of pain awaits irritation or 
stretching of the parietal peritoneum, 
there is usually a symptom-free inter-
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lude, which may be of several hours’ 
duration. During this time a trivial in­
jury can be forgotten, as in our first 
case. The usual complaints are of dif­
fuse, dull, epigastric and right upper 
quadrant pain, associated with one or 
two episodes of vomiting, rarely of 
blood. Retroperitoneal extravasation of 
air or fluid may produce loin or testi­
cular pain or even priapism.9 On exam­
ination, there is evidence of diffuse ten­
derness throughout the right abdomen 
and flank, but marked evidence of peri­
toneal irritation is often lacking. Bowel 
sounds are diminished or absent. Oc­
casionally air or fluid may be palpable 
posteriorly on rectal examination.10
The most helpful ancillary aid is the 
plain film of the abdomen which may 
show retroperitoneal air or fluid (Fig. 
1). Air in the right retroperitoneum, 
though it may be difficult to distin­
guish from air in the right colon, does 
not usually move with changes in posi­
tion and may outline the right kidney. 
Retroperitoneal fluid may obscure the 
right kidney or psoas shadows. In dif­
ficult cases, a water-soluble dye may be 
used to demonstrate the perforation. Ba­
rium studies are contraindicated.
Penetrating Injury
The diagnosis is usually more 
straightforward than with blunt inju­
ries. A skin wound may or may not 
point the way to a consideration of the 
duodenum but will, at least, indicate 
significant injury. In Cave’s series from 
World War II, 8% of entry wounds that 
involved the duodenum lay in a band 
stretching from the xiphoid to the um­
bilicus and from the midline anteriorly 
to the midline posteriorly. Another help­
ful feature is that the discharge of duo­
denal contents (with rare exceptions) is 
into the general peritoneal cavity, pro­
ducing a picture like that of perforated 
ulcer which is more obvious than that 
of retroperitoneal leak.
Free air may be evident on an up­
right radiograph of the abdomen but 
its absence does not exclude the diag­
nosis. If the patient’s general condition
permits, an intravenous pyelogram 
should always be done before operation.
Intramural Hematoma of the
Duodenum-
Tine diagnosis of this condition need 
not be rushed because the patients are 
seldom gravely ill. Typically, blunt trau­
ma is followed by a quiescent period 
which may last a few hours to a few 
days— commonly about 24 hours. There 
is then a gradual build-up of aching or 
epigastric and right upper quadrant 
pain, associated with repeated vomiting 
of bile-stained material and eventually, 
if obstruction is complete, with obsti­
pation.
Physical examination and labora­
tory determinations add little. There is 
usually moderate to severe right upper 
quadrant tenderness and rarely a pal­
pable mass. The blood loss is insufficient 
to lower the hemoglobin level. Coagula­
tion indices should be checked but are 
usually normal. Serum amylase is often 
slightly elevated. A large hematoma 
can, rarely, compress the ampulla of 
Vater and produce the biochemical 
changes of obstructive jaundice.
The upper gastrointestinal series 
shows a pathognomonic picture as de­
scribed by Felson and Levin.11 The 
smooth-edged filling defect and “ coil- 
strated in our Case 3) are reported in 
the literature with remarkable regular­
ity.
Treatm ent
Retroperitoneal Rupture of the
Duodenum
WKen the diagnosis of retroperitoneal 
rupture of the duodenum is made or 
even suspected, early exploratory lapa­
rotomy is essential. The importance of 
adequate exploration of the full length 
of the retroperitoneal duodenum cannot 
be over-emphasized. Over 30% of duo­
denal injuries have been missed at lapa­
rotomy with a corresponding rise in 
morbidity and mortality. To facilitate 
exploration, the duodenum should be 
mobilized by dividing the lateral peri­
toneum, and a second approach may be
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necessary through the traverse meso­
colon or the ligament of Treitz. Defini­
tive treatment usually consists of two- 
layer closure, if possible in the trans­
verse diameter of the duodenum, with 
tube drainage through a separate stab 
wound from a site near the repair. 
Cleveland and Waddell3 emphasized the 
necessity of adequate drainage; in their 
series, despite meticulous closure, 15% 
developed postoperative duodenal fis­
tula, all of which healed in time with 
conservative treatment. Repair of the 
perforation must leave an adequate duo­
denal lumen. Where this is impossible, 
or where the damage is more extensive 
than a simple “blow-out” , the surgeon 
can employ reanastomosis, bypass or 
patching.
The mortality attendant upon duo­
denal rupture has improved little in the 
last two decades, remaining at a de­
pressing 15% to 20%.2,9 This figure un­
doubtedly reflects the difficulty of diag­
nosis and will not be lowered without 
earlier diagnosis and better methods of 
treatment. Concomitant visceral inju­
ries, which occur in about 10% of pa­
tients with blunt trauma, may account 
in part for the high mortality.
Penetrating Wounds
Early laparotomy is essential not only 
for the management of the duodenal in­
jury but also for the associated injuries 
which are so common. At laparotomy, 
a careful assessment of associated inju­
ries must be carried out. The liver, he­
patic flexure, small bowel, stomach, 
right kidney and pancreas are all com­
monly wounded. In addition, injury to 
a major blood vessel in the immediate 
area is likely and the aorta, inferior 
vena cava, renal vessels, hepatic and 
pancreaticoduodenal arteries, superior 
mesenteric artery and portal vein are 
all at risk and should be inspected. Most 
of the fatalities in this type of duodenal 
injury are due to hemorrhage.
Intramural Hematoma
The best form of treatment is as yet 
unsettled. Three forms of therapy are
recognized, including expectant treat­
ment with gastric decompression and 
parenteral feeding, simple clot evacua­
tion and drainage, and more radical 
operations such as primary bypass gas­
trojejunostomy. In the case reported 
here, we felt that it would be meddle­
some to operate on the patient whose 
diagnosis was late, whose obstruction 
was partial and in whom clinical im­
provement was apparent. However, the 
patient with a complete obstruction who 
has undergone a prolonged period of 
gastric drainage and intravenous ali­
mentation is better served by early clot 
removal or gastrojejunostomy. There 
appears to be little justification for the 
physiologic derangement of a primary 
bypass in the uncomplicated case, par­
ticularly as most of these will resolve 
spontaneously.
Discussion
The lessons to be learned from these 
three illustrative cases concern mainly 
the need to recognize each individual 
type. Probably the retroduodenal inju­
ry, because the peritoneal cavity is not 
contaminated, leads most often to de­
layed diagnosis and subsequent morbid­
ity. Its recognition requires a high index 
of suspicion and careful examination of 
the plain films of the abdomen; here 
care must be taken to recognize retro­
peritoneal gas which may easily be con­
fused with air in the colon. With pene­
trating duodenal injuries, other visceral 
damage may confuse the diagnosis and, 
even if the duodenal injury has not been 
suspected before operation, it should be 
carefully excluded, particularly when 
retroperitoneal hematoma or extravasa­
tion of bile is evident in the adjacent tis­
sues. It should be stressed that free air 
is not always present in the peritoneal 
cavity following such an injury and, if 
other portions of the intestine have been 
damaged at the same time, free air may 
be attributed to the more obvious lesion 
rather than to one in the less visible 
duodenum. Associated injury to the bile 
duct may complicate the management, 
but such injury should be excluded at
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the time of the exploratory laparotomy.
In most instances intramural hema­
toma of the duodenum seems to be a 
self-limiting condition. However, if it is 
not recognized it may cause confusion in 
a patient who has suffered minor, and 
often unrecognized, abdominal trauma 
and presents with persistent vomiting. 
There appears to be no good reason for 
treating these patients by operation, at 
least in the initial stages, and the sur­
geon can follow a “wait-and-see” policy 
in the firm expectation that most pa­
tients will improve.
Su m m a r y
Three cases have been presented 
which illustrate the three main types of 
duodenal injury: retroperitoneal rup­
ture from blunt abdominal trauma, 
penetrating duodenal injury, and intra­
mural hematoma of the duodenum. The 
diagnosis of all three types may be dif­
ficult. Plain films of the abdomen are 
most useful in the first type, laparotomy 
in the second type, and upper gastroin­
testinal series in the third. Operation is 
essential in retroperitoneal rupture and 
penetrating duodenal injuries and 
should be done quickly to prevent un­
necessary contamination of the peri­
toneal cavity or retroperitoneal space by 
gastric and duodenal contents. A  con­
servative policy should be followed in 
the management of intramural hema­
toma of the duodenum.
Case 2 was admitted under the care of Dr. 
R. I. Mitchell and we are grateful to him for 
permission to publish it.
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R e s u m e
Les auteurs presentent trois cas typiques 
des trois formes principales de lesion duode- 
nale: rupture retroperitoneale par traumatisme 
abdominal contondant, lesion penetrante du duo­
denum et hematome intramural du duodenum. 
Ils soulignent la difficulty du diagnostic dans 
les trois types, mais font remarquer qu’un film 
simple de l ’abdomen est le meilleur moyen 
diagnostique dans le premier cas, la laparo- 
tomie dans le second cas et des radiographies 
en serie dans le troisieme. 11 faut operer la 
rupture retroperitoneale et la lesion penetrante 
du duodenum et il faut intervenir d’urgence 
pour empecher une contamination evitable de 
la cavite peritoneale ou de l’espace retroperi­
toneal par des matieres provenant de Testomac 
ou du duodenum. Ils soulignent que le traite- 
ment de Thematome intramural doit etre con- 
servateur.
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UNUSUAL CAUSE OF UPPER GASTROINTESTINAL BLEEDING: 
RUPTURE OF SPLENIC ARTERY ANEURYSM 
INTO STOMACH WITH SURVIVAL*
F. G. INGLIS, M.D., F.R.C.S.[C] and NANCY H. McKEE, M.D.,
Montreal, Que.
This paper describes a rare cause of upper gastrointestinal bleeding which should be considered in patients with bleeding from an obscure source.
Case Report
A 44-year-old white woman was first 
admitted to hospital in December 1969 be­
cause of melena and epigastric pain. Her 
pain resolved after treatment with antacids 
and diet. A barium meal was normal, but 
oral cholecystography revealed stones. 
Stools were negative for occult blood. In 
June 1970 she underwent a cholecystectomy 
for chronic cholecystitis and cholelithiasis. 
According to the operative report there was 
no evidence o f abnormality in the vicinity 
of the stomach or spleen. Following dis­
charge, oral iron therapy was continued 
because of an iron-deficiency anemia.
In October 1970 she was admitted to the 
Royal Victoria Hospital, Montreal, with me­
lena and burning epigastric pain. Her hemo­
globin was 11.5 g./lOO ml. Gastroscopy de­
monstrated mild gastritis which was attri­
buted to a moderate aspirin intake. Her 
barium meal was negative and, because her 
symptoms had subsided, she was discharged 
with instructions to continue on a bland 
diet. On December 1, 1970, she again had 
an episode of melena followed by vomiting 
of fresh blood. The hemoglobin on this ad­
mission was 9.6 g./lOO ml. Gastroscopy 
showed a hemorrhagic area on the 
posterior aspect of the mid-greater curva­
ture of the stomach, which was thought to 
represent a benign gastric ulcer. A barium 
meal showed an unusual filling defect at 
the same site (Fig. 1). After transfusion of 
1500 ml. of whole blood, her condition stab­
ilized and she was taken to the operating 
room with a differential diagnosis of bleed­
ing gastric ulcer, leiomyoma or other tu­
mour of the stomach. At operation she had 
a mass adherent to the greater curvature 
of the stomach in continuity with the hilus 
of the spleen. Initially we considered this
*From the Department of Surgery, Royal 
Victoria Hospital, Montreal, Que.
Reprint address: Dr. F. G. Inglis, Department 
of Surgery, University Hospital, Saskatoon, 
Sask.
Fig. 1.—Radiograph of the stomach showing 
a circular defect.
to be either a leiomyoma or leiomyosarcoma 
of the stomach wall which had ulcerated 
and bled. The mass was removed by a wedge 
resection of the greater curvature of the 
stomach in continuity with the spleen and 
submitted to the pathologist for examina­
tion and frozen-section diagnosis. The mass 
consisted of a saccular aneurysm of the 
splenic artery arising near the hilus of the 
spleen and the posterior aspect of the great­
er curvature of the stomach, through which 
it had ulcerated and bled (Fig. 2). Because 
the left (anterior) vagus nerve had been in­
terrupted intramu rally, a pyloroplasty was 
done. Her postoperative recovery was un­
eventful, and she was discharged on the 
twelfth day after operation. Final patho­
logical diagnosis of the specimen was 
atherosclerotic aneurysm of the splenic ar­
tery with rupture into the stomach. Ten 
weeks later she developed signs, symptoms 
and laboratory evidence of serum hepatitis 
from which she has recovered.
Discussion
This case illustrates the difficulty in 
diagnosing splenic artery aneurysms. 
These lesions have been attributed to 
factors such as congenital defects, arte­
riosclerosis, hypertension, trauma, and
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Fig. 2.—Pathology specimen showing com­
munication between the splenic artery aneu­
rysm and stomach.
infection. There is reported association 
with tuberculosis and syphilis. The pa­
tient whose case is described here had 
atherosclerosis of the splenic artery 
although she was premenopausal.
The autopsy incidence of splenic ar­
tery aneurysms varies from 0.4% to 
0.1%.' The incidence of rupture of the 
splenic artery aneurysm is around 
30%.2 When a splenic artery aneurysm 
does rupture, it is usually into the lesser 
sac. In a collective review, Sherlock and 
Learmonth3 reported that 11% of these 
aneurysms ruptured into the stomach.
A splenic artery aneurysm may 
present clinically with epigastric or 
left upper quadrant pain, indigestion, 
and weight loss, or it may be asympto­
matic. If the aneurysm ruptures, the pa­
tient may present with shock associated 
with the findings of an acute abdominal 
catastrophe. In some cases the rupture 
is more insidious and may develop in 
two stages.4 Our patient may have been 
in danger of sudden intra-abdominal ca­
tastrophe for a year because the origin­
al rupture probably occurred in Decem­
ber 1969. The most common abdominal 
findings are a pulsatile mass and a left 
upper quadrant bruit. Hypertension is 
a frequent associated finding.1 Radio­
graphs may show eggshell calcification 
in the left upper quadrant of the abdo­
men but such calcification does not 
show either a positive or negative cor­
relation with rupture.1 A barium meal 
may demonstrate deformity of the 
stomach as in the present case, but 
selective celiac arteriography is the ul­
timate diagnostic procedure.5 Gastro­
scopy may be valuable, as in this case 
where it demonstrated the ulcerating 
surface of the lesion. If splenic artery 
aneurysm is considered as a possible 
cause of bleeding, laparotomy will pro­
vide the definitive diagnosis.
Management depends on whether the 
patient has symptoms related to the con­
dition. If the aneurysm is asymptomatic 
and the patient subsequently becomes 
pregnant, the lesion should be resected 
because there is a high incidence of rup­
ture during the third trimester.2 Many 
older patients are unfit for operation 
and asymptomatic aneurysms may be 
followed for years. However, because 
there is serious risk that the aneurysm 
may rupture and kill the patient, re­
section should be considered in the 
asymptomatic patient who is a good 
surgical risk.
The splenic artery aneurysm as­
sociated with abdominal symptoms 
should be treated surgically. An aneu­
rysm near the hilus of the spleen should 
be resected with the spleen. A more 
proximal aneurysm may be simply re­
sected because the blood flow from the 
stomach to the spleen via the short gas­
tric arteries and the left gastroepiploic 
artery prevents splenic infarction.
The results of operations for ruptured 
aneurysm have been disappointing in 
the past, but improve with earlier 
diagnosis. In 1963, Heggtveit6 reviewed 
17 cases of splenic artery aneurysm 
rupturing into the stomach. Of these, 
seven patients were operated upon and 
one survived. In 1970, Pugeda and Hin- 
shaw7 discussed another four cases, all
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treated surgically, with three survivors. 
Another case, reported by Hootkin and 
Cocco8 survived resection of the aneu­
rysm and adherent gastric tissue. Over 
230 cases of ruptured splenic aneurysm 
have been recorded in the English lite­
rature. We have presented the twenty- 
third recorded case of an aneurysm rup­
turing into the stomach and the sixth 
in which the patient has survived.
Summary
Rupture of a splenic artery aneurysm 
into the stomach is a rare cause of gas­
trointestinal bleeding. A  44-year-old 
woman had three upper gastrointestinal 
hemorrhages before operation. A  mass 
composed of an aneurysm of the splenic 
artery, which had eroded into the 
greater curvature of the stomach, was 
resected in continuity with the greater 
curvature of the stomach, the aneurysm 
and the spleen. A  review of the litera­
ture indicated that the diagnosis was 
often overlooked, but was most frequent­
ly made on plain radiographs of the 
abdomen which showed a calcified mass 
in the left upper quadrant. Selective 
celiac angiography is the best technique 
to confirm the presence of an aneurysm. 
Operative treatment is indicated for all 
symptomatic splenic artery aneurysms 
and for all asymptomatic aneurysms in 
women of child-bearing age. In the past, 
the mortality has been high, but earlier 
operative management has decreased 
this mortality. The present case is the 
sixth recorded survival after rupture of 
a splenic artery aneurysm into the 
stomach. The authors propose that an­
giography and early operative interven­
tion will further decrease the mortality 
associated with this lesion.
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Resume
La rupture d’un anevrysme de l’artere sple- 
nique (anevrysme de Crisp) dans l’estomac ne 
cause que rarement une hemorragie gastro- 
intestinale. Une femme de 44 ans avait ce- 
pendant eu trois episodes d’hemorragie de l’ap- 
pareil digestif superieur avant d’etre operee. 
Le chirurgien, en presence d’une masse com- 
prenant un anevrysme de l’artere splenique 
qui s’etait rupturee dans la grande courbure 
de l’estomac, a reseque cette masse dans le 
prolongement de la grande courbure de l’es­
tomac, de l’anevrysme et de la rate. La revue 
de la litterature indique que le diagnostic est 
souvent meconnu, mais qu’on decouvre le plus 
frequemment cette lesion sur des radiogra- 
phies abdominales simples montrant une masse 
calcifiee dans le quadrant superieur gauche. 
La meilleure methode de confirmation d’un 
anecrysme est l’angiographie coeliaque selec­
tive. L’operation est indiquee dans tous les cas 
symptomatiques d’un anevrysme de Crisp et 
dans tous les cas asymptomatiques chez des 
femmes en age de devenir enceintes. Autrefois, 
cette lesion etait d’une forte mortalite, mais 
1’operation precoce a diminue cette mortalite. 
Le cas present est le sixieme ou le patient a 
survecu a la rupture de 1’anevrysme de Crisp 
dans l’estomac. Les auteurs estiment que l’an- 
giographie et la prompte intervention chirur- 
gicale reduiront encore la mortalite.
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written consent of the subject for publica­
tion has been obtained. Graphs and dia­
grams should be drawn in India ♦ink on 
suitable white paper. Lettering should be 
sufficiently large that after reduction to 
fit the size of the Journal page it can still 
be read. Legends to all illustrations should 
be typed separately from the text and sub­
mitted on a separate sheet of paper. Illustra­
tions should not be rolled or folded.
Language
It should be clearly understood that con­
tributors are at full liberty to submit articles 
in either English or French, as they please. 
Acceptance will be quite independent of 
the language of submission. If the contri­
butor wishes, he may submit an informative 
summary of not more than 300 words in 
the language other than that in which he has 
submitted the article. For example, an ar­
ticle in English must carry an English sum­
mary and may, if the author wishes, carry 
a more detailed summary in French.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal 
devra porter la mention “Le journal canadien 
de chirurgie” et etre adressee a l’Editeur, P.O. 
Box 8650, Ottawa, Ontario K1G 0G8.
Le journal est publie a tous les deux mois. 
Le prix de l’abonnement est de $15. par an 
($7.50 par an pour les medecins qui sont resi­
dents en chirurgie) et commence avec le nu­
mero de janvier de chaque annee. Un exem- 
plaire isole coute $2.50 et est payable d’avance.
INSTRUCTIONS A NOS 
COLLABORATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap­
ports cliniques etc. seront envoyes en deux 
exemplaires, accompagnes d’une lettre deman­
dant qu’on veuille bien considerer leur publica­
tion dans L e journal canadien de chirurgie. Ils 
ne seront acceptes qu’a la condition qu’ils 
n’aient ete soumis qu’a notre Journal et qu’ils 
ne soient pas reimprimes sans le consentement 
expres de l’editeur et l’auteur. L’acceptation 
ou le refus des articles soumis releve du Con- 
seil de la publication. Si la place est disponible, 
un nombre limite d’histoires cliniques pourront 
etre publiees. Les articles seront dactylographies 
sur un seul cote d’un papier non ligne, a dou­
ble espace et avec une large marge. L’auteur 
devra toujours conserver une copie au papier 
carbone du texte soumis. Tout article devra 
etre accompagne d’un resume. L’orthographe 
sera celle adoptee par le dictionnaire Larousse. 
Quant a la terminologie scientifique, elle sera 
basee sur le Dictionnaire des termes techniques 
de medecine ou tout autre ouvrage de refe­
rence serieux. Le Conseil de la publication se 
reserve le droit d’apporter au texte les change- 
ments qu’il jugerait a propos pour assurer la 
correction grammaticale et l’orthographe, pour 
eliminer d’eventuelles obscurites ou pour ren- 
dre la presentation conforme au style du Jour­
nal canadien d e  chirurgie. Aucun changement 
important ne sera apporte au texte sans que 
l’auteur ait ete prealablement consulte. Les 
auteurs recevront avant la publication des 
epreuves d’imprimerie de leur texte, auxquelles 
ils sont pries d’apporter le minimum de correc­
tions.
T ires-d-part
On pourra commander des tires-a-part sur 
une formule qui est envoyee avec les epreuves. 
II est important de les commander avant la 
publication de 1’article, sous peine de devoir 
payer un supplement pour une nouvelle com­
position.
Bibliographic
Les references bibliographiques seront indi- 
quees par des numeros dans le corps du texte. 
Elies comprendront dans l’ordre: le nom de 
l’auteur et ses initiales, en majuscules, le titre 
abrege du Journal, le numero du volume, le 
numero de la page et l’annee. Les abreviations 
admises pour les noms de revues sont celles qui 
figurent dans I’index Medicus. Les renvois aux 
livres comprendront dans l’ordre: le nom de 
l’auteur, ses initiales, le titre de l’ouvrage, le 
numero de l’edition (p. ex. deuxieme ed.), la 
ville et le nom de la maison d’edition, et 
l’annee de la publication; enfin, le numero de 
la page s’il s’agit d’un renvoi precis. Pour 
exemples, voyez l’issue de janvier 1971 et ceux 
a venir.
Illustrations
Le journal accepte de publier gratuitement 
un nombre raisonnable d’illustrations en noir 
et blanc. Les reproductions de cliches en cou- 
leurs seront publies aux frais de l’auteur. Les 
photographies seront imprimees sur papier bril- 
lant, ne seront ni montees ni calibrees et d’un 
format maximum de 6" x 8". En ce qui con- 
cerne les radiographies, nous demandons des 
copies et non pas l’original. On devra toujours 
fournir un agrandissement de microphotogra­
phies. II ne faut jamais ecrire ou dactylogra- 
phier un texte quelconque sur les photogra­
phies. Une legende les identifiant pourra etre 
jointe au dos. Dans les illustrations montrant 
des malades, ceux-ci ne pourront etre reconnus, 
a moins qu’ils n’en aient donne le consentement 
ecrit prealablement a la publication. Les gra- 
phiques et diagrammes seront dessines a l’en- 
cre de Chine sur un bon papier a dessin blanc. 
Le lettrage devra etre ecrit en caracteres assez 
grands pour que, apres reduction proportion- 
nelle au format du Journal, ils soient encore 
lisibles. Les legendes devant accompagner les 
illustrations seront dactylographies sur une 
feuille independante du texte. Les illustrations 
ne seront ni roulees ni pliees.
Langue vehiculaire
II doit etre clairement etabli que les colla- 
borateurs ont pleine liberte de soumettre leurs 
articles en franqais ou en anglais, a leur choix. 
L ’acceptation de l’article sera entierement inde­
pendante de la langue choisie par l’auteur. Si 
le collaborateur le desire, il peut decrire le 
contenu de l’article en un sommaire ne depas- 
sant pas 300 mots et dans une langue differente 
de la langue choisie pour l’article lui-meme. 
Par exemple, un article ecrit en frangais doit 
comporter un resume en frangais et peut, si 
l’auteur le desire, etre accompagne d’un som­
maire plus detaille en anglais.
Ceporan
(cephaloridine)
I.M.
I.V.
In post-operative infections, don’t save 
Ceporan just as the “last resort” antibiotic-
in recommended low-dosage treatment it is 
effective, safe and economical in the 
management of most common infections.
"It may be the drug of primary choice in serious post-operative infections where both 
gram-positive and gram-negative organisms may be responsible . . ."1 
Ceporan, the first cephalosporin antibiotic in Canada—rapidly kills a wide range of gram­
positive and gram-negative organisms. It is well tolerated by patients allergic to penicillin—• 
it is notably free from toxic effects. Injections are virtually painless. One of the safest 
antibiotics, its highly effective action ensures quick clinical response.
1Gunton R. W. A Current Evaluation of Newer Antibiotics”  Canadian Family Physician. 
P. 23, May, 1968.
n oU h ^ ', h j5 o 5 2 ™ « f ih lCi5fr ic i‘ia l ' An in -v itr°  concentration o f1 ng /m l. or less inhib ils most strains o f the follow ing 
gram positive bacteria. Staphylococcus aureus, Streptococcus pyogenes, Diplococcus pneumoniae Strentorocm<; 
n f f 'h f f^ in 0rynebacteriumidiphuthe/ iae- At an in-vitro concentration of 8V g , ml. o rle s T c e p o ra n a E o in h ib its m S s ts ta tin f 
rhoea,*Neisseha c^Ta'rrhafis^® baCtena: E> Co1'. Proteus m irabilis, K lebsiellaspp. Haemophilus influenzae, Neisseria gonor-
£ f P°tranj S especia' ly indicated where pen ic illin  cannot be used either because the patient is known or susDected to be 
sensitized, where the organism is penicillin-resistant, or where the infection is like ly to be mixed.
f ' fv■ V.■ ~  -------......................................  ...... .. uy m jetuon  or in travenous arip. in tra m u s c u la r or deeD su b c u ta n
hw?ol'-0n IS m° Si  ?om{™?n*y used, and is remarkably free from pain even w ith repeated Use. Large doses have been c bv n t avenous ririn  W ith o u t M i m n n  n h  o h i l i c  ^ :____ t ___________'-"-’oco nave ueen c.
i%ramfisrn?^rS'n > rtV'n^h0Ut 9aus'nd phlebitis; intravenous injection of a concentrated solution is not raifommended. A fter
6 toThours.ar J 10n' peak serum levels are attained in about 30 minutes, and good serum levels are maintained for
calculated by body weight. A  chart for th is purpose is included in the package. Moderate- 
due *° 9ram-positive organisms respond to 20 mg. kg/day. Infections due to gram-negative organisms 
and mixed infections usually respond to 40 mg/'kg/day. Doses as high as 100 m g/kg/day have been used bv c lin ica l invpsti' 
t^n 0c Snf5 t SneVf re of unknown aetiology, in septicaemia sub-acute bacterial endoca^ddis?post o p e ^
w?thS,h u f h aPdl?s tf°? 1yel't l .s- 11IS Probably undesirable to exceed 6 grams per day in the adu lt.C lin ica l experience 
w ith high dosage is lim ited, and the patient should be monitored for side effects.
not be usecl in p,e0nan' women unless' in lhe iudoment ^
L nd ^D halo ri^ine 'leve ls  S l d UE ?m o"nito reT  ^  bd ad,'USied accordin°  <° *he of excretion; renal function
a9ain■s, 0!'o,o2oa'. helminths, and fung i, including Candida albicans. A lthough Proteus m irab ilis  the 
commonest Proteus species, is sensitive to Ceporan, the antib io tic is generally not active against other Proteus soedes 
bactUed h ^ tu b e PrcLdosi^e^ fra m s nfCptrorVnnn US * 7  a 's ° '"se n s itive  to Ceporan, and it has only low activity against Mycol 
isms which d e v e f o n i ® ' S . / . d. .varyAn sensitivity. In general, organ-
Side Effects and Toxic ity With a dosage of 6 grams of Ceporan daily, cylinduria may occur, very rarely accomoanied bv 
proteinuria, and without disturbance of renal function Thp<xp pffprtc arc. rouoreihin — c ____  -rP. . . . . .  ydisturbance ° f re" al unc tio n . These effects are reversible w i t l T S t h e S ^ K S  ha?e 
been reports of disturbance of renal function associated w ith  high dosage, or in patients w ith pre-existent kidney dys- 
Shes have occ u rreri Hi in nn trpafmpni h. it t ho Hr. ,n i«- 11 — .. ..  i * .. ri o S i> n*ii?nWThashSS haHe 0CCUrred during treatment- but the drug is usually w e llto le ra ted  V S i e f f  R p e S w i t i f i  
Rpntinp 1 nThe*re have been rare reports of transient neutropenia and agranulocytosis and of a temporary rise m S G  O T
coagu^bfonestCu°dUiesSmay aPso^be desirab le?^ S in“  3 ' 6W Pa' ie" tS haVe Eh° w "  “ p ™
Presentation Ceporan is issued In vials containing 250 mg., 500 mg., and 1 gram of cephaloridine, in boxes o f 5. 
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GLAXO-ALLENBURYS
A  GLAXO C A N A D A  L IM IT E D  C O M P A N Y  
For fu ll in fo rm ation  and  references, w r ite  to :  
GLAXO-ALLENBURYS, 1 DORCHESTER AVENUE, 
TORONTO 550, ONTARIO • 9561 COTE DE LIESSE, 
DORVAL 760, P.Q.
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B O O K  R E V I E W S
ANGIOGRAPHY. Techniques and Proce­
dures. Joseph E. Whitley and Nancy
O’Neil Whitley. 122 pp. Illust. Warren
H. Green, Inc., St. Louis, 1971. $12.50.
The f irs t chapters in this book on phy­
sical requirem ents, methods and m aterials 
and complications contain useful inform a­
tion for the inexperienced angiographer 
but are fa r  too brief, occupying only 13 
pages. Considering tha t 14 pages have 
been le ft blank fo r “notes” it is a pity 
th a t so little  space has been found for 
the text.
The authors have included for each 
procedure a lis t of the m aterials, ca the­
ters, injection rates, etc. used a t their 
centre. This is the type of inform ation 
th a t m ight be of some use to one who had 
visited or worked in their centre and 
wished to recall the methods used but the 
descriptions are otherwise too b rief to be 
m eaningful to others. For example under 
renal arteriogram  “C atheter: No. 7 or 8 
double curve (80 cm.)” means little  to 
the experienced angiographer and is un­
intelligible to the neophyte.
The bulk of th is book (82 pages) is 
devoted to normal angiographic anatomy 
which, if well done, would have made it 
a welcome addition to any radiologic li­
brary. U nfortunately the full-page, re­
versed radiographs are so badly repro­
duced they are all but useless. Line draw­
ings of each angiogram do little to clarify  
the anatomy. In attem pting to trace the 
radiograph exactly, the identification of 
vessels has been made much more d iffi­
cu lt than  if schematic diagrams had been 
used.
In summary the few pages on general 
angiographic techniques are well done 
and contain useful information. The bib­
liography is fa irly  complete and as cur­
ren t as can be expected in a textbook. 
The sections on anatomy and specific 
techniques, which make up the bulk of 
the book, cannot be recommended for the 
inexperienced or experienced angio­
grapher.
ANORECTAL MALFORMATIONS IN 
CHILDREN. F. Douglas Stephens and 
E. Durham Smith. 411 pp. Illust. Year 
Book Medical Publishers, Inc., Chicago, 
1971. $25.00.
This book is the second in a series en­
titled “Surgical Conditions in Infancy and 
Childhood” , edited by Mark M. Ravitch 
and w ritten  by F. Douglas Stephens and 
E. Durham  Smith. The authors are mem­
bers of the Surgical Research Unit, Royal
Children’s Hospital Research Foundation, 
Melbourne, Victoria, A ustralia.
The dedication is particu larly  heart­
warming—“To children everywhere, de­
formed anywhere” . The contents of this 
text fill a need fe lt by those surgeons 
who must accept responsibility for cor­
recting anorectal anomalies and give 
function th a t will last a lifetime.
This is one of the few texts which is 
“up to date” when published. It is com­
prehensive, complete and accurate and 
attem pts to give international meaning to 
the language of anorectal anomalies, both 
in classification and the relationship of 
the type of anomaly to treatm ent. This 
the authors accomplish by an inclusive 
historical review, a trea tise  on the ana­
tomy and function of the normal rectum 
and anus, and a survey of individual de­
formities in the male and then in the 
female.
The classification is complete and con­
tains the ra re r  types of anomalies. Diag­
nosis and investigation are carefully set 
out, and the operative management of 
rectal deformities is clearly described and 
profusely illustrated. The same clear 
treatm ent directions are given for the 
operative management of anal deformities.
The associated anomalies and, most im­
portant of all, results of treatm ent, com­
plications, and assessm ent of continence 
are painstakingly discussed.
This book is destined to become a clas­
sic in its field. No surgeon can pick up 
a scalpel to correct an anorectal anomaly 
with a clear conscience, and be fully 
aware of the seriousness of his undertak­
ing, w ithout having read this book.
It is unfortunate th a t the title  does not 
make plain th a t the content covers the 
neonate and infant as well as the child. 
It is also unfortunate th a t Santulli’s in­
troduction of the “International Classifi­
cation” to North America describes the 
“low” anomalies firs t and the “high” anom­
alies last while this text trea ts them in the 
reverse order—perhaps this is one of the 
hazards of crossing the equator!
H. E. Beardmore
McGill University,
Montreal, P.Q.
ELLISON’S ATLAS OF SURGERY OF 
THE STOMACH AND DUODENUM. 
Larry C. Carey and Robert H. Albertin. 
165 pp. Illust. The C.V. Mosby Com­
pany, St. Louis, 1971. $25.90.
This atlas depicts the routine steps used 
and taught by Dr. Edwin H. Ellison in
perform ing  gastrectom y, vagotom y, g as­
troenterostom y, pyloroplasty , splenectom y, 
distal pancreatectom y and m esenteric lymph 
node and  liver biopsy.
Each operation  is p resen ted  by the  ne­
cessary  series of steps depicted  g rap h ic ­
ally  w ith sh o rt ad jo in ing  com m ents ex­
p la in ing  each p icture . The descrip tions 
a re  precise and  the  illu s tra tio n s  are  excel­
lent. This com bination m akes fo r  very 
enjoyable perusal by the surgeon, who in 
a sho rt time can review  the  su rg ica l p ro ­
cedure as ca rried  out by an  expert.
Sim plicity, gen tleness fo r tissu e  and 
o rderly  precision seem to be the  q ualities 
th a t  stand  fo rth .
This work w ill be app rec ia ted  on the 
reference shelf.
IDIOPATHIC ISCHEMIC NECROSIS OF 
THE FEMORAL HEAD IN ADULTS. 
Edited by Wilhelm M. Zinn. 220 pp. II- 
lust. Intercontinental Medical Book 
Corp., New York; Georg Thieme Verlag, 
Stuttgart, 1971. DM 78,000. $24.65 (ap­
prox.). Paperbound.
This book contains a sum m ary of an in te r­
national in te rd isc ip lin a ry  sym posium  on
ischem ic necrosis o f th e  fem oral head  in 
ad u lts . The c u rre n t concept o f the  
disease is covered well, in c lu d in g  etiology, 
pathogenesis, pathology, c lin ica l and  ra ­
diologic fea tu res , and  m anagem ent.
A considerable p o rtio n  o f the  book deals 
w ith  the d iffe re n tia l d iagnosis o f  a llied  
conditions such as L egg-P erthes disease, 
hip lesions in  compression disease (caisson 
disease), aseptic necrosis of the  fem oral 
head in sickle-cell anem ia, alcoholism, hyper- 
cortisonism , rheum atoid a r th r it is ,  system ic 
lupus erythem atosus, throm bocytopenia, an ­
kylosing spondylitis and fem oral head 
necrosis following kidney tran sp lan ta tio n . 
The possible roles in ischem ic necrosis of 
fa t  embolism and d iso rders of f a t  m eta­
bolism are discussed. The tex t also includes 
radiologic aspects of rou tine  stud ies, in tra ­
cap ita l or pertrochan teric  venography and 
radioisotopic studies.
The au th o rs  cover th e  ra tio n a le  of 
various su rg ica l tre a tm e n ts  in c lu d in g  in ­
te rtro c h a n te r ic  osteotom y, a r th ro d e s is , 
fem oral head  rep lacem en t a r th ro p la s ty  
and  total h ip  rep lacem ent a r th ro p la s ty  and 
give th e ir  follow -up resu lts .
The book contains 22 p ap ers  w ith  an 
excellent b ib liography . I t  is h ig h ly  re ­
commended fo r all m edical lib ra r ie s , o r­
thopedic surgeons, rad io lo g is ts , pa th o lo ­
g is ts , p a rticu la rly  to  g ra d u a te  s tu d e n ts  in
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f o r  c lin ic a l 
a p p lic a t io n s
• Designed for clinical O.R. 
or cath lab use
• Easily applied handle- 
type probe
• Patient safety assured 
through isolation circuitry
• Simple to operate - 
minimum controls - direct 
meter readout in milliliters 
per minute
BLI
Biotronex Laboratory has eliminated 
the guesswork in evaluating the effective­
ness of an aorto coronary vein bypass.
The BL-603 Clinical Blood Flowmeter 
provides a simple, yet effective method 
of determining graft patency prior to 
surgical closure.
The BL-603 is not a new instrument; 
it is simply an extension o f a device 
which has been thoroughly proven in 
hundreds of research applications 
throughout the world. It  is depend­
able; designed to highest safety 
standards; simple in operation; precise 
in measurement - a complement to 
modern day cardio-vascular surgery.
Biotronex Laboratory, Inc.
9153 Brookville Road Silver Spring, Maryland 20910 Phone: 301/588-6400
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these fields, and those involved in re­
search work on the subject.
For the information it provides, this 
publication seems well worth the price.
F. P. Patterson
University of British Columbia,
Vancouver, B.C.
LEHRBUCH DER KINDERUROLOGIE.
Alfred Sigel. 425 pp. Illust. Intercon­
tinental Medical Book Corp., New York;
Georg Thieme Verlag, Stuttgart, 1971.
DM 98,00. $31.00 (approx.).
This book, which is based on the ex­
periences of the University Clinics in Er­
langen, covers the whole field of pediatric 
urology. It deals with symptomatology and 
investigations, physiology of urine forma­
tion, renal disease, pathology of the lower 
urinary tracts and of the genitalia, and 
gives detailed descriptions of malforma­
tions and tumours. Special chapters are 
devoted to the radiologic examination in­
cluding angiography of the kidney and to 
the use of radioactive isotopes in pediatric 
urologic examinations. The latter methods 
are new and do not yet yield quantitative 
data when used in children of different 
ages. Specially important is a chapter on 
the biomechanical aspects of urinary flow 
and the measurement of pressure, flow 
and resistance associated with mictui’i- 
tion. Interestingly enough, this chapter is 
co-authored by a pediatric cardiologist 
and it is most refreshing to see the success 
of this type of multidisciplinary co-oper­
ation. The chapter devoted to urinary 
retention aptly entitled “Disturbances of 
Urinary Transport Mechanisms” is especi­
ally well documented. This book can be re­
commended to the specialist in urology 
and nephrology and others with a special 
interest in pediatric urology.
W. Zingg
The Hospital for Sick Children,
Toronto Ont.
MANAGEMENT OF ARTERIAL OCCLU­
SIVE DISEASE. Edited by W. Andrew 
Dale. 506 pp. Illust. Year Book Medical 
Publishers, Inc., Chicago, 1971. $25.00.
This book consists of 28 chapters based 
upon papers and discussions presented at 
a conference sponsored by the Vanderbilt 
University School of Medicine, St. Tho­
mas Hospital, Baptist Hospital and John­
son & Johnson, held in Nashville, Tenn., 
in 1970. Each chapter is written by a re­
cognized authority and includes the sub­
sequent discussion.
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This book covers all aspects of the man­
agement of vascular disease with chapters 
on diet, physiology, methods of angiogra­
phy, and medical management. It compares 
the long-term results of vein grafts, pros- 
theses and endarterectomies. There is a 
section on modified bovine grafts and a 
chapter on surface changes in prostheses. 
There are chapters on renovascular hyper­
tension, modern treatment of arterial 
emboli, distal arterial disease, cerebral 
and coronary arterial disease. The ma­
terial is up to date and based on wide ex­
perience. This book should interest sur­
geons performing vascular surgery and 
physicians with a wide interest in vascular 
disease. The format is attractive. There 
are excellent references, the illustrations 
are clear and of good quality. Many angio­
grams and diagrams are used to illustrate 
the text.
This texbook is recommended for sur­
geons and physicians with particular in­
terest in vascular disease. It is probably 
too detailed for student use.
MANUAL OF PREOPERATIVE AND  
POSTOPERATIVE CARE. 2nd ed. Com­
mittee on Pre and Postoperative Care, 
American College of Surgeons. Editorial 
Subcommittee: J. M. Kinney, R. H. Eg- 
dahl and G. D. Zuidema. 644 pp. Illust. 
W. B. Saunders Company, Philadelphia; 
W. B. Saunders Company Canada Lim­
ited, Toronto, 1971. $11.35.
This fine manual was prepared for the 
Committee of Pre and Postoperative Care 
of the American College o f Surgeons by 
distinguished teachers from Departments 
of Surgery throughout the U.S.A. and Can­
ada. The text itself is, in effect, an out­
growth of the excellent courses in this 
field of surgical management offered an­
nually at the Clinical Congress of the 
American College of Surgeons.
As stated at the outset, the manual 
provides practising surgeons and residents 
with a ready reference to current advances 
in management and describes specific 
problems encountered (or preferably to 
be avoided) in the care of patients under­
going operation.
In large measure, the goal has been 
achieved. Most chapters are well planned, 
lucid and readable and offer the clinical 
surgeon sound practical points in pre- 
and postoperative care. Most o f the 
chapters in the section “ General Prin­
ciples” offer enough to stimulate the 
academic surgeon without being so erudite
thlc..
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VlafleK0IV/y/tem
Drop it. Squeeze it for pressure 
infusion. A VIAFLEX container will 
not break crack or chip in normal use.
About 70% of all IV solutions have 
at least one, and sometimes two drug 
additives.* Drop a glass bottle and 
you lose the cost of the solution 
PLUS the cost of expensive drugs 
PLUS the cost of clean-up time, not 
to mention the loss of times 
because of the interruption.
You might say VIAFLEX is a real 
smash-less success. If you’re fed up 
with the headaches of glass bottles, 
try VIAFLEX. ^
-As with all parenterals, compatibilities f l B  
should be checker* when additives 
are used.
. L  BAXTER LABORATORIES O F  C A N ADA S H
V DIVISION Of TRAVINOl lAtOMATOmf S. INC 
—^  — \  6405 Northern Drive. Matt on. Ontario
Viaflex
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FROM P r o f e s s i o n a l
LOW FRICTION ARTHROPLASTY
Protasul
total hip 
prostheses
As designed and used by 
Prof. Maurice E. Muller
Professor of Orthopaedic Surgery, 
University of Berne,
Berne, Switzerland
•  Low-friction articulation
•  Wear-proof stem prosthesis
• Durable acetabulum unit
•  32mm head reduces pressure 
and wear on acetabulum unit
>
Choice of sizes to meet all needs
No. 1.32.21-Standard stem, medium neck 
(illustrated)
No. 1.32.31—Standard stem, long neck 
No. 1.32.41—Narrow curved stem, short neck 
No. 1.32.61—Straight stem, short neck
For special requirements—stainless steel prostheses 
with longer necks, longer stems, and replacement 
proximal third of femur. Available from stock.
• Eliminates need to remove 
greater trochanter
•  Designed for easy insertion
• Eliminates need for expensive 
inserting instruments
Literature Available
1. Reprint “ Total Hip Prostheses” , 
by Prof. M. E. Muller. As published
in volume 72 of Clinical Orthopaedics 
and Related Research
2. Complete catalogue of prostheses 
and instrumentation
3. Price list of prostheses and 
instrumentation
4. Colour sound film available:
Total hip replacement technique 
by Prof. M. E. Muller
CMW Bone Cement
The brand of cement 
currently used by 
both Muller and 
Charnley.
Highly purified to 
reduce allergenicity. 
Kit includes sterile 
powder, liquid and 
optional radiopaque 
material.
I I .  B O N E  mm H I D E S
C O N T E R T S  O F  T H IS  P A C K  A R E  S T E R IL E
S T S M I t Y  IS M A IN fA iH tO  BY
mmmimoi vapoub m m  m  pack
*o« t w .  f « «  *** *rt*c**o
Muller
Available for immediate delivery from stock
fjProfessional Orthopaedic (Supplies Jdunited
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(416) 625-3381
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Vancouver, B.C. 
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as to “scare off” the surgeon working in 
a community hospital. Certainly none of 
us can now afford to be without a reason­
able understanding of “The Metabolic 
Sequence After Injury” and “ The Patient 
in Shock” .
However, in some sections not enough 
space is given to the specific postoperative 
complications nor are they studied in 
sufficient depth. True, this is not a book 
about surgical complications but opera­
tions often go wrong and fortunate is the 
operator who is wise enough to take 
preventive measures, and can recognize 
and deal with the complications that 
develop.
A large number of appropriate reference 
articles are listed at the end of each 
chapter.
In summary, this text, placed in the 
hands of the practising surgeon and resi­
dent in training, will be a valuable asset. 
It will equip them with the knowledge and 
skills required in the management of the 
surgical patient before and after opera­
tion.
SPINAL DYSRAPHISM. Spina Bifida Oc­
culta. C. C. Michael James and L. P.
Lassman. 144 pp. Illust. Butterworth & 
Co. (Canada) Ltd., Toronto; Butter- 
worth & Co. (Publishers) Ltd., London, 
1972. $16.95.
This concisely written monograph of 136 
pages deals clearly and thoroughly with 
spinal disraphism and spina bifida oc­
culta. A copy of this monograph should 
be in the library of every teaching ortho­
pedic department for the use of teaching 
fellows and residents. All orthopedic sur­
geons and neurosurgeons who are in­
terested in this subject should have a copy 
on their shelves.
The illustrations are numerous and re­
markable for their clarity. A number in 
colour are of particularly high quality. 
The book is divided into two parts. The 
first deals with general considerations 
and has an introductory chapter followed 
by chapters on embryology and pathology, 
morbid anatomy research, syndromes and 
clinical presentation, radiology, diagnosis 
and treatment, anesthesia, principles of 
surgery and postoperative care and com­
plications.
Part two consists of an analysis of 100 
cases. It begins with a chapter “ The 
Reasons for Operation and Surgical Find­
ings” which is followed by four chapters
Tandearil
oxyphenbutazone FUII information is available
on request
G-2325-71
Geigy Pharmaceuticals
Montreal 308, P.Q.
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on operative findings. The first discusses 
diastematomyelia. The second deals with 
dermoid cysts. The third deals with trac­
tion lesions, simple traction by bands, 
tight filum terminale, lipoma in filum 
terminale, dermal sinus and coccygeal 
cyst. The last discusses meningocele man­
que. Following this are chapters on the 
cutaneous abnormalities seen on the back, 
the problem of incontinence, congenital 
foot abnormalities, problems in adults and 
the results obtained after laminectomy.
It is a pleasure to review a book written 
with such clarity and illustrated with such 
excellence.
W. H. Kirkaldy-W illis
University of Saskatchewan,
Saskatoon, Sask.
THE STRUCTURE AND SUPPORT OF 
CONTEMPORARY RESIDENCY PRO­
GRAMS IN SURGERY. Transactions of 
the 13th Annual Meeting of the Allen O. 
Whipple Surgical Society. Edited by 
Harold G. Barker. 290 pp. Charles C 
Thomas, Publisher, Springfield, 111.; 
McGraw-Hill Company of Canada, To­
ronto, 1971. $15.00.
This book reports the transactions of the 
13th Annual Meeting of the Allen 0. 
Whipple Surgical Society. In its introduc­
tion Dr. Barker, the editor, discusses the 
changes that occur in a society that is 
attempting to modify the traditional 
health-care delivery system. In part, he 
says “These trends threaten not only the 
way of life of the established physician, 
many of whom settled into a system 
which they believe permits them to serve 
their patients in an efficient and ef­
fective way, but also the entire educa­
tional process producing the physician 
and the specialist of the future. . .”
The book describes these problems by 
presenting a series of papers by distin­
guished surgical educators and one in­
terested non-surgeon from the newspaper 
system. A review by Dr. Dunphy of the 
Halsted Residency System with its con­
cepts of progressive responsibility is 
anecdotal, delightful and worthy of read­
ing. In his chapter, Dr. Varco has dis­
tilled out those educational elements that 
are crucial to the system; he carefully 
discusses the three options of private 
practice: preceptorial training with its
abrupt transition to total personal re­
sponsibility, the long competitive pro­
gram leading to operative experience on 
the indigent patient, and a third method 
which stratifies the assumption of ultim­
ate responsibility by working with 
qualified staff men and finally the grant­
ing of virtual total responsibility without
intellectual disregard of the superior 
supervisory staff. He relates the resi­
dency program to what he calls “the 
intellectual environment of reason which 
can be easily polluted by ridicule, in­
tolerance and affected omniscience” .
There is considerable discussion about 
the fiscal policies of Medicare, its guide­
lines and its ability to permit areas of 
responsibility for patient care which 
overlap with education. The issues are 
well stated, and, although Canadian 
Medicare has somewhat different guide­
lines, the issue of resident reimbursement 
is just as controversial in Canada as it 
is in the United States. Sources for sup­
port for residents are easier to identify 
in Canada with its comprehensive medi­
cal care program than in the United 
States where only small segments of the 
population are covered and resident 
reimbursement becomes clouded by many 
service and qualifying issues. There is 
frank discussion of the problems of 
residency education on an insured popu­
lation cared for by the fee-for-service 
payment system with its implicit judg­
ment that care by a physician not re­
ceiving the fee constitutes the imposi­
tion of a double standard of care and a 
dual payment for the service. These 
issues are well worth reading, although 
the reviewer believes they are temporary 
issues and will shortly be resolved by the 
universities, the training systems and the 
several provincial governments in Can­
ada.
The intellectual activity of the 1985 
surgeon is well described in the relation­
ships of surgery and surgeons to other 
elements of the university. Attempts to 
move the surgeon from his own sphere 
of surgical activity become an important 
part in creating the intellectual environ­
ment of reason. A discussion by three 
residents is pragmatic and practical.
It does not deal with the theory of 
education or the philosophy of education, 
but on the whole the book is a pot-pourri 
of ideas and discussions. It ranges widely, 
but scattered throughout the volume are 
pearls of wisdom which bear on education 
as seen from the surgeon’s viewpoint.
C. B. Mueller
McMaster University,
Hamilton, Ont.
SURGERY AND THE ALLERGIC PA­
TIENT. Edited by Claude A. Frazier.
191 pp. Illust. Charles C Thomas, Pub­
lisher, Springfield, 111.; McGraw-Hill
Company of Canada, Toronto, 1971.
$15.00.
This book is a complete description of
J u ly  1972 33
allerg ic phenomena to which the  surgeon will be exposed. Divided into 11 chap ters, it deals w ith anaphylaxis, m anagem ent of th e  allerg ic ad u lt and child, and the  pre- su rg ica l evaluation necessary fo r both these types of patien ts. There are  also two chapters on surgical trea tm en t of asthm a, and these presen t some h is to rica l in terest. The book also deals w ith drug  reactions, con tact derm atitis, the re la tion  of allergy to ear, nose and th ro a t surgery , and finally  a chapter giving a sum m ary of developments in organ tran sp lan t su r ­gery. This book gives a complete descrip ­tion  of precautions to take in a lle rg ic  persons as well as in the general popu la­tion. I t  gives detailed m anagem ent of allerg ic m anifestations of all kinds. I t  tends to be repetitious because d iffe ren t chap ters  have been w ritten  by d iffe ren t au th o rs ; hence the medical m anagem ent of allerg ic conditions is repeated. The surgeon will find  in teresting  the l i s t  of drugs, dyes and antiseptic solutions used commonly and th e ir tendency to cause sensi­tization. The chapter on ear, nose and th ro a t su rgery  will have more in terest fo r a surgeon specialized in th is field . The chap ter on organ tran sp lan ta tio n  is succinct and clear and will give good in ­form ation for those not directly involved in th is  field.In sum m ary, th is  book is easy to read  and gives many guidelines to the  m an­agem ent of allerg ic patien ts which are im portan t to good surgical care.
PADIATRISCHER EKG-ATLAS. 2nd ed.Joachim Stoermer and Wilhelm Heck.316 pp. Illust. Intercontinental MedicalBook Corp., New York; Georg ThiemeVerlag, Stuttgart, 1971. DM 130,00.$41.00 (approx.).
The electrocardiogram  is a most im por­ta n t tool for the ped ia tric  cardio logist, yet few  w ell-illustrated  books are devoted to th e  subject.
In  th is  unique “a tla s” from Germ any the  au thors convey the essence of th e ir  experience w ith a  large w ell-studied pa­tien t population. A sho rt in troduction de­scribes the pecu liarities of the e lec tro ­cardiogram  in in fancy and childhood and ou tlines the vectorial approach. Most im­po rtan t, th is f irs t  p a r t contains a series of tab les of normal values (intervals and vo ltages of the various ECG events) in e ight age groups including prem atures, based on 150 normal electrocardiogram s for each group.The second more extensive p a r t is a display of technically  perfect recordings of sim ultaneous six-lead ECG’s. I t shows
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representative examples of most congeni­tal abnormalities, followed by tracings in rheumatic heart disease and rheumatic fever, cardiac tumours and metabolic alterations.These figures have extensive legends that contain much clinical and hemody­namic data on individual patients—infor­mation which is often redundant and sometimes irrelevant. However, these de­scriptions contain many useful comments about characteristic features and hints for pattern recognition. An attempt is made also to correlate the ECG with the hemodynamic data. The authors compare their experience with data from the lite­rature, referring to an extensive interna­tional bibliography.A good index at the end allows easy retrieval of information.The book is written in German and will not be followed easily by the English or French physician without a knowledge of the German language, but an atlas with so many excellent illustrations and tables should nevertheless be useful to the North American pediatric cardiologist. The cost­ly paper and the many illustrations make ' it rather expensive.
B. F riedli
The Hospital fo r Sick Children,Toronto, Ont.
SEVEN TH ANNUAL 
IN STRU C TIO N A L COURSE
ACUTE INJURIES OF THE HAND
September 14 ond 15, 1972
T H U R S D A Y , SEPTEMBER 14:
Case p rese n ta tio n s , O pe ra tin g  Session and 
S ym pos ium , V ic to r ia  H osp ita l, London. 
F R ID A Y , SEPTEM BER 15:
Lectures a n d  G roup Discussions.
1. In fe c tio n s
2. F in g e r t ip  In ju ries
3. A m p u ta tio n s
4. F ra c tu re s  and D is loca tions
5. M a n a g e m e n t o f Skin Loss
6. E xtenso r Tendon In ju ry
7. F le xo r Tendon  In ju ry
8. N e rve  In ju ry
Presented b y  th e  D epa rtm e n t o f Surgery, The 
U n iv e rs ity  o f  W e s te rn  O n ta rio , in  coopera tion  
w ith  th e  W o rk m e n 's  C om pensation Board o f 
O n ta rio , Endorsed by the C om m ittee  on Educa­
tio n  o f the  A m e r ic a n  Society fo r  S urgery o f the  
H and .
For  f u r t h e r  i n f o r m a t i o n ,  p le a s e  w r i t e  to :
A. T. Hunter, M.D.,
Assistant to the Dean - Continuing Education, 
Faculty of Medicine,
THE UNIVERSITY OF WESTERN ONTARIO, 
London 72, Ontario.
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A rtificial Organs and Cardiopulmonary Sup­port Systems. Edited by Felix T. Rapaport and John P. Merrill. 186 pp. Illust. Grune & Stratton, Inc., New York; Longman Can­ada Limited, Toronto, 1971, 1972. $17.25.
Care of the Critically 111 Child. R. S. Jones and J . B. Owen-Thomas. 323 pp. Illust. Edward Arnold (Publishers) Ltd., London; The Macmillan Company of Canada Lim­ited, Toronto, 1971. $21.75.
The Care of Minor Hand Injuries. 3rd ed. A drian E. F la tt. 293 pp. Illust. The C.V. Mosby Company, St. Louis, 1972. $22.60.
Clinical Cardiac Roentgen Diagnosis. Alphons Jacob. 309 pp. Illust. W arren H. Green, Inc., St. Louis, 1972. $19.50.
Conduite Therapeutique d’Urgence chez les Polytraum atises. A. Trillat and A. Patel. 118 pp. Illust. Masson & Cie, Editeurs and Expansion Scientifique Frangaise, Paris,1971. 28 F. $5.45 (approx.). Paperbound.
La Diverticulose Colique. J. Bertrand. 74 pp. Illust. Expansion Scientifique Frangaise, P a­ris, 1972. 33 F. $6.40 (approx.). Paperbound.
Modern Trends in Orthopaedics — 6. Edited by A. Graham Apley. 273 pp. Illust. Butter- w orth & Co. (Publishers) Ltd., London; B utterw orth & Co. (Canada) Ltd., Toronto,1972. $28.90.
Nouveau T raite  de Technique Chirurgicale.Jean  Patel and Lucien Leger. Tome I. Tete et Cou. H. Redon. 508 pp. Illust. Masson & Cie, Editeurs, Paris, 1972. 162 F. $31.40 (approx.).
La Rectocolite Ulcero-Hemorragique et Puru- lente. B. Hillemand. 98 pp. Illust, Expansion Scientifique Frangaise, Paris, 1971. 35 F. $6.80 (approx.). Paperbound.
Resistance to Traum a. Zdenek Hruza. 97 pp. Hlust. Charles C Thomas, Publisher, Spring- field, 111.; McGraw-Hill Company of Canada, Toronto, 1972. $8.00.
Transplantation Reviews. 7. Immunological Surveillance A gainst Neoplasia. Edited by Goran Moller. 178 pp. Illust. M unksgaard, Copenhagen, 1971. Dan. Kr. 92,00. $13.25 (approx.). Paperbound.
Transplantation Reviews. 8. Immunological Tolerance. E ffect of Antigen on D ifferent Cell Populations. Edited by Goran Moller. 136 pp. Illust. Munksgaard, Copenhagen, 1972. Dan. Kr. 74.75. $10.75 (approx.). Paperbound.
Les Tumeurs Carcinoldes du Tube Digestif.P. Jouanneau and M. Malafosse. 193 pp. Illust. Masson & Cie, Editeurs and Expan­sion Scientifique Frangaise, Paris, 1971. 45 F. $8.75 (approx.). Paperbound.
